University of South Carolina

Scholar Commons
Theses and Dissertations
12-14-2015

Approaching Aromatic Interactions with Small Molecule Model
Systems: Assessing N-Heteroarene in ∏ -Stacking and CH-∏
CHInteractions, Crystal Engineering of Atropisomeric Rotors, and
Developing Responsive Organic Charge-Transfer Complex
Ping Li
University of South Carolina - Columbia

Follow this and additional works at: https://scholarcommons.sc.edu/etd
Part of the Chemistry Commons

Recommended Citation
Li, P.(2015). Approaching Aromatic Interactions with Small Molecule Model Systems: Assessing NHeteroarene in ∏ -Stacking and CH-∏ Interactions, Crystal Engineering of Atropisomeric Rotors, and
Developing Responsive Organic Charge-Transfer Complex. (Doctoral dissertation). Retrieved from
https://scholarcommons.sc.edu/etd/3233

This Open Access Dissertation is brought to you by Scholar Commons. It has been accepted for inclusion in
Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please
contact digres@mailbox.sc.edu.

APPROACHING AROMATIC INTERACTIONS WITH SMALL MOLECULE MODEL
SYSTEMS: ASSESSING N-HETEROARENE IN Π-STACKING AND CH-Π
INTERACTIONS, CRYSTAL ENGINEERING OF ATROPISOMERIC ROTORS, AND
DEVELOPING RESPONSIVE ORGANIC CHARGE-TRANSFER COMPLEX
Ping Li
Bachelor of Science
East China University of Science and Technology, 2006

Submitted in Partial Fulfillment of the Requirements
For the Degree of Doctor of Philosophy in
Chemistry
College of Arts and Sciences
University of South Carolina
2015
Accepted by:
Ken D. Shimizu, Major Professor
Linda S. Shimizu, Committee Member
Daniel L. Reger, Committee Member
Andreas Heyden, Committee Member
Lacy Ford, Senior Vice Provost and Dean of Graduate Studies

© Copyright by Ping Li, 2015
All Rights Reserved.

ii

DEDICATION
To my dad, Zhongyuan Li

iii

ACKNOWLEDGEMENTS
First and foremost, I would like to thank my advisor Dr. Ken D. Shimizu for his
years of guidance and support. I am truly grateful not only for the knowledge and skills he
passed on to me but, more importantly, the habit of thinking critically and the rigorous and
meticulous professionalism. All of these will surely benefit my career and life in future.
Next, I would like express me wholehearted appreciation to the Shimizu group members,
both current and former. Without the help and encouragements from theirs, I perhaps could
not have accomplished even half what I have now. I am also so honored to meet and work
with a highly talented group of fellow students, postdoc researchers, faculty, and staffs at
the chemistry department. I shall give special thanks to our personnel at the NMR, X-ray
crystallography, and MS facilities for their kind and patient help on various research
problems.
At last, I would like express my deepest gratitude to my dad, Zhongyuan Li, my
cousin Amanda Ling, my mentor Dr. Wei Wang, my best buddies Xinyue Wei and Zimu
Liu, and countless friends who have helped and supported me along the way. My pursuit
in chemistry took some unexpected turns at the beginning. Without their caring and help,
I would have never come out that miserable period of life. I owe this dissertation to them
much more than to myself. In the end, I want to close with a dedication to my dad: “Dad,
thank you for being so supportive over these years! I hope what I have accomplished make
you proud. I love you!”

iv

ABSTRACT
Non-covalent interactions involving aromatic species are important in many areas
in chemistry, biochemistry, and materials sciences. During the past two decades, small
molecule model systems have emerged as a powerful tool to advance our knowledge of the
stability trends for aromatic interactions in the condensed phase. Among these, the Cshape N-arylimide molecular balances developed by our laboratory have proven to be one
most successful and versatile model systems that can be readily adapted to investigate
various types of aromatic interactions. These molecular balances are particularly apt at
isolating and accurately measuring the targeted weak aromatic interaction energies for
different geometries. In this dissertation, our experimental efforts in utilizing the Narylimide molecular balance to examine the impacts of nitrogen-containing aromatic
surfaces (N-heteroarenes) on π-stacking and CH-π interactions are detailed. Polar Nheteroarenes displayed pronounced electrostatic character in these interactions which
influenced both their stability trends and geometric preferences. Introducing a formal
positive charge at the heterocyclic nitrogen greatly enhanced these electrostatic effects.
Next, this versatile molecular model system was applied to the study of the relationship
between the solution and solid-state conformational preferences for rapid interconverting
conformers. Close examination of a library of atropisomeric O-tolyl succinimide rotors
revealed that the solution conformational preferences were generally excellent predictors
of the conformational preferences in crystal structures. Interestingly, the correlation
function between the solid-state and solution mole fraction of syn- conformer (χsyn) were
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not linear but fit to a step-function trend where the solid-state χsyn was either 0 or 1 for most
rotors except for those with a solution χsyn of 0.50 ± 0.06. Finally, we examined the
behavior of a dynamic intramolecular aromatic stacking donor-acceptor-donor complex.
This system displayed interesting reversible color changes in the solid-state when treated
with different organic solvents. The unique responsive behavior was attributed to solventinduced changes in the intramolecular stacking geometry of the D-A-D complex.
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CHAPTER 1
MOLECULAR BALANCES AND THEIR APPLICATIONS IN EXPERIMENTAL
STUDIES OF NON-COVALENT AROMATIC INTERACTIONSi

i

Shimizu, K. D.; Li, P.; Hwang, J.; Maier, J. M. To be submitted to Acc. Chem. Res.
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1. Introduction
In this account, we briefly described our efforts to provide a refined experimental
knowledge of aromatic interactions, such π-stacking,1-4 heterocycle-π,5 cation-π,5 CH-π,6-9
and Ag-π interactions,10 through the developments and analyses of small molecular
balances. These non-covalent interactions of aromatic species have been found of great
importance in modern chemistry and biology and materials science.11-14 However, the
weak nature (usually several kilocalories per mole) of these aromatic interactions together
with their high sensitivity to changes in the interaction geometry, participant structure, and
solvent environments renders them rather elusive to experimental quantitative assessments.
One successful strategy for experimentally analyzing aromatic interactions is to develop
and analyze small molecular balances, a class of synthetic unimolecular model systems.15
These molecular balances often feature one or more easily trackable conformational events
that were craftily associated with the forming and breaking of one or more intramolecular
aromatic interactions of interest. Energy information of the aromatic interactions under
study thus could be easily accessed via conformational analyses of corresponding
molecular models. The strategy allows researchers to bypass the problematic entropic
penalty associated with intermolecular processes when assessing weak non-covalent
interactions. Moreover, the deliberately designed molecular models often provide a means
to control and interrogate the aromatic interaction geometry under study. Such character
is of crucial importance to quantitative assessments of weak aromatic interactions whose
geometric dependence matters but is hard to capture (vide infra)In the following sections,
we summarized our contribution of developing molecular balances to experimentally study
various aromatic interactions in solutions (Figure 1.1).
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Figure 1.1 Schematic demonstration of the versatile Narylimide molecular balance model system developed to
quantitatively assess various aromatic interactions of
different strengths in solution.

2. Molecular balances for studying aromatic π-stacking interactions
2.1 First generation N,N'-diphenyl naphthalenediimide molecular balances
Our journey of developing molecular balances started serendipitously from an
unsuccessful attempt to develop pyrene-based fluorescent molecular switches.1

We

synthesized an atropisomeric N,N’-diphenyl naphthalenediimde compound (1) in which
two pyrene fluorophores could be held at distinctly different distances in the syn- and anticonformers (Figure 1.2A). While we failed to observe any associated change in the
emission properties, we were surprised and puzzled by a significantly imbalance in the
equilibrium syn-/anti- ratio favoring the anti-conformer (20:80). A clue later surfaced from
the X-ray crystal structure of anti-conformer of 1 where the two pyrene arms each formed
an intramolecular stacking interaction on both sides of NDI core (Figure 1.2C). The
formation of two such interactions obviously was not possible in the syn-conformer as the
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NDI core could only accommodate one pyrene unit to form intramolecular π-stacking
interaction per face. The skewed syn-/anti- ratio thus might reflect the net stabilizing
aromatic stacking interaction in the anti-conformer. This was indeed the case! As we
strategically varied the arm arene to biphenyl, naphthalene, and eventually benzene, the
syn-anti equilibrium energy gradually shrunk. This stability trend consisted with the
expected weakening of aromatic stacking interaction due to the reduced size and
polarizability of participant arene (Figure 1.2B).

To our fascination, these simple

atropisomeric molecules, much resembling the renowned Wilcox torsional balances,16
demonstrated an excellent ability in accurately quantifying weak non-covalent aromatic
interactions in solution. For example, a change in equilibrium ratio of 50/50 to 45/55
corresponds to a change in equilibrium energy as small as 0.12 kcal/mol. However, we
also realized there were some drawbacks with these first generation balances. First, these
model did not provide rigorous control over the aromatic interaction geometry as the
alternative edge-to-face interaction mode could also occur in certain cases. Second,
structural diversity was rather limited with these first generation balances as one aromatic
surface, the NDI core, had to be fixed as part of the framework. Lastly, the excessively
high rotational barrier (~27 kcal/mol) in the N-arylimide rotor resulted in a slow
equilibration process that would require elevated temperatures to accomplish (10 h at 80
°C), limiting their applications in exploring aromatic interaction at rt.
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Figure 1.2 (A) ChemDraw representation of the syn-anti
conformational equilibrium for our first generation molecular balance
1, highlighting the formation of different number of intramolecular
aromatic π-stacking interactions in the syn and anti-conformers; (B)
The plot of measured equilibrium energies (ΔG’s in TCE) of our
generation balances versus calculated polarizability of the arm arenes
(B3LYP, 6-31G*), highlighting the systematic change in ΔG as the
arm arene varied; (C) Partial side-view of X-ray crystal structure of
anti-1, highlighting the formation of two intramolecular aromatic πstacking interactions.

2.2 Second generation bicyclic C-shape N-arylimide molecular balances.
We then developed our second generation molecular balances for quantitatively
assessing aromatic stacking interactions. These molecular balances were built on a rigid
C-shape bicyclic framework with an asymmetrically fused N-arylsuccinimide rotor (Figure
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1.3A).2 Two aromatic surfaces of interest could be incorporated respectively into the ortho
substituent in the N-aryl rotor, referred to as the “arm”, and the base region of the C-shape
bicyclic framework, referred to as the “shelf”. Rotation around the Caryl-Nimide single bond
led to distinct folded and unfolded atropisomers in which the arm arene was positioned
differently toward the aromatic shelf. In the folded conformer, the two surfaces were held
close to each other forming an intramolecular aromatic stacking interaction.

More

importantly, owing to the rigid molecular framework, the arm and shelf aromatic surfaces
were forced to adopt exclusively the face-to-face off-set stacking geometry upon
interaction. Such excellent control over interaction geometry was predicted by simple
molecular modeling and later on confirmed by X-ray crystal structure (vide infra). In the
unfolded conformer, in contrast, the arm and shelf were held far apart and the
intramolecular aromatic interaction was broken. The folded/unfolded ratios of these
molecular balances therefore provided an accurate measure for the strength of the
corresponding intramolecular aromatic π-stacking interactions in solution. Restricted
rotation of the N-arylimide rotor caused the two conformers to undergo slow exchange in
solution at rt giving distinct sets of peaks in 1H NMR spectrum. The folded/unfolded ratios
thus were easily and accurately (less 5.1% error) obtained through comparing integration
of the corresponding peaks in 1H NMR spectra (Figure 3B). Unlike with their N,N’diphenyl naphthalenediimde predecessors, the moderate rotational barrier (~21 kcal/mol)
in atropisomerization of these π-stacking balances allowed the folded-unfolded equilibrium
to be reached in 30 min (~10 half-lives) at rt in solution.
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Figure 1.3 (A) ChemDraw representation of the foldedunfolded equilibrium of π-stacking balance 2, highlighting the
formation of intramolecular aromatic stacking interaction as
well as the oxygen-pi repulsion in the folded conformer; (B)
The region for quantifying folded/unfolded ratio of 2 in the 1H
NMR spectrum (in chloroform).
Formation of intramolecular aromatic stacking interactions in these second
generation π-stacking balances was confirmed both in solution by 1H NMR and in the solidstate through X-ray crystallography. First, distinct anisotropic effects were observed for
the protons on the aromatic arm and shelf in the folded conformer in 1H NMR spectra,
suggesting the formation of aromatic stacking interaction in solution. In the folded 2, for
instance, clear upfield shifts were observed for the protons at the ortho positions on the
arm phenyl group (Δδ up to -0.6 ppm) and the central bay region on the phenanthrene shelf
(Δδ up to at least -1.2 ppm) due to the shielding effect upon assuming the face-to-face
aromatic stacking geometry. However, the presence of multiple aromatic motifs in these
7

molecules complicated the further conformational analyses in solution. Fortunately, these
second generation molecular balances readily crystallized in the solid-state, providing an
easy access to their X-ray crystal structures to study the intramolecular aromatic stacking
interactions formed therein.

To ensure one arm arene always stayed in the folded

conformation with the shelf arene in the crystallization process, “two-armed” balance
analogues in which two identical aromatic arms are attached to both ortho-positions in the
N-phenyl rotor were often invoked (Figure 1.4). These two-armed balances otherwise
inherited all the structural properties of their one-armed relatives and thus served as an
ideal surrogate in X-ray crystallographic studies. As expected, the intramolecular aromatic
offset stacking interaction was unequivocally observed in the folded conformational region
in the resolved crystal structures of these molecular balances. For example, the folded arm
benzene ring in 2' stacked on top of one outer benzene ring on the shelf; the two aromatic
rings adopted an approximate parallel geometry (with the dihedral angle of 7.8°) and the
vertical (centroid-to-plane) distance of 3.75 Å. Moreover, the top benzene ring was
positioned to extend beyond the bottom shelf benzene ring with a horizontal off-set of 0.82
Å. This unique geometric constraint clearly differentiated the ortho-, meta-, and parapositions on the arm benzene ring upon forming π-stacking interaction, laying the
foundation for many later investigations (vide infra).
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Figure 1.4 Partial side- and top-views of the X-ray crystal
structure of the “two-arm” balance 2’ (left) together with their
ChemDraw representations (right), highlighting the
formation of a well-defined intramolecular aromatic off-set
stacking interaction. The bridgehead phenyl groups are
omitted for visual clarity.

2.3 Quantitative measurements of aromatic π-stacking interactions in solution
We then moved on to assess the strength of aromatic π-stacking interactions using
our second generation π-stacking molecular balances. To our surprise, even with such
relative simple molecular model systems as ours, quantifying weak aromatic interactions
under experimental settings was not an easy job due to the inevitable interferences from
secondary interactions and factors. For instance, we were initially rather bewildered that
the folded conformers with stabilizing intramolecular aromatic interactions often existed
as the minor conformers. It was only after we carefully examined two control balances
with smaller benzene (3) and alkene shelves (4) did we realize the problem was caused by
a concurrent repulsive secondary interaction between the linker oxygen and aromatic shelf
in the folded conformers (Figure 1.5).

This repulsive oxygen-pi interaction often
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outweighed the stabilizing aromatic stacking interaction, tipping the conformational
equilibrium to the unfolded conformer side. We became alerted that other secondary
interactions, changes in dipole, and solvophobics might exit and influence the foldedunfolded equilibrium of these seemingly simple model systems (vide infra). Therefore,
single measurements of the folded/unfolded ratio in solution provided little useful even
misleading information regarding the strength of aromatic interactions under study. To
address this problem, we began to invoke appropriate control models to help assess the
aromatic interactions in these second generation balances.

Figure 1.5 Measured folding ratios for our second generation
π-stacking balance (2) and two control balances with smaller
benzene (3) and alkene (4) shelves, highlighting the impact of
secondary repulsive oxygen-pi interaction on the foldedunfolded equilibrium.
When quantitatively analyzing the intramolecular π-stacking interactions, we
utilized the benzene shelf balances as control models to help isolate the impacts of
secondary O-π repulsive interactions as well as other structural effects and solvation
interferences (vide infra) over the folded/unfolded ratios. These benzene control balances
could not form the intramolecular aromatic π-stacking interaction, due to its truncated
10

aromatic shelf, and thus mostly reflected the impacts from secondary interactions and
factors over the folded-unfolded equilibrium. Therefore, the difference in folding energies
(ΔΔG) between the π-stacking and control balances provided a good estimate for the
strength of intramolecular π-stacking interactions in solution. For example, the measured
folding energies (ΔG) in chloroform were found to be 0.48 kcal/mol for the π-stacking
balance 2 and 1.39 kcal/mol for the control balance 3. The intramolecular aromatic
interactions in π-stacking balance 2 were thus estimated to be -0.91 kcal/mol in chloroform.
Admittedly, these benzene shelf balances were not supposed to, and possibly could
not, accurately quantify the O-π repulsion in corresponding π-stacking and CH-π balances.
Instead, these control balances were designate to quantitatively estimate the influences of
linker oxygen, such O-π repulsion, solvent effects (vide infra), possible dipole change, and
other unknown intramolecular force of bias, over the equilibrium folded/unfolded ratios.
For instance, the measured ΔG for π-stacking balance 2 was found to become more
negative as the solvent polarity rises, suggesting the folded former became more stabilized
in polar environment (Figure 1.6). However, this trend was found to rise from the
interaction between the linker oxygen and solvent since the control benzene shelf balance
3 displayed the same ΔG trend. The strength of aromatic π-stacking interactions, which
was estimated as ΔΔG between balances 2 and 3, appeared to stay relatively constant across
these non-polar and polar organic solvents. Such observed solvent trend agreed with the
dispersion dominant nature of aromatic stacking interactions.
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Figure 1.6 Folding energies of π-stacking (red dots) and
control balances (blue dots) and their difference (ΔΔG) used
to estimate the strength of intramolecular aromatic stacking
interaction (black dots).

2.4 Versatile molecular balance system
Another attractive feature of our C-shape bicyclic N-arylimide molecular balances
was their high synthetic versatility. These molecular balances could be readily assembled
via one of the two modular synthetic routes from readily accessible building blocks bearing
the arm and shelf motifs (Figure 1.7). For instance, a Diels-Alder reaction between maleic
anhydride and a cyclic diene bearing the aromatic shelf yielded the endo-bicyclic
anhydride. Next, the thermal imide formation between the anhydride and an aniline
derivative bearing the aromatic arm gave the desired molecular balance. Alternatively, an
N-phenyl maleimide derivative bearing the aromatic arm could be used to react with the
shelf-containing diene in a thermal Diel-Alder reaction to give the C-shape molecular
balance. Both synthetic routes were, simple, robust, and applicable to building blocks with
12

varying functionalities. This high versatility allowed us to stick with one molecular model
system to systematically examine many aspects of aromatic π-stacking interactions in
solution, such as the influences of heteroatom and formal charge, substituent effects, and
dispersion contribution (vide infra), but also investigate other aromatic interactions, such
as CH-π and metal-π interactions (Figure 1.1). Such unifying approach is particularly
valuable in experimentally exploring weak aromatic interactions because it effectively
lowers problematic inter-system bias.

Figure 1.7 Schematic representation of the two modular synthetic
routes to assemble the N-arylimide molecular balances.

4. In-depth experimental studies of aromatic π-stacking interactions
4.1 Impact of N-heterocycles in aromatic π-stacking interactions
Next, we experimentally examined the impacts of presence, positioning, charge,
and substituent effects of heterocyclic nitrogen in aromatic stacking interactions with a
series of heterocyclic π-stacking balances.5 Aromatic N-heterocycles are ubiquitous in
both synthetic and biological systems, and their aromatic interactions are frequently found
vital to various important chemical and physical processes. However, our knowledge on
N-heterocyclic aromatic stacking interactions had been largely relying on theoretical
computations17-19 due to the difficulty in appropriately handling the geometric variables in
N-heterocyclic π-stacking interactions with molecular model systems (vide infra). The
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excellent ability of π-stacking balance 2 to effectively enforce a well-defined
intramolecular off-set π-stacking interaction (Figure 1.4) presented us an opportunity to
solve this problem. Incorporating one or more neutral or charged pyridine unit(s) into the
arm or shelf arene of the N-arylimide balance model provided a series of heterocyclic πstacking balances that formed intramolecular aromatic π-stacking interactions much
resembling those of a neutral or charged pyridine-benzene off-set stacking complex at
various geometries (Figure 1.8A). Their ΔG’s thus offered a measure for the influences of
heterocyclic nitrogen in aromatic stacking interactions in solution. Examination of the
measured ΔG’s for these heterocyclic π-stacking balances revealed that the presence of
nitrogen in aromatic surface in general stabilized the aromatic stacking interaction (Figure
1.8B) possibly due to an enhanced electrostatic interaction.18 For example, introducing a
neutral nitrogen was found to bring an additional stabilization of -0.4 to -0.7 kcal/mol to
the measured ΔG for π-stacking balances 5-7 in comparison to their non-heterocyclic
analogue 2. The stabilizing effect was expected to become even more pronounced when a
positive charge was introduced to the heterocyclic nitrogen.19

Indeed, the cationic

heterocyclic π-stacking balances 8-11 were more stabilizing than their neutral counterparts
by up to -1.4 kcal/mol.
We also experimentally examined the influence of the positioning of nitrogen in Nheterocyclic aromatic stacking interactions. Built upon the same rigid C-shape bicyclic
framework, these heterocyclic π-stacking balances possessed a unique ability to isolate
varying orientations within N-heterocyclic π-stacking interactions. Strategic incorporation
of pyridine units into the arm or shelf arene allowed the N-heterocyclic ring in
intramolecular π-stacking interactions to position its nitrogen far way, referred to as the
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Figure 1.8 (A) Schematic representation of the heterocyclic πstacking molecular balances developed to experimentally examine
the influences of heterocyclic nitrogen in aromatic stacking
interactions; (B) Measured ΔG’s of non-heterocyclic (2) and
heterocyclic π-stacking balances (5-11) in DMSO-d6, highlighting
the impacts of presence, charge, positioning, and substituent of
heterocyclic nitrogen over the strength of aromatic stacking
interactions in solution.
“distal” orientation, or closely approaching, referred to as the "proximal" orientation,
against the opposing aromatic surface as later confirmed by X-ray crystal structures
(Figure 1.9). ΔG analyses revealed clear orientational dependences in the strength of Nheterocyclic π-stacking interactions. For example, the distal orientation was favored (by 0.3 to -0.7 kcal/mol) in neutral heterocyclic π-stacking interactions, while the proximal
orientation was much more preferred (by at least -1.0 kcal/mol) among the charged ones.
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Such observed orientational trend in N-heterocyclic π-stacking interactions reaffirmed the
significant electrostatic nature of these aromatic interactions.17 Besides, good overall
correlations were found between these experimentally measured ΔG’s and literature
benchmark theoretical predictions,17-19 demonstrating the excellent performance of
molecular balances in reporting aromatic stacking interactions.

Figure 1.9 Partial top-views of the folded conformational regions in
the X-ray crystal structures of heterocyclic π-stacking balances 5,
7'(two-armed), and 8-11, highlighting the distinct distal and proximal
orientations of N-heterocyclic ring in aromatic stacking interactions.

4.2 Additive electrostatic substituent effects (ESEs) in aromatic π-stacking
interactions.
Greatly encouraged by the success with N-heterocyclic π-stacking interactions, we
took on another challenge to experimentally probe the additivity (or the lack thereof) in the
electrostatic substituent effects (ESEs).3 Introducing substituents has been one of the most
commonly used methods to modulate the electrostatic nature of aromatic surfaces and thus
their π-stacking strengths. Recent theories had predicted additive ESEs in aromatic
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stacking system with multiple substituents.20,21

In addition, a "direct substituent-pi

interaction theory" had emerged to challenge our conventional perception of aromatic
stacking interactions.22 However, a complimenting experimental investigation was still yet
to be seen, presumably a consequence of the difficulty in experimentally dissecting the
substituent effects in multi-substituent aromatic stacking systems. As demonstrated earlier,
our N-arylimide π-stacking balance system had a unique ability to distinguish the ortho-,
meta-, and para-positions in the arm phenyl group upon forming the intramolecular off-set
π-stacking interactions. Such geometric feature presented an opportunity to experimentally
parse the substituent effects in multi-substituent aromatic systems (Figure 1.10A). Five
substituents (CH3, OCH3, Cl, CN, and NO2) of varying electronic nature in various
substitution patterns (mono-, di-, and tri-substituted) were introduced to the arm phenyl
group to produce a library of 21 substituted π-stacking balances. The strengths of these
substituted aromatic stacking interactions in solution were then quantitatively evaluated in
a similar fashion as before with the aid of corresponding control balances. Additive ESEs
were clearly observed for these substituted aromatic stacking interactions; experimental
ESEs of di- and tri-substituents system could be accurately (within 0.01 to 0.02 kcal/mol)
predicted by adding up the ESEs in mono-substituent systems (Figure 1.10B).
Furthermore, the para- and meta-substituents were found to exert distinctly different ESEs
(Figure 1.10C), suggesting a distance dependence in ESEs. meta-ESEs were consistently
stronger than the para-ESEs, and the energy gap clearly widened as the ESEs increased.
These observations pointed to a distinct electrostatic nature of ESEs in aromatic stacking
interactions, lending an experimental support to the recent direct substituent-pi interaction
theory.23
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Figure 1.10 (A) Schematic representation of the substituted πstacking balances developed to experimentally examine the
electrostatic substituent effects (ESEs) in aromatic stacking
interaction; (B) Correlation between the calculated and measured
ESEs in multi-substituent stacking systems, highlighting the additive
ESEs; (C) Measured ESEs of mono-substituent aromatic stacking
systems, highlighting the distinctly different trends of meta- (blue
dots) and para-ESEs (red dots).

4.3 Dispersion contribution in aromatic π-stacking interactions in solution
Very recently, we further innovated our N-arylimide π-stacking balances and
examined contributions of dispersion forces to the strength of aromatic stacking
interactions in solution (Figure 1.11A).4 Dispersion forces have been deemed as the
dominant source of attraction in aromatic stacking interactions in vacuum or the gas
phase,24-26 whereas their role in solution has been controversial.

Specifically, the

dispersion contributions were proposed to be much weakened in solution27 presumable due
to the competing solvent-solute interactions.28 Assessments of the dispersion contributions
in solution were often complicated by the solvophobic effects (the solvent dispersion
effects),29 which also scale with the size of aromatic surfaces. One strategy to circumvent
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the interference from solvophobic effects was to fix the contact area of aromatic stacking
interactions in analysis. Our N-arylimide balances in turn offered a suitable venue for such
analyses of dispersion contribution (vide infra). The arm aromatic surface was thus
systematically varied in the size and conjugation length (benzene, naphthalene,
phenanthrene, biphenyl, diphenylethene, and diphenylacetylene) to yield a series of
dispersion balances. Like their parent 2, these dispersion balances enforced the welldefined off-set π-stacking geometry regardless the variations in the arm arene and thus
essentially fixed a relative constant area of direct contact across various intramolecular πstacking interactions. Examination of these aromatic stacking interactions involving large
size arenes revealed that increase in size of the aromatic surface did result in increasing
stabilization in solution, but the extent was much smaller than predicted by theory (Figure
11B). For instance, increasing the arene from benzene to naphthalene only increased the
strength of corresponding aromatic interaction by 26% in solution as opposed to a 230%
increase predicted by theory. Extending the conjugation length, like changing from
biphenyl to diphenylethene, brought a destabilizing effect to aromatic stacking interactions,
conflicting the positive correlation with polarizability predicted by theory.

Further

analyses revealed that a large portion (up to 50%) of the apparent stabilizing effects
associated with the arenes of larger size and conjugation might in fact rise from the
corresponding ESE’s. Overall, our results suggested that dispersion contributions in
aromatic stacking interactions were rather weakened in solution, pointing the significant
competing solvent dispersion effects.
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Figure 1.11 (A) Schematic representation of the unfolded-folded
equilibrium of dispersion balances developed to assess the dispersion
contributions to aromatic stacking interactions in solution; (B) Plot
of the estimated aromatic stacking strengths (in CDCl3) versus the
polarizabilities (Spartan 10, B3LYP, 6-31G*) of arm aromatic
surfaces, highlighting the lacking of correlation in-between.

5. Molecular balances for studying aliphatic CH-π interactions
Another important family in aromatic interactions is the ubiquitous weak attractions
between alkyl and arene groups, that is, the aliphatic CH-π interactions.30 These CH-π
interactions had been primarily studied in solid-state crystal structures31,32 and
computational models,33-35 but remained elusive to direct quantitative assessments in
solution due to their weak and non-directional nature. We reckoned that the C-shape
framework of our N-arylimide molecular balances should well accommodate the typical
CH-π interaction geometry (the H-to-C distance cutoff of 3.05 Å),36,37 providing us an
opportunity to study weak CH-π interactions in solution. In this section, we briefly
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described our efforts in developing various CH-π balances to assess the strength, Nheterocycle effects, cooperativity, and deuteratium isotope effects in CH-π interactions in
solution.

5.1 Quantitative measurements of CH-π interactions in solution
Incorporating alkoxyl groups of varying size and shape (OR: R=Me, Et, i-Pr, n-Bu,
and c-Hex) as the arm motif of the C-shape N-arylimide bicyclic platform yielded a series
of CH-π balances for quantitatively studying CH-π interactions in solution (Figure 1.12A).6
The formation of intramolecular CH-π interactions in these balances was confirmed both
in solution by 1H NMR and in the solid-state by X-ray crystal structures. Corresponding
benzene shelf balances were utilized as control models to help isolate the interferences of
the repulsive O-π interaction and solvent dispersion in quantitative analyses of CH-π
interactions. The CH-π interaction between the methoxyl arm and aromatic shelf was
found to be weakly attractive (-0.95 kcal/mol) in solution. Increasing the alkyl group size
from methyl to ethyl, however, only slightly enhanced the CH-π interaction (by -0.15
kcal/mol or 16%) in contrast to the expected nearly two-fold enhancement. Such lowerthan-expected increase in strength was attributed to the additional CH3 group extending
beyond the aromatic shelf and thus unable to form a strong CH-π interaction. This
explanation was supported by the small enthalpic difference between the OEt and OMe
arm CH-π balances (ΔΔH = -0.14 kcal/mol) observed in the van't Hoff analyses (Figure
1.12B). Furthermore, we spotted an increased entropic penalty (-TΔΔS = ~0.6 kcal/mol)
in the folded OEt arm balances, which was likely associated with the loss of rotational
freedom around the C-O bond.38 This unfavorable entropic change might also contribute
in part to the weak CH-π interaction observed in the OEt arm balance. Similar entropic
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penalties were also suspected to occur but to a greater degree in the OR arms with larger
alkyl groups (i-Pr, n-Bu, and c-Hex), which would significantly attenuate the CH-π
interactions. However, these CH-π interactions could not be accurately measured with our
molecular balances due to the folding ratios exceeding the lower limit (1/20) for accurate
quantitative analysis (± 0.03 kcal/mol).

Figure 1.12 (A) Schematic representation for the CH-π and control
balances developed to quantitatively study the CH-π interactions in
solution; (B) Folding enthalpy (ΔH), entropy (-TΔS) and free energy
(ΔG) values for the CH-π and control balances with OMe and OEt
arms.

5.2 Impacts of N-heterocyclic arene in CH-π interactions
We next to investigate the impacts of nitrogen-containing heterocycles (Nheterocycles) in CH-π interactions (Figure 1.13). N-heteroarenes had been found in a
higher percentage of the carbohydrate-aromatic interactions in Nature.39,40 However, Nheteroarenes were not considered to form stronger CH-π interactions than their isosteric
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Figure 1.13 (A) ChemDraw representations of CH-π balances
developed to examine the affinity trend of the OCH3 with Nheterocyclic and non-heterocyclic arenes (top), and partial top-views
of the CH-π interaction regions in the crystal structures of
corresponding two-armed CH-π balance analogues (bottom),
highlighting the dipole alignments between the O-C bond and Nheterocyclic unit; (B) Folding energies (in CD2Cl2) for the Nheterocyclic and non-heterocyclic CH-π balances and two control
models with the non-polar CH2CH3 arm. ChemDraw representations
of the CH-π interaction in each balance were provided.
non-heterocyclic analogues. Thus, whether this phenomenon was a statistical consequence
of the greater abundance of N-heteroarenes in Nature or due to a greater affinity actually
occurred between N-heteroarenes and carbohydrates remained unclear. Our OCH3 arm
CH-π balances offered a means to investigate this issue: 1) the arm OCH3 structurally
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resembled the polarized CH units in carbohydrates and thus served as a minimalistic model
in probing the corresponding aromatic interactions, and 2) the tricyclic aromatic shelf could
be easily mutated into isosteric N-heteroaromatic surfaces allowing easy assessments of
the N-heterocycle effects (Figure 1.13A). Examination of ΔG’s of these OCH3 arm CH-π
balances revealed that presence of heterocyclic nitrogen did significantly increase the
affinity (by -0.3 kcal/mol) between the OCH3 and aromatic surface (Figure 1.13B). The
stabilizing effect, however, was not due to an enhanced CH-π interaction itself but the
favorable dipole-dipole interaction between the C-O bond and N-heterocyclic ring.
Structurally implementing an unfavorable dipole alignment in the N-heterocyclic CH-π
region effectively decimated the stabilizing effect. Analysis of control models that had the
polar C-O bond mutated to a non-polar C-C bond confirmed the CH-π interactions stayed
little changed between non-heteroarene and isoteric N-heteroarene (Figure 1.13B).

5.3 Experimental assessments of cooperativity in CH-π interactions
We then redesigned our CH-π balances and experimentally examined the
cooperativity of CH-π interactions. Cooperative CH-π interactions had been widely
observed in various applications but still remained less understood. Theory suggested a
decrease in interaction energy per carbon as the alkyl group increased in size, that is, a
negative cooperativity.41,42 However, a complement experimental investigation on this
matter was still in void. To effectively examine cooperative CH-π interactions, the C-shape
N-arylimide CH-π balances were redesigned to have the arm alkyl group directly attached
to the N-succinimide rotor so that large alkyl groups, such as ethyl and isopropyl could
access the shelf arene to form strong CH-π interactions (Figure 1.14). This improved
design also conveniently eliminated the repulsive O-π secondary interaction. Measured
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ΔG’s of these CH-π balances therefore directly reflected the strength of intramolecular CHπ interactions in solution. This method was confirmed by the near-zero ΔG’s observed for

Figure 1.14 Schematic representations of the CH-π and control
balances developed to experimentally examine the cooperativity
in CH-π interactions, and measured folding energy (in
chloroform) for these redesigned molecular balances,
highlighting a positive cooperativity in the CH-π interaction of
isopropyl group.
the control balances with a truncated alkene shelf. The CH-π interactions of methyl and
ethyl groups were found to linearly correlate with the number of participating alkyl carbons
rather than the observed CH-π short contacts, agreeing well with the dispersion dominated
nature of CH-π interactions.43 In contrast, the large iso-propyl group was found to form
much stronger CH-π interactions than predicted by the additive trend, suggesting a positive

25

cooperativity in CH-π interactions. The discrepancy with the precedented computational
studies was likely attributed to the difference in aromatic surfaces of choice. The literature
computations utilized relative small surfaces to accommodate large alkyl groups, which
might cause weakened CH-π interactions and thus an apparent negative cooperativity.41

5.4 Deuterium isotope effects in CH-π interactions
We also experimentally investigated the D/H isotope effects in CH-π interactions
with a series of methyl arm CH-π balances.9 D/H isotope effects had been a powerful tool
for studying non-covalent interactions in terms of verifying the formation of interactions
of interest, probing their stability trends, and their corresponding isotope labeling in various
occasions.44 However, whether the CH-π interactions showed any D/H isotope effect
remained controversial due to conflicting reports in literature.45-47 The methyl arm CH-π
balances had demonstrated an excellent performance in directly reporting the CH-π
interaction strengths in solution with high accuracy (±0.03 kcal/mol), offering us a venue
to experimentally investigate the D/H isotope effects (or the lack thereof) in CH-π
interactions. Thus a series of deuterated and protic methyl arm balances that contained
various aromatic shelves and molecular frameworks were assembled to thoroughly
examine the CH-π and CD-π interactions in solution (Figure 1.15). Analyzing ΔG’s of
these deuterated and protic balances found the very small even insignificant difference in
strength (within the error of ±0.03 kcal/mol in quantitative analysis) between CH-π and
CD-π interactions. Further van't Hoff analyses and dispersion-corrected DFT calculation
(PDE-D2/6-31+G*) confirmed the very small or non-existent D/H isotope effect in the CHπ interactions. Reevaluating the literature cases that reported D/H isotope effects in CH-π
interactions suggested that the isotope effects observed therein might actually rise from the
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attenuated sterics rather than enhanced CH-π interactions.45,46

The slightly shorter

vibrationally averaged bond length of C-D bonds than C-H bond (by ~0.005A) would ensue
a noticeable steric-driven D/H isotope effect if deuterated alkyl group of interest was
confined to a crowded environment. Such steric-driven D/H isotope effect was rather
minimal in our molecular balance as the methyl arm had sufficient conformational freedom
in the folded conformers to avoid severe steric clashing with other functional groups.

Figure 1.15 Measured ΔG’s (in chloroform) for a series
of deuterated and protic methyl arm balances developed
to investigate D/H isotope effects in CH-π interactions

6. Molecular balances for studying the silver-π interactions in solution
We recently reengineered a series of N-(3-methylpyridin-2-yl) succinimide
balances to experimentally study the silver-π interactions in solution.10
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The weak

attractions between silver atoms and aromatic surfaces, often referred to as the silver-π
interactions, had been widely utilized in many chemical processes and applications. 48,49
However, individual silver-π interactions had been weak and difficult to capture and
measure experimentally. Relevant experimental studies had been mostly focus on systems
having multiple Ag-π interactions,50-54 and the strength of individual silver-π interactions
in solution remained unclear. Incorporating an ortho-nitrogen in the N-aryl rotor enabled
the N-arylimide balances to accommodate intramolecular Ag-π interactions as later
confirmed in the solid-state by X-ray crystal structures (Figure 1.16A). In solution, these
reengineered balances stoichemically bound silver ions (1:1) and thus displayed distinct
changes in folding energy. The strength of individual intramolecular Ag-π interactions in
solution was quantified via double mutant cycle (DMC) analyses on the measured ΔG’s
for the silver-bound and unbound balances (Figure 1.16B). We found that an individual
intramolecular Ag-π interaction was stabilizing in nature and quantified to be -1.34 to 2.63
kcal/mol in dichloromethane. Increase in solvent polarity brought a detrimental influence
on the Ag-π interaction, presumable due to the competing binding between the silver ions
and solvent molecules. Through tweaking the C-shape molecular framework, we also
investigated the impact of interaction geometry in Ag-π interactions. These weak silver-π
interactions were found to be highly sensitive to changes in interaction geometry. A
decrease in the N-Ag-π angle from 161° to 145°, for instance, ensued approximately 1.3
kcal/mol or 50% drop in the Ag-π interaction strength (Figure 1.16A).
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Figure 1.16 (A) Schematic representation of the silver-bound Npyridyl rotor balances and partial side-views of their crystal
structures, highlighting the formation of intramolecular Ag-π
interactions; (B) Double mutant cycle analysis of silver-bound and
unbound N-pyridyl rotor molecular balances to quantify the strength
of individual Ag-π interaction in solution.

7. Re-evaluation of the C-shape N-arylimide molecular balance system
Another fascinating aspect of continuously and intensely working on these Narylimide molecular balances is that we could gain a tremendous amount of knowledge
regarding the model system itself. This knowledge helps avoid false interpretations of
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experimental data and aids to the development of future models. In this section, we further
elaborated our C-shape N-arylimide molecular balance system through discussions of the
framework and linker effects. We hoped such close-up examinations would help readers
better apprehend the capability of our molecular balances in experimentally studying
aromatic interactions as well as the potential directions for future innovation.

7.1 Framework effects
One unparalleled character of small molecular balances in studying non-covalent
interactions is the excellent control over interaction geometry. Not only do they provide a
higher certainty in the non-covalent interactions under study, but they offer a unique
opportunity to interrogate the geometry of non-covalent interactions experimentally. An
example in this regard was from Ams and co-workers on the Wilcox balance.55 Our Cshape N-arylimide balances turned out to be particularly apt in modulating the aromatic
interaction geometry. For instance, we had demonstrated with a series of methyl arm
balances that the dihedral angle (θ) between the succinimide and aromatic shelf could be
gradually altered up to 10° simply by varying the backbridge functionality (Figure 1.17).56
These variations in θ angle translated into pronounced changes in the relative positioning
of the methyl arm and shelf arene upon forming the CH-π interactions (up to 0.7 Å in the
C-to-arene distance). This structural versatility pointed to the possibility of experimentally
probing the Lennard-Jones type of potential for various aromatic interactions. Indeed, we
had briefly demonstrated such research strategy in our Ag-π interaction study in which
different backbridge functionalities ensued different Ag-π interaction geometries and
stability profiles.10
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Figure 1.17. Schematic representation of the dihedral angle (θ) between
the succinimide and arene residing planes (top), and the histogram of θ
angle (bottome) observed in the crystal structures of various methyl arm
balances containing various backbridge functionalities (Y): 1,2-arylene,
carbonyl, ether, and methylene.

7.2 Arm linker effects
Secondary interactions are a persistent problem associated with experimental
models in quantitative assessments of non-covalent interactions. One such interaction in
our molecular balances is the repulsive O-π interaction between the linker oxygen and shelf
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arene in the folded conformers. In our OAr and OR arm balances, the repulsive O-π
interaction shifted the folded-unfolded equilibrium significantly towards the unfolded side.
Moreover, the oxygen linker was found to strongly interact with solvents causing the
balances to display a solvophobic behavior in polar solvents. Quantitative analyses of
aromatic π-stacking and CH-π interactions in these molecular balances therefore required
using control balances with a smaller benzene shelf to help remove the impacts of repulsive
secondary interaction and solvent effects caused by the oxygen linker.
Another strategy to resolve the arm linker effects is to modify the molecular
balances to contain a CH2 linker and invoke DMC analyses to quantify the non-covalent
interaction under study (Figure 1.18). The CH2 linker formed a stabilizing CH-π interaction

Figure 1.18 Schematic representation of DMC analysis on the
CH2 linker molecular balances and control balances.
resulting in much higher equilibrium folded/unfolded ratios.7,8 Both the linker effects and
aromatic interaction of interest could be accurately isolated through DMC analyses with
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appropriate control balances. Such analyses, however, might not be applicable to the
oxygen linker molecular balances as the OH arms in the corresponding control balances
would experience significantly different H-bond interactions than the oxygen linkers did
in the OAr and OR arm balances. Moreover, the OH arm might fail to effectively slow
down the rotation of N-phenyl rotor due to a "proton grease" phenomenon.57

8. Conclusion and outlook
Molecular balances have emerged as one quintessential tool in the experimental
studies of weak non-covalent aromatic interactions in condensed phase media. These
unimolecular model systems capture the weak interactions of interest intramolecularly in
one or more readily measurable conformational events, nicely bypassing problematic
entropic penalties encountered otherwise. Their ability to precisely control interaction
geometry is particularly desirable in the studies of weak or non-directional aromatic
interactions, such as π-stacking and CH-π interactions.

Our C-shape N-arylimide

molecular balances and other model systems in literature have showcased the viability and
advantages of such molecular balance strategy to study aromatic interactions in solution.
Results from these molecular balances not only provided a more realistic understanding of
aromatic interactions but also helped corroborate and revise theory. Future research on
small molecule model systems are expected to address several challenging aspects: 1) "how
to experimentally facilitate accurate crossover comparison among non-covalent
interactions of various types?"; 2) "how to access to the non-deuterated solvent
environments?"; 3) "how to quantitatively examine geometric aspect of various noncovalent interactions in solution?", 4)"how to effectively evaluate weak van de Waal forces
to provide a conciliating view between the steric repulsion and stabilizing dispersion" and
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5) "how to access to the gas phase and solid state?" We hope this account will help fellow
researchers gain a clear picture of our efforts in pursuing an improved experimental
knowledge on aromatic interactions, and also inspire peer experimentalists to develop more
efficient model systems in future.
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CHAPTER 2
A COMPREHENSIVE EXPERIMENTAL STUDY OF N-HETEROCYCLIC Π-STACKING
INTERACTIONS OF NEUTRAL AND CATIONIC PYRIDINESi

i

Reproduced with permission from Li, P.; Zhao, C.; Smith, M. D.; Shimizu, K. D. J. Org.
Chem. 2013, 78, 5303. Copyright 2013 American Chemical Society.
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1. Introduction
Attractive non-covalent interactions between aromatic surfaces play an important
role in many key molecular recognition processes.1,2 The majority of π-stacking interaction
studies, to date, have focused on the interactions of non-heterocycles such as benzene3-7
and substituted benzene dimers.8-19 Yet, N-heterocycles are ubiquitous in synthetic20,21 and
biological systems22 and their π-stacking interactions are often key to their function and
utility.23,24 The fewer experimental studies with N-heterocycles can be attributed to the
greater synthetic challenge and the greater number of possible π-stacking geometries.
Consequently, the majority of N-heterocyclic π-stacking studies have been theoretical
computational studies.25-30
In this paper, we describe the development of a versatile and rigid molecular model
system that can fix an N-heterocyclic and a non-heterocyclic ring into specific π-stacking
geometries. The model system also provides a quantitative measure of the strengths of
these interactions via their conformational equilibrium ratios (Figure 2.1).

These

“molecular balances” are in conformational equilibrium between unfolded and folded
conformations due to restricted rotation around the Caryl-Nimide single bond. In the folded
conformation, the rigid bicyclic framework forces the aromatic surfaces of the arm and
shelf into an off-set parallel π-stacking geometry. In the unfolded conformation, these two
surfaces are held apart. Therefore, the folded/unfolded ratio provides a sensitive measure
of the relative strengths of the intramolecular π-stacking interactions in solution.
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Figure 2.1 A general depiction of the molecular balance
model system utilized in this study to measure the
intramolecular N-heterocyclic π-stacking interactions
formed in the folded conformer between an N-heterocyclic
and a non-heterocyclic aromatic ring.
The structural rigidity and synthetic versatility of our molecular balance model
system enabled the systematic study of the influences of position of the nitrogen atom,
charge, and substituent on the nitrogen atom within a single molecular framework. This is
important, as much greater structural and geometric diversity of π-stacking complexes can
form with N-heterocycles (Figure 2.2A) than with simple benzenes (Figure 2.2B). First,
the nitrogen atom disrupts the symmetry of the π-stacking complexes giving rise to multiple
geometries. These can be grouped into two distinct classes: the distal geometry where the
pyridine nitrogen is far from the π-face of the opposing benzene ring, and the proximal
geometry where the pyridine nitrogen is close to the π-face of the opposing benzene ring.
Second, N-heterocyclic complexes can be neutral or charged via the absence or presence
of a substituent on the nitrogen. Finally, the cationic N-heterocyclic complexes can have
a proton or alkyl N-substituent.
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Figure 2.2 Comparison highlighting the greater structural
and geometric diversity of the π-stacking complexes of (A)
non-substituted N-heterocycles versus (B) non-substituted
benzene rings.
Similar small molecule model systems that use conformational equilibriums to
study non-covalent interactions have been widely employed with great success.31 This
includes the studies of the π-stacking interactions of N-heterocycles. However, these
studies have not been comprehensive and have only focused on specific pairwise
comparisons. For example, Gellman and co-workers used a flexible secondary amide-
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based model system to demonstrate the enhanced affinity of a neutral six-membered
heterocycle versus a phenyl ring.32 Gung and co-workers also observed the stronger πstacking interactions of an N-heterocyclic versus non-heterocyclic aromatic rings using a
three-state triptycene-based model system.33 Dougherty and co-workers used an electronrich cyclophane aromatic host to measure the enhanced affinities of cationic versus neutral
quinoline guests.34 Waters and co-workers used a flexible rotamer model system to
demonstrate that the position of the nitrogen atom in cationic π-stacking interactions had a
profound influence on the interaction energies.35

However, the results from these

pioneering studies cannot be combined to produce an accurate comprehensive quantitative
comparison of all of the N-heterocyclic π-stacking complexes shown in Figure 2.2.
To simplify the discussions, the following abbreviations will be used to describe
the different complexes shown in Figure 2.2. The aromatic groups are abbreviated as
follows: phenyl (Ph), pyridine (Py), pyridinium (PyH+), N-methylpyridinium (PyMe+).
Thus, the interactions and complexes shown in Figure 2.2 (from top to bottom) are Py–Ph,
PyH+–Ph, PyMe+–Ph and Ph–Ph. In addition, we will use the term, “π-stacking”, to
describe the interactions shown in Figure 2.2 in order to maintain consistency with the
literature. However, we realize this term is somewhat misleading as the π-π interaction is
repulsive.36-39 The attractive components of π-stacking interactions are generally attributed
to dispersion interactions of molecular surfaces and electrostatic attraction between dipoles
and/or quadrupoles of aromatic rings.
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2 Results and discussion
2.1 Molecular balance design
The molecular balance model system developed in this study has the same rigid
bicyclic N-arylimide framework that we have successfully used to study face-to-face
aromatic π-stacking (balance 1)40 and aliphatic CH–π41 interactions (not shown). This
similarity provided a number of advantages for the present study. First, the N-heterocyclic
and non-heterocyclic aromatic surfaces could be predictably and precisely positioned
relative to each other. We have previously demonstrated that the bicyclic framework fixes
the arm and shelf aromatic surfaces into an off-set parallel π-stacking geometry in the
folded conformer.40 The proximity of the two interacting surfaces in the folded conformers
also prevents the formation of the other commonly observed edge-to-face, perpendicular
geometry. Second, a series of molecular balances with N-heterocyclic units incorporated
into either the arm or shelf surfaces can be rapidly assembled owing to the highly modular
syntheses of this framework. Third, the folded/unfolded ratios can be easily and accurately
measured via the integration of the 1H NMR spectra. The two conformers are in slow
exchange at room temperature (23 ˚C), and differences as small as ±0.03 kcal/mol can be
accurately measured.

Fourth, the crystallinity of these molecular balances provided a

unique opportunity to simultaneously characterize and study the geometry of Nheterocyclic π-stacking interactions in the solid-state.
For this study, six new molecular balances (2-7) were developed (Figure 2.3). The
intramolecular interactions in 2-7 mirror the different types of the N-heterocyclic πstacking complexes shown in Figure 2.2A. The relative position of the nitrogen atom in
the complexes was controlled by placing the N-heterocyclic ring into either the arm or shelf.
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Incorporation of a pyridine ring into the aromatic arm of 2 yielded a molecular balance that
adopts a distal geometry. The pyridine ring of the arm extends beyond the edge of the
aromatic shelf so the pyridine nitrogen is away from the π-face of the aromatic shelf.
Conversely, incorporating pyridine rings into the arene shelf in 3 yielded a molecular
balance that adopts a proximal geometry. In this case, the benzene arm extends out and
over one of the nitrogens in the aromatic shelf. Similarly, cationic N-protonated and Nmethylated balances with the N-heterocycles in the arm (4 and 6) adopt distal geometries
and with the N-heterocycles in the shelf (5 and 7) adopt proximal geometries.

Figure 2.3 The folded conformers of molecular balances 1-7 that form intramolecular Ph–
Ph, Py–Ph, PyH+–Ph and PyMe+–Ph stacking interactions. The two interacting rings are
highlighted in red (N-heterocycle) and blue (non-heterocycle). Balances 1’ and 3’ are twoarmed analogues used in the crystallographic analysis and balance 1’’ is a control used to
examine influence of the difference in bridgehead Z group over the folded/unfolded ratios
in solution.
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2.1 Synthesis
The syntheses of balances with the N-heterocyclic ring in the arm (2, 4 and 6)
followed the previously reported the two-step convergent route.40,41 A representative
synthesis of 2 is shown in Scheme 2.1. First, the SNAr reaction between 3-hydroxypyridine
(8) and 2-fluoronitrobenzene (9) followed by Pd/C catalyzed reduction of the nitro group
yielded aniline 10.42 The thermal condensation of aniline 10 with the endo-bicyclic
anhydride 11 yielded the endo-bicyclic balance 2. Pyridyl arms with the nitrogen in the
meta-position were prepared because the SNAr reaction with the para-pyridyl precursor, 4hydroxypyridine, was not successful due to preferential N- versus O-arylation.43 Despite
its lack of symmetry, the meta-pyridyl arm was able to adopt the desired distal geometry,
as was later confirmed in the X-ray crystallographic study and the solution 1H NMR study.
Scheme 2.1 Syntheses of balances 2 and 6 a

aKey:

(a) i. Cs2CO3, 23 °C; ii. H2, Pd/C, MeOH, 23 °C,
76% for two steps (b) HOAc, reflux, 81% (c) MeI,
acetone, reflux, quantitative.
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Incorporation of the N-heterocyclic rings into the shelf of balances (3, 5 and 7)
required the synthesis of a new diene building block (13) that contained an N-heterocyclic
phenanthroline shelf. Diene 13 was formed in two-steps from the Knovenagel cyclization
reaction of dione 12 and 2-pentanone.44 The Diels-Alder reaction between diene 13 and
maleimide 14 gave the endo-bicyclic balance 3 (Scheme 2.2). The choice of 1,10phenanthroline with two heterocyclic nitrogens as the shelf motif was intended to ensure
the symmetry of the arene shelf, as the arene of arm can form π-stacking interactions with
either of the two outer rings of the shelf.
Scheme 2.2. Syntheses of balances 3 and 7 a

aKey:

(a) i. K2CO3, MeOH, 23 °C; ii. py-SOCl2, 23 °C
37% for two steps (b) CH2Cl2, pressure tube, 90 °C,
45% (c) MeI, acetone, reflux, quantitative.
In addition, two new control balances 3’ and 1’’ were prepared. Balance 3’ is a
“two-armed” analogue of 3, which was synthesized from diene 11 and two-armed Nphenylmaleimide 15 following the previously reported method.40
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Balance 1’’ is a

structural analogue of 1 with methyl groups instead of phenyl groups attached to the
bridgeheads (Figure 2.4). Balance 1’’ was prepared by a similar route as 3 via the DielsAlder reaction between maleimide 14 and the known diene 16.45

Figure 2.4 Maleimide 15 and diene 16 precursors used
in the syntheses of the control balances 3’ and 1’’.
The cationic balances (4-7) were formed by methylation or protonation of the Nheterocycles in the arms or shelves. The N-methylated balances 6 and 7 were obtained
through methylation of the neutral balances 2 and 3 using methyl iodide in acetone
(Scheme 2.1 and 2.2). The protonated balances 4 and 5, on the other hand, were obtained
by in situ treatment of balances 2 and 3 with methanesulfonic acid.

2.2 X-Ray crystal structure analysis
To confirm the formation and correct geometry of the intramolecular Nheterocyclic π-stacking interactions in our model systems, the molecular balances were
characterized using X-ray crystallography. X-ray quality single crystals of balances 2, 3,
4, 6, and 7 were successfully obtained from chloroform-acetonitrile mixtures; only balance
5 did not form X-ray quality crystals. All but one of the molecular balances crystalized in
the folded conformation. This observation provided the first indication of the greater
strength of the N-heterocyclic π-stacking interactions. In contrast, the non-heterocyclic π-
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stacking balance 1 consistently crystalized in the unfolded conformation.40 The only Nheterocyclic balance that crystalized in the unfolded conformation was balance 3 that
contains the weakest N-heterocyclic π-stacking interaction, as was later confirmed by the
solution study. To characterize the intramolecular π-stacking interaction in balance 3, a
two-armed version 3’ was synthesized and crystalized. The presence of two identical
phenyl ether arms attached to both ortho-position of the N-aryl rotor ensured that one arm
would always adopt the folded conformation.
The crystal structures of 2, 3’, 4, 6, and 7 all showed intramolecular parallel πstacking interactions between the aromatic arm and shelf surfaces. Representative crystal
structures of balances 2 and 3’ are shown in Figure 2.5. The rigid C-shaped endo-bicyclic
framework brings the aromatic arm surface in close proximity to the aromatic shelf in the
folded conformation. Examination of the geometries of the interacting six-membered rings
confirmed the formation of the expected off-set face-to-face π-stacking interactions in
balances 2, 3’, 4, 6 and 7. The center-to-plane distance distances (D) were 3.31–3.63 Å,
which were well within the typical range of 3.3–3.8 Å for face-to-face aromatic stacking
interactions.46 The two rings were roughly parallel as shown by the relatively small
dihedral angles (α) (4.81°–17.04°) between the planes of the interacting rings, which were
below the cutoff (< 20°) for the face-to-face π-stacking geometry.47 Finally, the centroidto-centroid horizontal off-set (H) of the two interacting rings (0.82–1.98 Å) compared
favorably with the reported average value (1.30 Å) for the off-set geometry in the
literature.46 (Definition for these geometric parameters is provided in Figure 2.13 in
Supporting Information)
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Figure 2.5 X-ray crystal structures of balances 2 and 3’ (the
bridgehead phenyl and methyl functional groups are omitted
for viewing clarity). The intramolecular N-heterocyclic πstacking interactions are highlighted: N-heterocycle in red
and non-heterocycle in blue.
Table 2.1. Measured plane-to-plane angle (α), centroid-to-plane distance (D)
and horizontal centroid-to-centroid off-set (H) between the two π-stacking
six-membered rings in the crystal structures of balances 1’, 2, 3’, 4, 6, and 7.
π-stacking
Balance.
geometry
D [Å]
H [Å]
α
interaction
Ph–Ph
–
7.8°a
3.75a
0.82a
1’
Py–Ph
distal
9.3°
3.63
1.67
2
Py–Ph
proximal
15.3°
3.60
1.82
3’
+
PyH –Ph
distal
17.0°
3.37
1.27
4
+
b
b
PyMe –Ph
distal
4.8°, 6.4° 3.29, 3.36 1.78, 1.98b
6
PyMe+–Ph proximal
10.3°
3.31
1.65
7
aRef. 40
bThe crystal structure of 6 contains two crystallographically
independent molecules.
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Analysis of the crystal structures also provided verification of the formation of the
predicted proximal and distal π-stacking geometries. To better visualize the geometries,
top views of the interacting rings in the crystal structures were examined (Figure 2.6). In
particular, we were concerned that the mobility of the arene arm in the plane of the arene
shelf might lead to alternative geometries. However, examination of each structure in
Figure 2.7 shows the expected distal geometries in the folded conformers 2, 4 and 6, and
the proximal geometries in the folded conformers 3’ and 7. We were also concerned with
the ability of balances 3’, 4 and 6 to adopt the less favorable geometries (proximal, distal
and distal) for their respective N-heterocyclic π-stacking interactions.

However,

examination of these structures shows the N-heterocyclic nitrogen has been positioned into
the designed geometry. This study confirmed the ability of the rigid framework to control
the intramolecular interaction geometries.

Figure 2.6 Top views of the crystal structures of balances 1’, 2, 3’, 4, 6, and 7 highlighting
the intramolecular π-stacking interactions in the folded conformers. The corresponding
ChemDraw representations are also provided for viewing clarity.
Third, analysis of the crystal structures for balances 1’, 2, 3’, 4, 6 and 7 confirmed
the structural continuity of the intramolecular π-stacking interactions providing supports
for the ability to compare the energies of the respective interactions.

These new

heterocyclic balances contained a much wider diversity of functional groups, charges, and
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geometries which, we were concerned, might lead to different secondary interactions and
steric effects and thus mask the π-stacking interactions of interest. The similarity in the
structures of the balances was demonstrated by the conformity of the positions of the ether
oxygen linkers to the arene shelves. Figure 2.7 shows the overlaid structures of the ether
oxygen linkers and the arene shelves of the folded conformers 1’, 2, 3’, 4, 6, and 7. The
position of the oxygen linkers was remarkably consistent among the seven crystal
structures, confirming that the geometric and steric constraints in the folded conformers
were very similar.

Figure 2.7 Top and front views of the overlaid crystal structures for
balances 1’, 2, 3’, 4, 6, and 7 highlighting the relative geometries
of the oxygen linkers on the arm over the arene shelf. Only the
arene shelves and arm ether oxygens are shown, and the
overlapping center six-membered aromatic ring of the shelves is
highlighted in yellow.

2.3 Characterization in solution
The relative strengths of the intramolecular π-stacking interactions in the Nheterocyclic molecular balances were assessed by their folded/unfolded equilibrium ratios.
These were measured for balances 1-7 in solution via integration of their 1H NMR spectra
at 23 °C. The polar solvent DMSO-d6 was chosen for these studies due to its ability to
dissolve both the neutral and cationic balances. The equilibrium ratios were measured from
the areas of the separate peaks for the unfolded and folded succinimide methylene protons,
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which were singlets at ~4.9 ppm. The assignment of the unfolded succinimide peak was
made by matching its area to the distinct doublet of doublet for the unfolded conformer’s
ortho-proton of the N-aryl rotor, which is shifted drastically upfield (~ 4.5 ppm) due to its
proximity over the aromatic shelf. The folded/unfolded equilibrium ratios were converted
to energies using the equation: ΔG = –RTln([folded]/[unfolded]). The folded/unfolded ratio
for balance 7 was estimated to be greater than 19:1 because only the folded conformer was
observed.
For some of the cationic balances, the folded/unfolded ratios were measured
indirectly. The cationic N-protonated balances 4 and 5 were formed by adding MsOH to
solutions of balances 2 and 3, respectively. Unfortunately, in the presence of 1 equiv. of
MsOH, the broad water peak obscured the key succinimide singlets that were used to
measure the folded/unfolded ratios (See SI Figure 2.15). The folded/unfolded ratios,
however, could be accurately measured at lower equiv. (< 1.0) of MsOH and the
equilibrium energies (ΔG’s) were observed to change linearly with the amount of added
MsOH (See SI Figure 2.16 and 2.17). Therefore, ΔG’s for balances 4 and 5 were obtained
from the linear extrapolation to 1 equiv. of added MsOH.
Another concern was that the differences in the substituents at the bridgehead
carbons of the balances might not allow accurate comparison. Balances 1, 2, 4, and 6 have
bridgehead phenyl rings and balances 3, 4, and 7 had bridgehead methyl groups. Thus
balance 1” with a bridgehead methyl group was prepared and compared with balance 1
with a bridgehead phenyl group. Balances 1 and 1” had idential unfolded/folded ratios in
DMSO-d6 (0.58 verus 0.53), suggesting that the bridgehead group did not influence the
folded/unfolded equilibrium ratio.
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2.4 Quantitative analysis of the stability trends
Comparison of the measured ΔG’s for balances 1-7 is shown in Figure 2.8.
Stronger π-stacking interactions in the folded conformer led to higher folded/unfolded
ratios and more negative ΔG values. In general, the ΔG values were consistent with the
expected N-heterocyclic π-stacking trends, confirming the ability of the balances to
accurately compare these π-stacking interactions. For example, neutral N-heterocyclic
balances 2-3 showed stronger π-stacking interactions than the non-heterocyclic balance 1.29
Cationic N-heterocyclic balances 4-7 also showed stronger π-stacking interactions than the
neutral N-heterocyclic balances 2-3.27

0.32

ΔG (kcal/mol)

0.0
-0.5

-0.05
-0.22

-0.45

more folded

0.5

-0.76

-1.0
-1.5

-1.43

-2.0
≤-1.74
-2.5

Figure 2.8 1H NMR measured ΔG’s (kcal/mol) for balances 1-7 at 23 °C in
DMSO-d6 at 23 °C. The ChemDraw representation of the π-stacking
interaction in each balance is shown. The uncertainty in 1H NMR integration
measurements gives an error of less than ± 0.03 kcal/mol.
To facilitate the comparison of the respective π-stacking interactions, ΔΔG’s were
calculated for the N-heterocyclic balances 2-7 relative to the non-heterocyclic balance 1,
which contained the weakest π-stacking interaction (Table 2.2).
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Table 2.2 Measured conformational equilibrium energies (ΔG,
kcal/mol) for balances 1-7 in DMSO-d6 at 23 °C and relative energies
(ΔΔG, kcal/mol) of the N-heterocyclic balances 2-7 relative to the
non-heterocyclic balance 1.
π-stacking
geometry
ΔGa
ΔΔGb
interaction
Ph–Ph
–
0.32
0.00
1
distal
-0.22
-0.54
2
Py–Ph
proximal
-0.05
-0.37
3
distal
-0.45
-0.77
4
PyH+–Ph
proximal
-1.43
-1.75
5
distal
-0.76
-1.08
6
PyMe+–Ph
proximal ≤-1.74c
≤-2.06
7
a DMSO-d , 23 °C; uncertainty less than ± 0.03 kcal/mol b ΔΔG =
6
(ΔG[x] – ΔG[1]); x = 2-7; uncertainty less than ± 0.06 kcal/mol c
Only the folded conformer of balance 7 was observed on the 1H NMR
spectrum, and thus ΔG[7] was estimated to be ≤ -1.74 kcal/mol.
Balance

The neutral N-heterocyclic (Py–Ph) π-stacking interactions in balances 2 and 3 were
found to be modestly stronger (ΔΔG = -0.4 to -0.5 kcal/mol) than the non-heterocyclic (Ph–
Ph) π-stacking interaction in balance 1. This was consistent with the influence of the
electronegative heterocyclic nitrogen that enhances the electrostatic attraction between
rings due to the formation of a permanent dipole.29 The magnitude of this trend compared
favorably with the values measured by Gung and co-workers using their triptycene-based
molecular model system.33
The cationic N-heterocyclic π-stacking interactions (PyH+–Ph and PyMe+–Ph) in
balances 4-6 were found to be much stronger than the non-heterocyclic (Ph–Ph) π-stacking
interaction in balance 1 (ΔΔG = -0.8 to ≤-2.1 kcal/mol), and also stronger than the neutral
Py–Ph π-stacking interactions in balances 2-3 (ΔΔG = -0.2 to ≤-1.7 kcal/mol). This
significant increase in strength is consistent with the greater electrostatic attraction arising
from cationic nitrogen ring and the π-cloud of the opposing aromatic surface.27 This
observation helps explain the prevalence of cationic N-heterocyclic π-stacking interactions
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in applications that rely on π-stacking interactions such as biomimetic catalysis of SN2
reactions,48 conformational molecular switches,49 diastereotopic control of stereoselective
reactions,50 and the threading of rotaxanes and catanenes.51

2.5 Influence of the position of N-heterocyclic nitrogen
The rigidity of the bicyclic framework of this model system provided the unique
opportunity to investigate how the relative position of the N-heterocyclic nitrogen atom
influenced the stabilities of the π-stacking interaction.

However, the ability of the

molecular balances to maintain the distal and proximal geometries in solution was first
verified. Balances 2-7 adopted the expected distal and proximal geometries in the solidstate. However, these geometries are more dynamic in solution. Computational studies of
our model system have shown that the arene arm can sweep back and forth over the arene
shelf.52 Thus, the conformational equilibrium energies in solution of the proximal (2, 4
and 6) and distal (3, 5 and 7) balances were compared. Specifically, for each type of Nheterocyclic π-stacking interaction (Py–Ph, PyH+–Ph and PyMe+–Ph), the energies of
balances designed to adopt distal and proximal geometries were compared. In each case,
the distal and proximal balances had distinctly different ΔG values. More importantly, the
distal versus proximal stability trends for each type of interaction matched well the
predictions of Hunter and Sander’s electrostatic model.53 This suggests that the balances
were adopting the expected geometries in solution.
For the Py–Ph stacking interaction, the distal geometry (balance 2) was found to be
slightly stronger than the proximal geometry (balance 3) by ΔΔG = -0.17 kcal/mol. Figure
2.9 shows the electrostatic origins of this geometric preference. The electronegative
nitrogen of the pyridine ring bears a partial negative charge (δ–) and creates a partial
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positive charge (δ+) on the opposite end of the ring. Thus, the distal geometry provides
better electrostatic complementarity to the quadrupole of the opposing phenyl ring. The
proximal geometry, on the other hand, lacks an electropositive hydrogen on the pyridine
nitrogen which eliminates one of the attractive electrostatic interactions. In addition, the
proximal geometry contains an additional repulsive interaction between the electronegative
pyridine nitrogen and the π-surface of the opposing phenyl ring. The weaker proximal Py–
Ph stacking interaction in balance 3 was also evident in the solid-state studies, as balance
3 was the only balance that did not crystalize in the folded conformation.

N

N

d+

d-

d-

d+

Py-Ph stacking
distal
N

d-

d-

d+

dd+

Py-Ph stacking
proximal

d-

d+

N
dd-

d+

Figure 2.9 Schematic representations comparing the neutral
Py–Ph π-stacking interactions in the proximal and distal
geometries using Hunter and Sander’s electrostatic quadruple
model.
For the cationic N-heterocyclic (PyH+–Ph and PyMe+–Ph) π-stacking interactions,
the opposite geometric preference was observed. The proximal geometry (balances 5 and
7) were considerably more stable than the distal geometry (balances 4 and 6) by ΔΔG = ≤0.98 kcal/mol. The preference for the proximal geometry in the cationic N-heterocyclic πstacking interactions can also be explained using Hunter’s electrostatic model. The
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positive charge caused by protonation or alkylation of the pyridine is electrostatically
attracted to the π-cloud of the opposing phenyl ring. This attractive force is stronger in the
proximal geometry as the positively charged nitrogen is closer to the face of opposing
phenyl ring. The observed preference for the proximal geometry in PyH+–Ph stacking
interactions is also consistent with the “orientation effect” of cationic π-stacking
interactions observed by Waters and co-workers in their flexible folding model system.35
Furthermore, the larger difference in energy between the proximal and distal geometries
for the cationic (|ΔΔG| ≥ 0.98 kcal/mol) versus neutral (|ΔΔG| = 0.17 kcal/mol) π-stacking
interactions reinforced the electrostatic origins of these geometrical preferences.

2.6 Influence of the N-Substituent
Next the influence of different N-substituents (methyl versus proton) in the cationic
balances was analyzed. To isolate this variable from the geometric preference noted above,
the proximal (5 and 7) and distal (4 and 6) balances were compared separately. For the
proximal balances, the N-methylated balance 7 had a stronger π-stacking interaction than
the N-protonated balance 5 by ΔΔG ≤ -0.31 kcal/mol. The greater stability of the proximal
N-methylated heterocycle complex was attributed to the ability of the N-methyl group to
form an additional stabilizing CH–π interaction. Evidence for the additional CH–π
interaction was provided by the crystal structure of balance 7. As shown in Figure 2.10, a
proton of the N-methyl group points towards the opposing phenyl ring with two short H to
C distances (atom-to-atom distance) of 3.02 Å and 3.03 Å, respectively, which falls within
the common cut-off distance (3.05 Å) for a CH–π interaction.54 We have also observed
that similar intramolecular CH–π interactions can stabilize the folded conformer of our Narylimide bicyclic balances by up to -1.0 kcal/mol in organic solvents.41 The similar
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supporting role of CH–π interactions in the cation–π interactions of alkylated ammonium
has been mentioned in several studies, such as the folding of a β-hairpin peptide and the in
vitro binding of trimethyllysine to the HP1 chromodomain.55
A similar analysis was performed on the distal cationic balances (4 and 6).
However, the equilibrium ratios of these distal balances were much more susceptible to
solvent effects which made the N-methyl versus N-proton preference solvent dependent.
These solvent effects are explained in the next section.

Figure 2.10. Truncated side-view (left) of the crystal
structure of folded-7 highlighting the presence of a CH–π
interaction between the proximal N-methylated heterocycle
on the shelf and the phenyl ring on the arm. A ChemDraw
representation is also provided (right). The short distance
contacts between N-methyl proton and phenyl carbon are
highlighted with red dotted lines.

2.7 Solvent effects
The ability to measure the folded/unfolded ratios in different solvents provided an
additional method of probing the origins of the stability trends. Thus, the above analyses
were also carried out in two additional organic solvents: CDCl3 and CD3CN. The measured
relative energies are shown in Table 2.3. Overall, the similar stability trends were observed
in all three solvents, providing further confirmation of the observed N-heterocyclic stability
trends.
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Table 2.3 Measured relative energies (ΔΔG, kcal/mol) a of the N-heterocyclic balances
2-7 relative to the non-heterocyclic balance 1.
ΔΔGa
CDCl3
CD3CN
DMSO-d6
1
–
0.00
0.00
0.00
2
distal
-0.60
-0.54
-0.54
Py–Ph
3
proximal
-0.19
-0.21
-0.37
4
distal
-0.89
-1.06
-0.77
PyH+–Ph
5
proximal
-1.43
-1.66
-1.75
6
distal
-0.40
-0.98
-1.08
PyMe+–Ph
7
proximal
≤-2.23
≤-1.89
≤-2.06
a The relative energy were quantified as ΔΔG = (ΔG[x] – ΔG[1]); x = 2-7; propagated
uncertainty less than ± 0.06 kcal/mol. The measured ΔG’s for balances 1-7 in CDCl3
and CD3CN were included in Table 2.4 in SI
Balance

π-stacking
interaction
Ph–Ph

geometry

The only inconsistency was in the trends for the distal N-protonated and Nmethylated cationic balances 4 and 6, as noted in the last section. In CDCl3, the Nprotonated balance 4 had a stronger interaction, whereas in DMSO-d6, the N-methylated
balance 6 had a stronger interaction. In CD3CN, the two balances had very similar
interaction energies. The greater solvent effects for these distal balances may be due to the
greater interaction of the solvents with the charged cationic surfaces in 4 and 6. This may
be due to the more solvent exposed positive charge of the distal geometry. By comparison,
the more shielded positive charge of the proximal balances (5 and 7) show much smaller
solvent effects and consistent N-methyl versus N-proton trends in each solvent. These
differences could also be due to differences in solvation of the different counter-ions (I- and
MsO-) for the N-methylated and N-protonated distal balances (4 and 6), respectively.

2.8 Correlation with benchmark-quality computational calculations
Finally, the experimentally measured values in this study provided an opportunity
to test the accuracy of current computational methods as well as the performance of our
model system in accurately assessing N-heterocyclic π-stacking interactions. Benchmark
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quality calculations (CCSD(T) or SCS–MP2 methods) from the literature for π-stacking
interactions were used in the correlation analysis (Figure 2.11).27,29,56 The geometries of
the calculations were matched to the geometries of the π-stacking interactions observed in
the crystal structures of the balances, and the calculated interaction energies were matched
to the experimentally measured relative energies (ΔΔG) in DMSO-d6 from Table 2.2.

-1.0
0.5
0.0

Experimentally observed
relative stabilites in DMSO-d6
(kcal/mol)

Computationally predicted stabilities
(kcal/mol)
-11.0
-9.0
-7.0
-5.0
-3.0

-0.5
-1.0
-1.5
-2.0
CCSD(T)/CBS
CCSD(T)/CBS
-2.5
SCS-MP2/aug-cc-pVTZ

Figure 2.11 Correlation plot between the calculated energies from
the benchmark quality computations in literature and the
experimentally observed relative energies (ΔΔG’s) in DMSO-d6 for
the π-stacking interactions in balances 1-7. The computational data
were from ref. 27 (open diamonds), ref. 29 (open squares) and ref.
56 (open triangles).
The correlation plot showed a good general agreement between the computational
and experimentally measured energies.

For example, both methods provide similar

stability trends: Ph–Ph < Py–Ph < (PyH+–Ph and PyMe+–Ph). There was also good
agreement for the geometry-related stability trends (distal versus proximal) for the both
neutral and cationic N-heterocyclic π-stacking interactions. For example, both methods
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found that the distal geometry was more stabilizing for the neutral Py–Ph stacking
interaction; whereas the proximal geometry was more stabilizing for the cationic PyH+–Ph
and PyMe+–Ph stacking interactions.
Two minor deviations in the experimental and calculated trends were observed.
The first deviation was that the neutral and cationic N-heterocyclic π-stacking interactions
appeared to form separate trend lines on the correlation plot. This may be explained by the
different environments (vacuum versus solvent) of the two methods. The solvent in the
experimental studies screen the electrostatic interactions of charged groups, which reduces
their interaction strengths as compared to the in vacuo computational studies.
The second inconsistency was that the experimental study found that the proximal
Py–Ph interaction in 3 was slightly stronger than the Ph–Ph stacking interaction in 1. This
trend is in opposition to the computational studies that predicted that positioning an
electronegative nitrogen over an opposing aromatic π-surface in the proximal geometry
should be a destabilizing interaction. We attribute this deviation to the mobility of the
phenyl arm in solution, which allows the balance to also adopt geometries that avoid this
destabilizing interaction. This minimizes the contribution of the destabilizing interaction
to the folded/unfolded ratio and leads to an overestimation of the strength of the proximal
Py–Ph stacking interaction in balance 3. It should be pointed out that the mobility of the
arene arm will have less of an impact on balances that only contain attractive stabilizing
interactions, as the arm will preferentially seek out and adopt these more stabilizing
geometries.
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2.8 Evaluation of the Design of the Molecular Balances
Overall, our N-arylimide bicyclic balance model system appeared to provide an
effective platform to systematically and quantitatively study many aspects of the Nheterocyclic π-stacking interaction. However, as with all model systems, we had a number
of concerns. In this section, we re-analyzed the data to check whether each concern was
warranted.
The first concern was that the repulsive O-π interaction from the oxygen linker of
the arm with the arene shelf might obscure or prevent accurate comparisons of the
intramolecular π-stacking interactions of interest. However, this repulsive interaction was
actually advantageous feature, which enabled more accurate measurement of the stronger
N-heterocyclic π-stacking interaction. The strength of the intramolecular interactions that
can be measured by our balances is limited by the highest folded/unfolded ratio that can be
accurately measured.

Based on a conservative detection limit of 5% of 1H NMR

spectra,57,58 the highest folded/unfolded ratio that can be measured is 19:1.

If the

folded/unfolded ratio in the absence of the interaction was 1:1, this would correspond to a
maximum measureable interaction energy of only -1.74 kcal/mol. This low limit is
particularly important for this study because the cationic N-heterocyclic π-stacking
interactions were all stronger than -2.0 kcal/mol. However, the repulsive interactions of
the oxygen linkers in our balances acts like a “spring”, which shifts the resting state of the
balance toward the unfolded conformer to give a folded/unfolded ratios of approximately
1:7 in DMSO-d6.40 This spring effect allows for a larger change in folded/unfolded ratio
from 1:7 to 19:1, which corresponds to a maximum measurable interaction of up to -2.88
kcal/mol.
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A second design concern was whether we could compare balances with Nheterocycles in the arm against those with N-heterocycles in the shelf. These two surfaces
are not identical and possess different degrees of π-conjugation. However, analysis of the
ΔG’s for balances 1-7 suggested that this concern was unwarranted or was very minor, as
the expected stability trends; Ph–Ph < Py–Ph < (PyH+–Ph and PyMe+–Ph), were clearly
observed. More importantly, the expected and more subtle geometry-related stability
trends (proximal versus distal) were accurately reproduced by the molecular balances.
These geometry-related trends relied on directly comparing balances with N-heterocycles
in the arm and shelf.
A third design concern was whether the mobility of the arm arene in the folded
conformer balances would compromise their ability to distinguish the distal and proximal
geometries of the N-heterocyclic π-stacking interaction. Generally, the expected distal
versus proximal stability trends were observed. However, the ability of the arene arm to
slide back and forth across the arene shelf could lead to underestimations of the difference
in energy of proximal and distal geometries when destabilizing repulsive interactions are
involved. To address this problem, we are currently utilizing advanced NMR methods such
as through-space coupling and nuclear Overhauser effects to investigate the mobility of the
arene arm and measuring the population of various sub-conformations to refine the energy
calculations.
The last design concern was the asymmetry of the cationic aromatic shelves in
balances 5 and 7. Ideally, both heterocyclic nitrogens would be charged so that the arm
arene could form the same π-stacking interactions with either outer ring of the arene shelf,
but this was not synthetically feasible. Clearly, these singly charged balances are still able
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to form the expected cation-π interactions, as these balances had significantly stronger πstacking interactions than their neutral counterparts. This highlights one advantage of arm
mobility in the study of attractive interactions, as the arms will preferentially form the more
stabilizing π-stacking interaction with the cationic versus neutral outer ring. However, we
cannot eliminate the possibility that the ability of these balances to also form the neutral πstacking interaction may lead to an underestimation of the energies of the cationic πstacking interactions in balances 5 and 7. Again, advanced NMR techniques will be applied
in future studies to quantify the contribution of these less stable geometries.

3. Conclusion
A new series of molecular balance model systems (2-7) were designed and used to
perform a comprehensive study of the influences of position, charge, and substitution of
the nitrogen atom on N-heterocyclic π-stacking interactions in the solid-state and in
solution. The formation and geometry of the intramolecular N-heterocyclic π-stacking
interactions in the folded conformation models were verified via X-ray crystallographic
analysis in the solid-state. The relative stabilities of these N-heterocyclic π-stacking
interactions in solution were systematically studied by comparing the folded/unfolded
ratios of the corresponding molecular balances that were measured via integration of the
1

H NMR spectra. The stability trend: Ph–Ph < Py–Ph < (PyH+–Ph and PyMe+–Ph) was

quantitatively measured for the first time within a single model system. The position of
the heterocyclic nitrogen was found to influence the strengths of both the neutral and
cationic N-heterocyclic π-stacking interactions leading to opposite stability trends. For the
neutral Py–Ph stacking interaction, the distal geometry was found to be slightly more
favorable. For the cationic PyH+–Ph and PyMe+–Ph stacking interactions, the proximal
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geometry was found to be significantly more favorable. The influence of N-methylation
and N-protonation was also compared.

For the proximal complex, the PyMe+–Ph

interaction was found to be significantly stronger than the PyH+–Ph stacking interaction.
This was attributed to the formation of additional CH–π interaction between the N-methyl
proton and the opposing phenyl ring. The measured trends were consistently observed in
three common organic solvents (chloroform, acetonitrile and DMSO) confirming the
generality of these trends. The experimentally measured stabilities for the N-heterocyclic
π-stacking interactions in balances 1-7 were found to generally agree with the
corresponding benchmark quality computational values in literature. Discrepancies were
mainly attributed to the presence of solvent in the experimental studies and the difficulties
in experimentally measuring interactions strength of unfavorable geometries.
The quantitatively measured stability trends for the N-heterocyclic π-stacking
interactions provide guidance in the design and optimization of applications that rely on
these molecular recognition processes. For example, insertion of N-heterocycles will
strengthen attractive aromatic π-stacking interactions but only if the nitrogen atoms are
appropriately positioned away from the π-face of the opposing aromatic surface. The
insertion of positively charged N-heterocycles also provide a simple means to significantly
strengthen the π-stacking interaction, but these charged heteroarenes also impose an even
stronger directional preference. Finally, to study the stability trends for the non-covalent
interactions of aromatic surfaces in more biologically relevant aqueous environments, we
have developed a water-soluble version of these molecular balances and will be reporting
these results in future studies.
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Supporting Information
1. Synthesis and characterization
1.1 General experimental
All chemicals were purchased from commercial suppliers and used as received
unless otherwise noted. All reactions were carried out under a dry N2 atmosphere in oven–
dried glassware. Dry organic solvents were obtained by passing the degassed solvents
through activated alumina columns. Flash chromatography was carried out using either
silica gel (60 Å, 200–400 mesh) or aluminum oxide (60 Å, 20–200 mesh) as noted. Thin
layer chromatography (TLC) for monitoring the reaction progress was performed using
either precoated 0.25 mm silica gel 60 F254 plates or precoated 0.25 mm aluminum oxide
60 F254 plates. NMR spectra were recorded on 300 MHz, 400 MHz spectrometers.
Chemical shifts are reported in ppm (δ) and were referenced to TMS. HRMS was recorded
with a magnetic sector spectrometer using EI sources and the Q-TOF 1 spectrometer using
ESI sources.

1.2 Synthesis
Balances 1 and 1’, anhydride 11, N-(2-phenyloxyl)phenyl maleimide (17), and N(2,6-diphenoxylphenyl) maleimide were prepared utilizing our previously described routes
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for the analogous parent compounds. i Diene 13 ii and ortho-pyridin-3-ylaniline (10) iii
were obtained using literature procedures.
(9R,9aS,12aR,13S)-9,13-Dimethyl-11-(2-phenoxyphenyl)-12a,13-dihydro-9H9,13-methanophenanthro[9,10-f]isoindole-10,12,14-(9aH,11H)-trione (1’’).

Diene 16

(0.20 g, 0.77 mmol) and N-(2-phenyloxylphenyl) maleimide (17) (0.24 g, 0.92 mmol) were
dissolved in dry toluene (10 mL). The mixture was stirred and heated at reflux under N2
for 24 h.

The solvent was removed under vacuum to give a light yellow solid.

Recrystallization from ethanol gave 1’’ as a white crystalline solid (0.36 g, 87%). mp 310
ºC dec. 1H NMR (400 MHz, CDCl3) δ 8.79 (dd, J = 8.3 Hz, J = 1.2 Hz, 2H major), 8.38
(dd, J = 8.2 Hz, J = 1.3 Hz, 2H major), 8.26 (dd, J = 8.3 Hz, J = 1.0 Hz, 2H minor), 8.14
(dd, J = 8.4 Hz, J = 1.0 Hz, 2H minor), 7.61–7.72 (m, 4H major), 6.81–7.49 (m, 5H major,
12H minor), 6.65 (dd, J = 8.3 Hz, J = 1.2 Hz, 1H major), 6.44 (td, J = 7.7 Hz, J = 1.3 Hz,
1H major), 5.96 (dd, J = 8.4 Hz, J = 1.2 Hz, 1H minor), 5.73–5.78 (m, 1H major), 4.68 (dd,
J = 7.9 Hz, J = 1.6 Hz, 1H major), 3.60 (s, 2H minor), 3.42 (s, 2H major), 2.31 (s, 3H
major), 2.28 (s, 3H minor). 13C NMR (100 MHz, CDCl3): 201.1, 199.6, 174.2, 173.7, 156.2,
153.0, 133.3, 133.1, 130.9, 130.8, 130.4, 129.9, 129.3, 128.9, 128.2, 127.5, 127.4, 127.3,
126.7, 126.5, 125.3, 125.0, 124.2, 123.5, 123.4, 123.3, 121.8, 121.7, 121.6, 119.5, 118.8,
116.1, 77.5, 77.2, 77.2, 76.8, 55.2, 55.1, 48.4, 47.9, 14.8. HRMS (EI) m/z calcd for
C35H25NO4 (M+): 523.1784; found: 523.1778.

i

Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547
Warrener, R. N.; Schultz, A. C.; Houghton, M. A.; Butler, D. N. Tetrahedron 1997, 53,
3991.
iii
Huang, D. H.; Poon, S. F.; Chapman, D. F.; Chung, J.; Cramer, M.; Reger, T. S.; Roppe,
J. R.; Tehrani, L.; Cosford, N. D. P.; Smith, N. D. Bioorg. Med. Chem. Lett. 2004, 14,
5473.
ii
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(9R,9aS,12aR,13S)-9,13-Diphenyl-11-(2-(pyridin-3-yloxy)phenyl)-12a,13dihydro-9H-9,13-methanophenanthro[9,10-f]isoindole-10,12,14(9aH,11H)-trione (2). To
a solution of anhydride 11 (0.29 g, 0.60 mmol) in acetic acid (25 mL), ortho-pyridine-3ylaniline (10) (0.15 g, 0.81 mmol) was added. The mixture was stirred and heated at reflux
under N2 for 24 h. The solvent was removed under vacuum to give a brown solid. The
solid was suspended in Na2CO3 aqueous solution (50 mL), and then extracted with CH2Cl2
(3 x 30 mL). The organic layer was collected, washed with brine (30 mL) and dried over
MgSO4.

The solvent was removed under vacuum to give a brown solid. Flash

chromatography (aluminum oxide, MeOH/CH2Cl2 = 1/100) provided 2 as a pale white
solid (0.29 g, 81%). mp 280 ºC dec. 1H NMR (400 MHz, CDCl3) δ 8.73 (d, J = 8.5 Hz,
2H minor), 8.45–8.35 (m, 2H minor, 2H major), 8.33–8.26 (m, 1H major, 2H minor), 8.16
(d, J = 8.5 Hz, 2H major), 6.86–7.75 (m, 19H major and 16H minor), 6.65 (dd, J = 8.3 Hz,
J = 1.1 Hz, 1H minor), 6.47 (td, J = 7.9 Hz, J = 1.1 Hz, 1H minor), 6.18 (ddd, J = 8.3 Hz,
J = 2.6 Hz, J = 1.4 Hz, 1H major), 5.93 (dd, J = 8.3 Hz, J = 1.1 Hz, 1H major), 4.68 (s, 2H
major), 4.64 (dd, J = 7.9 Hz, J = 1.6 Hz, 1H minor), 4.58 (s, 2H minor).

13

C NMR (100

MHz, CDCl3): 197.0, 195.7, 173.5, 173.0, 154.4, 152.5, 150.5, 145.7, 145.5, 143.8, 142.4,
133.9, 133.7, 133.7, 133.5, 131.3, 131.2, 131.1, 130.9, 130.7, 129.5, 129.4, 129.3, 129.2,
129.1, 128.9, 128.8, 128.6, 128.5, 128.4, 127.4, 127.0, 126.8, 126.7, 126.4, 126.3, 126.2,
126.0, 125.9, 124.4, 124.1, 123.9, 123.1, 122.9, 122.6, 122.2, 120.8, 118.4, 116.0, 77.5,
77.2, 77.1, 76.8, 63.7, 63.6, 45.6, 45.2. HRMS (EI) m/z calcd for C44H28N2O4 (M+):
648.2049, found: 648.2059.
(9R,9aS,12aR,13S)-9,13-Dimethyl-11-(2-phenoxyphenyl)-12a,13-dihydro-9H9,13-methanoisoindolo[5,6-f][1,10]phenanthroline-10,12,14(9aH,11H)-trione (3). Diene
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13 (0.20 g, 0.77 mmol) and N-(2-phenyloxylphenyl) maleimide (17) (0.24 g, 0.92 mmol)
were dissolved in CH2Cl2 (15 mL) and sealed in a medium pressure tube after flushing with
N2. The pressure tube was heated to 90 ºC with stirring for 24 h. After cooling, the solvent
was removed under vacuum. The solid residue was washed with cold acetonitrile and
acetone to give 3 as an off-white solid (0.18 g, 45%). mp 280 ºC dec. 1H NMR (400 MHz,
CDCl3) δ 9.18 (d, J = 4.2 Hz, 2H major), 8.82 (d, J = 4.2 Hz, 2H minor), 8.67 (d, J = 8.4
Hz, 2H major), 8.48 (d, J = 8.4 Hz, 2H minor), 7.63 (dd, J = 8.4 Hz, J = 4.3 Hz, 2H major),
7.29 (dd, J = 8.4 Hz, J = 4.3 Hz, 2H minor), 6.75–7.25 (m, 5H major and 8H minor), 6.61
(d, J = 8.3 Hz, 1H major), 6.42 (t, J = 7.7 Hz, 1H major), 5.90–5.99 (m, 1H major, 1H
minor), 4.68 (dd, J = 7.9 Hz, J = 1.1 Hz, 1H major), 3.56 (s, 2H minor), 3.41 (s, 2H major),
2.25 (s, 3H major), 2.21 (s, 3H minor).

13

C NMR (100 MHz, CDCl3): 199.9, 198.6, 173.7,

173.4, 155.9, 154.8, 153.7, 152.6, 150.8, 149.9, 146.4, 146.1, 133.3, 133.1, 132.6, 132.0,
130.7, 130.5, 129.9, 129.6, 128.4, 127.8, 124.8, 124.6, 124.4, 124.2, 123.5, 122.8, 121.7,
121.5, 121.2, 119.9, 119.4, 118.7, 116.6, 77.5, 77.2, 77.1, 76.8, 55.4, 55.3, 47.9, 47.5, 14.4,
14.2. HRMS (EI) m/z calcd for C33H23N3O4 (M+): 525.1689; found: 525.1679.
(9R,9aS,12aR,13S)-11-(2,6-Diphenoxyphenyl)-9,13-dimethyl-12a,13-dihydro9H-9,13-methanoisoindolo[5,6-f][1,10]phenanthroline-10,12,14(9aH,11H)-trione

(3’).

Diene 13 (0.20 g, 0.75 mmol) and N-(2,6-diphenoxylphenyl) maleimide (18) (0.32 g, 0.75
mmol) were reacted using the same procedure as described for balance 3, the product 3’
was obtained as a pale white solid (0.28 g, 60 %). mp 280 ºC dec. 1H NMR (400 MHz,
CDCl3) δ 8.98–9.01 (m, 2H), 8.69 (dd, J = 8.4 Hz, J = 1.3 Hz, 2H), 6.93–7.55 (m, 11H),
6.45 (d, J = 8.2 Hz, 1H), 6.12 (d, J = 7.7 Hz, 2H), 5.85 (d, J = 8.5 Hz, 1H), 3.63 (s, 2H),
2.37 (s, 6H). 13C NMR (100 MHz, CDCl3): 198.8, 173.2, 156.3, 155.8, 153.7, 149.7, 146.3,
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133.1, 131.9, 130.3, 129.9, 129.5, 124.8, 124.4, 124.3, 122.6, 121.2, 119.5, 111.4, 111.0,
110.6, 77.4, 77.1, 76.8, 55.2, 47.7, 14.2. HRMS (EI) m/z calcd for C39H27N3O5 (M+):
617.1951; found: 617.1939.
1-Methyl-3-(2-((9R,9aR,12aS,13S)-10,12,14-trioxo-9,13-diphenyl-9a,10,12a,13tetrahydro-9H-9,13-methanophenanthro[9,10-f]isoindol-11(12H)-yl)phenoxy)pyridin-1ium iodide (6). To a solution of balance 2 (0.20 g, 0.31 mmol) in acetone (40 mL), methyl
iodide (1.0 mL, 16.1 mmol) was added. The reaction mixture was stirred at 45 ˚C for 12 h
in the dark under N2. After cooling to room temperature, a yellow precipitate was collected
by filtration and washed with cold acetone to quantitatively give 6 as a yellow solid (0.25
g, 100%). mp 240 ºC. 1H NMR (400 MHz, DMSO-d6) δ 8.99–9.02 (m, 1H minor), 8.94
(d, J = 8.5 Hz, 2H minor), 8.79–8.83 (m, 1H minor), 8.73 (d, J = 6.0 Hz, 1H major), 8.51
(d, J = 8.5 Hz, 2H major), 8.31 (d, J = 7.8 Hz, 2H major), 8.20 (d, J = 7.8 Hz, 2H minor),
8.05–8.10 (m, 1H minor), 7.97–8.02 (m, 1H minor), 6.92–7.85 (m, 20H major, 17H minor),
6.63 (td, J = 7.9 Hz, J = 1.1 Hz, 1H minor), 6.31–6.36 (m, 1H major), 5.01 (s, 2H minor),
4.99 (s, 2H major), 4.44 (dd, J =7.9 Hz, J = 1.6 Hz, 1H minor), 4.34 (s, 3H minor), 4.31 (s,
3H major).

13

C NMR (100 MHz, DMSO-d6): 195.6, 174.0, 152.9, 152.4, 142.2, 138.8,

137.1, 133.98, 133.6, 131.0, 130.5, 129.1, 129.1, 128.3, 128.2, 126.5, 126.0, 125.8, 125.3,
124.4, 123.2, 121.8, 63.1, 62.9, 47.9, 45.3, 40.1, 39.9, 39.7, 39.5, 39.5, 39.3, 39.1, 38.9,
HRMS (ESI) m/z calcd for cation [C45H31N2O4]+ (M+): 663.2284; found: 663.2277.
(9S,9aR,12aS,13R)-4,9,13-Trimethyl-10,12,14-trioxo-11-(2-phenoxyphenyl)9a,10,11,12,12a,13-hexahydro-9H-9,13-methanoisoindolo[5,6-f][1,10]phenanthrolin-4ium iodide. (7). To a solution of balance 3 (80 mg, 0.15 mmol) in acetone (20 mL), methyl
iodide (0.47 mL, 7.55 mmol) was added. The reaction mixture was heated at reflux for 12
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h in the dark under N2. After cooling to room temperature, a yellow precipitate was
collected by filtration and washed with cold acetone to quantitatively give 7 as a yellow
powder (102 mg, 100%). mp 280 ºC dec. The racemic form 7 was used without resolution.
1

H NMR (400 MHz, DMSO-d6) δ 9.34 (d, J = 8.5 Hz, 1H), 9.12–9.19 (m, 2H), 8.87 (d, J

= 8.6 Hz, 1H), 8.10 (dd, J = 8.4 Hz, J = 5.9 Hz, 1H), 7.98 (dd, J = 8.4 Hz, J = 4.2 Hz, 1H),
6.89–7.31 (m, 6H), 5.90 (d, J = 8.4 Hz, 1H), 5.82 (d, J = 7.5 Hz, 2H), 4.86 (s, 3H), 4.04 (s,
2H), 2.20 (s, 3H), 2.19 (s, 3H).

13

C NMR (100 MHz, CDCl3): 198.3, 174.3, 174.1, 154.1,

153.5, 150.4, 149.1, 141.8, 140.3, 137.9, 137.4, 133.4, 132.9, 130.6, 129.9, 129.5, 127.7,
126.9, 125.3, 125.2, 124.5, 122.3, 120.6, 120.5, 115.8, 54.9, 54.9, 54.8, 47.5, 47.4, 40.2,
39.9, 39.7, 39.52, 39.5, 39.3, 39.1, 38.9, 13.9, 13.5. HRMS (ESI) m/z calcd for cation
[C34H26N3O4]+ (M+): 540.1923; found: 540.1918.

1.3 Characterization
1

H and 13C NMR spectra for all the newly synthesized molecular balances and X-

crystal data (CIF) of 1’’, 2, 3, 3’, 4, 6 and 7 are available free of charge via Internet at
http://pubs.acs.org/doi/abs/10.1021/jo400370e
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2. Additional Figures and Tables

Figure 2.12 (a) Front-view of the crystal structure overlapping for 1’, 2, 3’,
4, 6 and 7 (the six atoms for overlapping operation are highlighted with
yellow threads). The bridgehead groups are omitted for visual clarity; (b)
Truncated back-view of the arm aromatic unit and shelf aromatic motifs; (c)
Truncated top-view of the arm oxygen (with connected aromatic carbon)
and the shelf aromatic motif.

Figure 2.13 Geometric parameters defined
for the characterizing the intramolecular πstacking interactions in the folded conformers.
(α: plane-to-plane angle, D: centroid-to-plane
vertical distance, and H: centroid-to-centroid
horizontal off-set). The top ring is aromatic
ring of the arm, and the bottom is ring the
outer ring of the arene shelf.
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Table 2.4. The measured ΔG’s a,b [kcal/mol] in deutrated solvents at rt.
1

2

3

4c

5c

6

7

CDCl3

0.49

-0.11

0.30

-0.40

-0.94

0.09

≤-1.74d

DMSO-d6

0.32

-0.22

-0.05

-0.45

-1.43

-0.76

≤-1.74d

CD3CN

0.15

-0.39

-0.06

-0.91

-1.51

-0.83

≤-1.74d

ΔG = –R*298*ln([folded]/[unfolded]). b Propagation of errors gives an
uncertainty less than ± 0.03 kcal/mol. c The ΔG’s of balances 4 and 5 were
obtained as the linear extrapolation to 1 equiv. of MsOH added to solutions of
balances 2 and 3, respectively (See below section). d Conservative estimate of
the folded/unfolded ratio to be greater than 19/1 as only the folded conformer 7
was observed in the 1H NMR spectra.
a

Table 2.5 Tabulated data for the correlation plot in the text.
Ph–Ph

PyH+–Ph

Py–Ph

PyMe+–Ph

Geometry
–
distal
proximal
distal
proximal distal proximal
a,b
Eexp
-0.82
-1.36
-1.19
-1.59
-2.57
-1.90
-2.88c
Ecalc b,d
-2.48
-3.04
–
-8.34
–
-7.88
-9.36
Ecalc.b,e
-2.71
-3.23
-2.36
–
–
–
–
b,f
Ecalc.
-2.61
–
–
–
-8.91
–
-9.35
a Eexp = ΔΔG = ΔG[x] - ΔG[1]; x = 2-7. ΔG’s were measured in DMSO-d at rt.
6
b [kcal/mol] c The Eexp for PyMe+–Ph stacking at the proximal configuration was
estimated to be greater than -2.88 kcal/mol. d CCSD(T)/CBS. Tsuzuki, S.; Mikami, M.;
Yamada, S. J. Am. Chem. Soc. 2007, 129, 8656. e SCS-MP2/aug-cc-pVTZ. Sherrill, C.
D.; Hohenstein, E. G. J. Phys. Chem. A 2009, 113, 878. f CCSD(T)/CBS. Singh, N. J.;
Min, S. K.; Kim, D. Y.; Kim, K. S. J. Chem. Theory and Comput. 2009, 5, 515.

3. Characterizations of the O-π repulsion in crystal structures
The atom-to-centroid distance (r) and the horizontal displacement (h) between the
arm ether oxygen and the interacting shelf six-membered aromatic unit were found to be
3.32–3.48 Å and 0.22–0.88 Å, respectively (Figure 2.14, Table 2.6). According to our
previous study,i this repulsive interaction counteracts the attractive aromatic interaction

i

Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547.
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and favors the open conformers. These measured parameters fit well with the reported
unfavorable above-surface fashion lone pair-phenyl interaction (r < 5.0 Å; h < 4.2 Å) in
the recent CSD study.i

Figure 2.14. Geometric parameters defined for
characterizing the O-π interaction. (r: the atom-to-plain
distance; h: atom-to-centroid horizontal displacement)
Table 2.6 Measured geometric parameters (r and h) defined for
characterizing the O-π interactions in crystal structure 1’, 2, 3’, 4, 6
and 7.

a

balance

1’

2

3’

4

6

r [Å]

3.48

3.715

3.48

3.48

3.33-3.43a

h [Å]

0.57

0.44

0.22

0.53

0.37-0.48a

Observation of the two crystallographically independent cations.

4. Quantification of the folded and unfolded conformers in solution
The quantification for the folded and unfolded conformers in solution was based on
their spectral integrations of the differentially shifted succinimide methide protons in the
two conformers. The signal for the ortho proton (Ha) from the aromatic pivoting unit in
the unfolded conformer was shifted upfield off the aromatic region and distinctly appeared
as a doublet of doublets, which helped to identify the Hb signal for the unfolded conformer

i

Mooibroek, T. J.; Gamez, P. CrystEngComm 2012, 14, 1027.
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The folded/unfolded ratios for balances 1-7 in the noted deuterated solvents were
measured after 1 h (~ 20 half-lives) of equilibration at rt on Varian 400 MHz spectrometer.
The folded/unfolded ratio in each case was obtained by tracking the differently shifted
succinimide methide proton signals (the spectral deconvolution using VNMRJ software
fitspec command was used). The corresponding folding energy (ΔG) was calculated using
ΔG = –RTln([folded]/[unfolded]). The ΔG’s of balances 4 and 5 were measured by adding
MsOH to solutions of balances 2 and 3, respectively. Good linear correlations were
observed between the ΔG and the amount of added MsOH in both case (Figure 2.16 and
2.17). To avoid the interference from the broad water peak, the ΔG’s of balances 4 and 5
were obtained by extrapolating the observed linear correlation trend to one equivalent of
MsOH added (See below section for details).

5. Measuring the ΔG’s for balances 4 and 5
In DMSO-d6: The relative amount of added MsOH against the balance in each
sample was calculated based on the integrated areas of the MsOH’s methyl proton (Hc)
peak (s, δ: ~2.4) and the balance’s succinimide methide proton (Hb) peaks for the two
conformers (s, δ: ~5.0) (Figure 2.15). Multiple data points were acquired within 0 to 1
equiv. range. The obtained folded/unfolded ratios, ΔG’s and relative amount of added
MsOH are shown in Table 2.7 and 2.8. The plots of ΔG’s against the relative amount of
added MsOH are shown in Figure 2.16 and Figure 2.17. The ΔG’s were found to change
linearly against the relative amount of added MsOH during the processes of |2 + MsOH →
4| and |3 + MsOH → 5|. The slopes of the linear fitting were used to extrapolate the ΔG’s
to 1 equiv. of MsOH to give ΔG[4] and ΔG[5], respectively, that is, ΔG[4] = -0.23 + ΔG[2] =
-0.45 kcal/mol; ΔG[5] = -1.38 + ΔG[3] = -1.43 kcal/mol.
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Figure 2.15 The compiled integration areas on 1H-NMR
spectra in the experiment process of |2 + MsOH →4|.
Table 2.7 The measured relative amounts of added MsOH, folded/unfolded ratios and
calculated ΔG’s in the titration experiment of |2 + MsOH → 4| in DMSO-d6
equivalent of added
0.04
0.14
0.30
0.46
0.59
0.71
0.91
0.98
MsOHa
1.55
1.67
1.77
1.85
1.97
2.06
2.15
folded/unfolded ratioa 1.47
-0.23 -0.26 -0.30 -0.34 -0.36 -0.40 -0.43 -0.45
ΔG[kcal/mol]b
a Relative error in the folded/unfolded ratios is less than ± 5%. b The error in the ΔG’s is
less than ± 0.03 kcal/mol.
Table 2.8. The measured relative amounts of added MsOH, folded/unfolded ratios and
calculated ΔG’s in the titration experiment of |3 + MsOH → 5|in DMSO-d6
equivalent of added
0.05
0.17
0.31
0.46
0.59
0.71
0.89
1.00
MsOHa
1.31
1.76
2.36
3.22
5.08
7.30 11.00
folded/unfolded ratioa 1.08
b
-0.05 -0.16 -0.33 -0.51 -0.69 -0.96 -1.18 -1.42
ΔG [kcal/mol]
a Relative error in the closed/open ratios is less than ± 5%. b The error in the ΔG’s is less
than ± 0.03 kcal/mol.
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Figure 2.16 The plot of ΔG’s against the
relative amount of added MsOH in the
titration experiment of |2 + MsOH → 4| in
DMSO-d6

0.2
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0.6
0.8
equivalence of MsOH

1

Figure 2.17 The plot of ΔG’s against the
relative amount of added MsOH in the
titration experiment of |3 + MsOH → 5| in
DMSO-d6

In CD3CN: The experiment followed the same procedure described above. The
obtained folded/unfolded ratios, ΔG’s and relative amount of added MsOH are shown in
Table 2.9 and 2.10. The plots of ΔG’s against the relative amount of added MsOH are
shown in Figure 2.18 and 2.19. ΔG[4] = -0.52 + ΔG[2] = -0.91 kcal/mol; ΔG[5] = -1.45 +
ΔG[3] = -1.51 kcal/mol.
Table 2.9 The measured relative amounts of added MsOH, folded/unfolded ratios
and calculated ΔG’s in the titration experiment of |2 + MsOH → 4|in CD3CN
0.37
0.54
0.64
0.71
0.83
equivalent of added MsOHa
2.65
3.06
3.37
3.56
3.99
folded/unfolded ratioa
b
-0.58
-0.66
-0.72
-0.75
-0.82
ΔG [kcal/mol]
a Relative error in the closed/open ratios is less than ± 5%. b The error in the ΔG’s
is less than ± 0.03 kcal/mol.
Table 2.10 The measured relative amounts of added MsOH, folded/unfolded ratios
and calculated ΔG’s in the titration experiment of |3 + MsOH → 5|in CD3CN
0.26
0.39
0.59
0.75
0.84
equivalent of added MsOHa
a
1.72
2.22
3.57
5.63
7.27
folded/unfolded ratio
b
-0.32
-0.47
-0.75
-1.02
-1.17
ΔG [kcal/mol]
a Relative error in the closed/open ratios is less than ± 5%. b The error in the ΔG’s
is less than ± 0.03 kcal/mol.

78

0.4

0.4

ΔG (kcal/mol)

ΔG (kcal/mol)

0.0
2→4

-0.4
-0.8

y = -0.52x - 0.39
R² = 1.00

-1.2

-0.1
3→5

-0.6
-1.1

y = -1.45x + 0.08
R² = 0.99

-1.6

-1.6
0.0

0.2
0.4
0.6
0.8
equivalence of MsOH

0.0

1.0

0.2

0.4

0.6

0.8

1.0

equivalence of MsOH

Figure 2.18 The plot of ΔG’s against the
relative amount of added MsOH in the
titration experiment of |2 + MsOH → 4| in
CD3CN

Figure 2.19 The plot of ΔG’s against the
relative amount of added MsOH in the
titration experiment of |3 + MsOH → 5| in
CD3CN

In CDCl3: The experiment followed the same procedure described above. The
obtained folded/unfolded ratios, ΔG’s and relative amount of added MsOH are shown in
Table 2.13 and 2.14. The plots of ΔG’s against the relative amount of added MsOH are
shown in Figure 2.20 and Figure 2.21. ΔG[4] = -0.29 + ΔG[2] = -0.40 kcal/mol; ΔG[5] = 1.24 + ΔG[3] = -0.94 kcal/mol
Table 2.11 The measured relative amounts of added MsOH, folded/unfolded ratios and
calculated ΔG’s in the titration experiment of |2 + MsOH → 4| in CDCl3
equivalent of added
0.04
0.14
0.33
0.48
0.64
0.79
0.84
0.99
MsOHa
1.31
1.44
1.56
1.69
1.81
1.83
1.98
folded/unfolded ratioa 1.25
b
-0.13 -0.16 -0.22 -0.26 -0.31 -0.35 -0.36 -0.40
ΔG [kcal/mol]
a Relative error in the closed/open ratios is less than ± 5%. b The error in the ΔG’s is less
than ± 0.03 kcal/mol.
Table 2.12 The measured relative amounts of added MsOH, folded/unfolded ratios and
calculated ΔG’s in the titration experiment of |3 + MsOH → 5| in CDCl3
equivalent of added MsOHa 0.09 0.15 0.33 0.44 0.59 0.73 0.88 0.96
0.64 0.78 1.04 1.33 1.72 2.36 3.34 4.32
folded/unfolded ratioa
b
0.27 0.14 -0.02 -0.17 -0.32 -0.51 -0.71 -0.87
ΔG [kcal/mol]
a Relative error in the closed/open ratios is less than ± 5%. b The error in the ΔG’s is
less than ± 0.03 kcal/mol.
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Figure 2.20 The plot of ΔG’s against the
relative amount of added MsOH in the
titration experiment of |2 + MsOH → 4|
in CDCl3
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Figure 2.21 The plot of ΔG’s against the
relative amount of added MsOH in the
titration experiment of |3 + MsOH → 5|
in CDCl3

6. Error analysis and maximum folded/unfolded ratios
The NMR samples in this work were prepared by dissolving ~10 mg of the purified
balance in 0.7 mL of the deuterated solvent of choice, giving a total concentration of ~22
mM (assuming an average molecular weight of 650). NMR peak areas were measured
using peak-fitting software, which greatly reduces the error of the integration analysis.
Using peak-fitting methods, NMR integration error is less than 1% for concentrations
above 10 mM.i
Therefore, the error for a 1:1 folded/unfolded ratio is very small as peaks for both
conformers correspond to concentrations greater than 10 mM. This error is equal to the
square root of the sum of the squares of 1% and 1%, which is only 1.4% (Equation 2.1).

𝐸𝑟𝑟𝑜𝑟

i

[𝑓𝑜𝑙𝑑𝑒𝑑]
[𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑]

2
2
= √𝐸𝑟𝑟𝑜𝑟[𝑓𝑜𝑙𝑑𝑒𝑑]
+ 𝐸𝑟𝑟𝑜𝑟[𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑]

Rizzo, V.; Pinciroli, V. J. Pharmaceut. Biomed. 2005, 38, 851
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(Equation 2.1)

However, for non-unity ratios, integration error will depend mostly on the
concentration of the minor conformer as the integration error. Precise measurements of
error at different concentrations could not be found. However, Rizzo et al. states that, viii
“In our experience with 400–500 MHz instruments and non-refrigerated 1H-probes, qNMR
may be applied to solutions with concentration as low as 1 mM if a precision of 5% is
acceptable.” This observation is consistent our own observations of integration errors at 1
mM. Below 1 mM the error percentages increase rapidly above 5%, therefore, the 1 mM
concentration was used as a limiting value.
Thus, for a 22 mM sample, the highest ratio that we can accurately measure is 19:1,
where the minor conformer concentration is at the limiting concentration of 1 mM. This
ratio will also have the highest percent error. Using equation 1 and plugging in a 1% error
for the major conformer and 5% error for the minor conformer, the error in the
folded/unfolded ratio will be 5.1%.
The highest error in ΔG for the unfolded-folded conformational equilibrium is
calculated using Equations 2.2 and 2.3 for the maximum ratio of 19:1. Therefore, the
propagated error in ΔG (𝐸𝑟𝑟𝑜𝑟Δ𝐺 ) is dependent on 𝐸𝑟𝑟𝑜𝑟
ratio is 19/1, 𝐸𝑟𝑟𝑜𝑟

[𝑓𝑜𝑙𝑑𝑒𝑑]
[𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑]

[𝑓𝑜𝑙𝑑𝑒𝑑] .
[𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑]

When the folding

is ±5.1% which is 0.0026. Plugging into equation 3 provides

a maximum 𝐸𝑟𝑟𝑜𝑟Δ𝐺 of ±0.03 kcal/mol.
[𝑓𝑜𝑙𝑑𝑒𝑑]

∆𝐺 = 𝑅𝑇𝑙𝑛 ([𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑])
𝐸𝑟𝑟𝑜𝑟Δ𝐺 = 𝑅 × 𝑇 × 𝐸𝑟𝑟𝑜𝑟

(Equation 2.2)
(Equation 2.3)

[𝑓𝑜𝑙𝑑𝑒𝑑]
[𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑]

2
2
𝐸𝑟𝑟𝑜𝑟ΔΔ𝐺 = √𝐸𝑟𝑟𝑜𝑟Δ𝐺
+ 𝐸𝑟𝑟𝑜𝑟Δ𝐺

(Equation 2.4)
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CHAPTER 3
THE CH-Π INTERACTION OF METHYL ETHERS AS A MODEL FOR
CARBOHYDRATE-N-HETEROARENE INTERACTIONSi

i

Reproduced with permission from Li, P.; Parker, T. M.; Hwang, J.; Deng, F.; Smith, M.
D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. Org. Lett. 2014, 16, 5064. Copyright
2014 American Chemical Society.
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1. Introduction
Carbohydrate recognition plays a key role in many biological processes1 such as
fertilization,2 immune response,3 and inflammation.4 Thus, the study of factors that
enhance carbo-hydrate affinity and selectivity has been the focus of extensive research
efforts.5 While hydrogen bonding is generally considered the primary interaction,6 CH-π
interactions7 have also been cited as key contributors to carbohydrate binding.8
Interestingly, a high percentage of the CH-π interactions of carbohydrates involve
heterocyclic aromatic surfaces.9 For example, the protein-sugar complex between Urtica
dioica agglutinin and the triose NAG3 contains four CH-π interactions each involving a
different heterocyclic aromatic residue (Trp21, Trp23, His67 and Trp69) (Figure 3.1A).10
Thus, the goal of this work was to determine whether carbohydrates form stronger CH-π
interactions with heterocyclic versus non-heterocyclic aromatic surfaces. Our strategy was
to employ a small molecule model system in conjunction with computational studies to
address this question. In this study, methyl ether groups were used as minimalistic models
of carbohydrates.

Methyl ethers can form similar CH-π interactions as those in

carbohydrates as they have alkyl groups directly attached to polar oxygens (Figure 3.1B).
In addition, the methyl ether groups lack hydrogen bond donating OH groups that would
complicate the analysis. We found that the presence of the ether oxygen plays a key role
in modulating the interaction energies and geometries of this moiety.
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Figure 3.1 (A) Crystal structure of the active site of the
Urtica dioica agglutinin with a bound tri-N-acetylchitotriose
(NAG3).9 The heterocyclic residues that form CH-π
interactions (Trp69, Trp23, His67 and Trp21) are highlighted
(PDB entry 1EHH); (B) Schematic representation of the CHπ interactions of a methyl ether group with an N-heterocyclic
and non-heterocyclic aromatic ring.
Molecular torsional balances are small molecule model systems designed to
measure the strength of intramolecular non-covalent interactions via shifts in a
conformational equilibrium.11 Utilizing this strategy, we have recently developed a rigid
bicyclic molecular balance that has been successfully applied to study a number of weak
non-covalent interactions including π-π,12 CH-π,13 deuterium-π,14 and heterocyclic-π
interactions.15 For this study, these balances were modified to study the CH-π interactions
of heterocyclic and non-heterocyclic aromatic surfaces (Figure 3.2). Balances 1-6 were
designed with a methyl arm (OCH3 or CH2CH3) and an aromatic surface containing two,
one, or zero N-heterocyclic units that could form an intramolecular CH-π interaction. The
balances were synthesized via the same modular route.11-14
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Figure 3.2 (A) Schematic representation of the unfolded–
folded conformational equilibrium of molecular balances 1-3
for measuring the CH-π interactions of the methyl ether
group; (B) Structures of the folded conformers of molecular
balances with methyl ether (1, 2, 3, and 6) and with ethyl arms
(4 and 5) and their two-armed analogues (1’, 2’, 3’ and 6’) for
X-crystallographic analysis.

2. Results and Discussion
First, the ability of balances 1-6 to form an intramolecular CH-π interaction in the
folded conformer between the methyl arm and the aromatic shelf was assessed in solution
and in the solid-state. In solution (CD2Cl2), large upfield chemical shifts were observed
for the folded versus unfolded methyl arm protons in the 1H NMR spectra (Table 3.1).
These upfield shifts (∆δ = 1.3 to 1.5 ppm) were consistent with the methyl groups being in
contact with the aromatic shelf in the folded conformers and forming the desired
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intramolecular CH-π interactions. The differences in the chemical shifts of the methyl
protons were readily measured at rt, as the unfolded and folded conformers were in slow
exchange in the 1H NMR spectra.11-14
Table 3.1 1H NMR solution measurements of balances 1-6 in
CD2Cl2 at 25 °C.
b
CH-π
a
[
folded
]
∆δCH3
balance
∆G c
interaction
[unfolded ]
1

1.42

1.04

-0.02

2

1.48

0.59

+0.31

3

1.45

0.79

+0.14

4

1.20

1.33

-0.17

5

1.15

1.41

-0.20

6

1.31

0.66

+0.25

in 1H chemical shift (ppm) of the CH3 protons between
the unfolded and folded conformers. b Measured from the
integration areas of the CH3 peaks in the 1H NMR spectra (error <
± 5%). c Folding energies in kcal/mol (±0.03 kcal/mol).
a Difference

The intramolecular CH-π interactions were also characterized in the solid-state by
X-ray crystallography. To ensure the formation of the folded conformers in the solid-state,
‘two-armed’ balances (1’, 2’, 3’ and 6’) were prepared and crystallized. The two-armed
balances have the same arm at both ortho-positions of the pivot ring, and thus, one arm is
always in the folded conformation, and the other arm is in the unfolded conformation. Xray crystallographic analysis of 1’-3’ and 6’ showed the expected intramolecular CH-π
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interactions (Figure 3.3). In each structure, a proton on the methyl group of the folded arm
was within the proper atom-to-plane distance (2.56 - 2.61 Å) to form a CH-π interaction
with the aromatic shelf.16

Figure 3.3 Truncated front views of the X-ray crystal structures of
balances 1’ (A), 2’ (B), 3’ (C) and 6’ (D), highlighting the intramolecular
CH-π interactions. In the structure for 3’, both the 3’ major and 3’ minor
configurations were observed with a ratio of 62:38. The atom-to-plane
distances for the intramolecular CH-π interactions are highlighted as red
lines.
Next, the strengths of the CH-π interactions were measured in solution (Table 3.1).
The folding ratios were measured in solution (CD2Cl2) by integration of the corresponding
peaks in the 1H NMR spectra and converted into folding energies [∆G = -RT ln
([folded]/[unfolded])]. First, the folding energies of balances 1 and 2 were compared to
test whether the methyl ether arm formed stronger interactions with heterocyclic or nonheterocyclic aromatic surfaces. Balances 1 and 2 had folding energies of -0.02 and +0.31
kcal/mol, respectively. Thus, the intramolecular interactions in heterocyclic 1 were more
stabilizing by -0.33 kcal/mol than in non-heterocyclic 2. Analysis of hybrid balance 3,
which contained a heterocyclic and a non-heterocyclic ring, provided further evidence that
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the heterocyclic surface formed stronger intramolecular interactions. The OCH3 group in
3 can flip back and forth between the heterocyclic and non-heterocyclic outer ring of the
benzoquinoline surface.17 Indeed, both intramolecular CH-π configurations were observed
in the crystal structure of 3’ (Figure 3.3C). The populations of the two configurations were
unequal in the crystal structure, as the OCH3-heterocyclic interaction was favored by
approximately 2:1 (62:38). Analyses of the folding ratios of 3 in solution were also
consistent with the heterocyclic ring forming stronger intramolecular interactions. The
folding energy of 3 (+0.14 kcal/mol) fell almost halfway between the folding energies of
the purely heterocyclic and non-heterocyclic balances 1 and 2 (-0.02 and +0.31 kcal/mol).
In assessing the reason for the above stability trends, we arrived at the conclusion
that they probably did not arise from differences in the strengths of the CH-π interactions.
Our reasoning was that CH-π interactions are generally considered to be dispersion
dominated interactions.18 The dispersion interactions for an N-heterocyclic and an isosteric
non-heterocyclic ring should be very similar as the difference in polarizability of a nitrogen
to a CH group is minor.19 Furthermore, the dipole of the N-heterocycle should have little
effect on the CH-π interaction. To confirm that heterocyclic and non-heterocyclic surfaces
form similar strength CH-π interactions, we conducted ab initio calculations (estimated
complete-basis-set-coupled-cluster, CCSD(T)/CBS) comparing the CH-π interactions of
methane with benzene and pyridine, respectively. Although differences in geometry were
observed, the intermolecular interactions in the two systems were isoenergetic (-1.39
versus -1.41 kcal/mol).
Thus, an alternative hypothesis was developed based on the role of the oxygen
linkers in balances 1-3. To isolate the influence of the oxygen linker, we synthesized two
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analogous heterocyclic and non-heterocyclic balances 4 and 5 without oxygen linkers
where the OCH3 groups were replaced by CH2CH3 groups. Balances 4 and 5 formed
similar intramolecular CH-π interactions as balances 1-3. This was evident from the
similarly large upfield chemical shifts (~1.2 ppm) of their terminal methyl protons in the
folded conformers (Table 3.1).
In contrast to methyl ether balances 1-3, balances 4 and 5 had very similar
interaction energies for the heterocyclic and non-heterocyclic surfaces. Balances 4 and 5
had folding energies of -0.17 and -0.20 kcal/mol, respectively, which were within
experimental error (±0.03 kcal/mol). Thus, both computational and experimental studies
concurred that the differences in the interactions between the heterocyclic and nonheterocyclic aromatic surfaces appeared to be due to the oxygen linker.
Two hypotheses were formulated to explain the influence of the oxygen linker on
the intramolecular interactions. The first hypothesis was that the oxygen linker was
polarizing the C-H bond of the methyl ether. This polarization hypothesis was consistent
with theoretical20 and experimental21 studies that found that more polarized or acidic C–H
bonds form stronger CH-π interactions. The second hypothesis was that the C-O bond
dipole was interacting with the heterocyclic dipole. The two hypotheses were tested
computationally and experimentally by positioning the OCH3 group at different angles over
the N-heterocyclic ring (Figure 3.4). The dihedral angle (α) of the C-O bond dipole with
respect to the heterocycle dipole was systematically varied and the corresponding
interaction energies were measured (Figure 3.4). For the C-H bond polarization hypothesis,
the interaction energy should not vary substantially and would only be weakened when the
electronegative oxygen and nitrogen atoms were in close proximity. However, for the
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dipole hypothesis, there should be a strong stabilizing as well as a destabilizing effect,
depending upon the orientation of the dipoles.

X=H
X = OMe

1.5

ΔE (kcal/mol)

1.2

+1.33

0.9
+0.44

0.6
0.3

+0.03

+0.07

+0.11

+0.07

0.0
-0.3
-0.6

-0.40

α = 180°

-0.20

120°

60°

0°

Figure 3.4 (A) Calculated CCSD(T)/CBS [i.e., MP2/CBS from aug-ccpVQZ/aug-cc-pV5Z extrapolation + (CCSD(T)/aug-cc-pVTZ –
MP2/aug-cc-pVTZ)] interaction energy differences (ΔE) between the
heterocyclic and non-heterocyclic CH-π complexes [ΔE = E (CH3X/Py)
- E (CH3X/Bz); X = H or OMe] at four different orientations of the
dipoles ( = 180˚, 120˚, 60˚ and 0˚);i (B) Partial top-views of the CH-π
interaction regions in crystal structures 1’ (top) and 6’ (bottom)
highlighting the orientations of the C-O bond and heterocycle dipoles.
The results from our computational and experimental studies were consistent with
the dipole hypothesis. First, the computational study estimated the complexation energy
of dimethyl ether with pyridine or benzene. The CH3 group of dimethyl ether was
positioned over the aromatic ring with a single C–H bond forming a CH-π interaction.
Intermolecular interaction energies were computed for a series of dihedral angles α. The
difference in interaction energies when pyridine was replaced by benzene, ∆E, was plotted
as a function of α in Figure 3.4 (red curve). When the C-O and pyridine dipoles were
antiparallel (α = 180°), the interaction between dimethyl ether and pyridine was stabilized

i

Details and Results of Theoretical Calculations are available free of charge via Internet
at http://pubs.acs.org/doi/abs/10.1021/ol502418k
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compared to the interaction energy between dimethyl ether and benzene (∆E = -0.40
kcal/mol). When the C-O and pyridine dipoles were parallel (α = 0°), the interaction energy
was strongly destabilizing for pyridine versus benzene (∆E = 1.33 kcal/mol). To confirm
that these geometric effects were indeed due to interactions between the C-O dipole and
the heterocycle dipole, a control study was performed in which dimethyl ether was replaced
in the computations by methane (blue curve in Figure 3.4). Consistent with our hypothesis,
the removal of the C-O dipole by replacing dimethyl ether with methane resulted in very
small values for ∆E (the difference between methane/pyridine and methane/benzene) that
are nearly constant with respect to α.
A similar experiment was carried out using our molecular balances. The precise
positioning of the OCH3 and heterocycle dipoles was more difficult using model system.
However, we were able to synthesize and test a new balance 6 which had the heterocyclic
nitrogens at the 4- and 7-positions. This places the N-heterocyclic nitrogens on opposite
edge of the aromatic shelf in comparison to the original 1,10-phenanthroline shelf.
Comparison of balances 1 and 6 provided a means to study two different geometries of the
interaction. The orientation of the heterocycle dipole of the outer ring on the shelf and the
C-O bond from the crystal structures of 1’ and 6’ (Figure 3.4B) most closely correlates to
α = 120° and 60°, respectively. Thus, the dipoles in 1 point in opposite directions and the
dipoles in 6 point in the same direction. The measured folding energies for 1 and 6 (-0.02
and +0.25 kcal/mol) revealed the same stability trend predicted by the computational study.
When the dipoles were antiparallel as in balance 1, the OCH3-heterocyclic interaction was
more stabilizing (lower in energy). When the dipoles were aligned in the same direction
as in 6, the OCH3-heterocyclic interaction was destabilized (higher in energy).
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3. Conclusion
In conclusion, we have utilized a combination of theory and model systems to study
the CH-π interactions of N-heterocyclic and non-heterocyclic surfaces. There was excellent agreement between the two approaches. The -OCH3 group was found to be capable of
forming stronger non-covalent interactions with N-heterocyclic surfaces. In contrast, the CH2CH3 group showed similar interaction energies for the two types of surfaces. Thus, the
methyl ether oxygen appears to play a key role in modifying the interaction energies with
heterocyclic surfaces. The oxygen atom does not appear to enhance the CH-π interaction
directly. Instead, the C-O dipole is interacting with the heterocycle dipole, which can
strengthen or weaken the OCH3-aromatic interaction. These stability trends may have
bearing on many biologically important carbohydrate-aromatic interactions. The attraction
between C-O and heterocycle dipoles explain the prevalence of carbohydrate-Nheteroarene interactions. This dipole-dipole interaction could also be used to optimize
carbohydrate binding in synthetic and bioengineered carbohydrate receptors.

New

molecular balances containing other biologically relevant heterocyclic motifs, such as
tryptophane, pyrimidine and purines, are currently being developed in our laboratory to
further investigate this phenomenon.
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Supporting Information
1. Synthesis and characterization
1.1 Synthesis
Diones 7 and 8 were purchased from commercial suppliers. Diones 9i, 10ii were
obtained according to the literature procedures without modification. Dienes 11iii, 12iv, 13
and 14 were synthesized according to a modified two-steps procedure from diones 7, 8, 9
and 10, respectively. These crude dienes 11-14 were obtained as a mixture of monomer
and dimer forms v and used directly in the next step without purification. vi

N-

arylmaleimides 15, 16, and 17 were obtained according to literature procedure using maleic
anhydride and a substituted aniline. vii The one-armed balances 1-6 and two-armed
balances 1’, 3’ and 6’ were synthesized following the previously reported Diels-Alder
reaction between the corresponding diene and maleimide.viii Balances 1-6, 1’, 3’ and, 6’

i

Chen, Y. M.; Liu, Y. J.; Li, Q.; Wang, K. Z. J. Inorg. Biochem. 2009, 103, 1395.
Bonhote, P.; Wrighton, M. S. Synlett 1997, 897.
iii
Warrener, R. N.; Schultz, A. C.; Houghton, M. A.; Butler, D. N. Tetrahedron 1997, 53,
3991
iv
a) Jones, D. W. J. Chem. Soc. Perk. Trans. I 1977, 980; b)Fuchs, B.; Pasternak, M.
Tetrahedron 1981, 37, 2501; c) Plater, M. J.; Schmidt, D. M.; Howie, R. A. J. Chem. ResS 1997, 390
v
Fuchs, B.; Pasternak, M.; Scharf, G. J. Chem. Soc. Chem. Comm. 1976, 53
vi
The dimerized dienes can dissociate to the monor form during the thermal Dials-Alder
reaction. The NMR spectra of dimerized dienes were less clear due to the [3,3] Cope
rearrangement which occurs rapidly on an NMR timescale at rt in solution. (see note iii
for detail explanation). The HRMS data were given for verification purpose.
vii
Matuszak, N.; Muccioli, G. G.; Labar, G.; Lambert, D. M. J. Med. Chem. 2009, 52, 7410.
viii
Li, P.; Zhao, C.; Smith, M. D.; Shimizu, K. D. J. Org. Chem. 2013, 78, 5303.
ii
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are newly reported compounds. Balance 2’ was obtained as previously described.i The
synthesis of balance 2 is detailed below as an example for the modular synthetic route for
assembling these balances.

Figure 3.5 List of molecular balances 1-6 (shown in their folded conformers)
and precursors used in this study and the general synthetic route

Diene 12. Potassium carbonate (1.32 g, 9.55 mmol) and pentan-3-one (0.82 g, 9.52
mmol) were suspended in dry methanol (30 mL). To the above suspension, phenanthrene-

i

Carroll, W. R.; Zhao, C.; Smith, M. D.; Pellechia, P. J.; Shimizu, K. D. Org. Lett. 2011,
13, 4320.
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9,10-dione (8) (1.00 g 4.81 mmol) was added portion-wise over 10 min, and the mixture
was stirred at rt for 12 h. The reaction mixture was then concentrated to 5 mL under
vacuum and suspended in water. The insoluble solid was collected and dried under vacuum
to give the β-hydroxyketone-A as a solid (1.20 g, 90 %), which was used in the next step
without further purification. 1H NMR (400 MHz, CDCl3) δ 8.02-7.96 (m, 1H), 7.95-7.90
(m, 1H), 7.73 (dd, J = 7.6 Hz, J = 1.3 Hz, 1H), 7.35-7.58 (m, 5H), 3.08 (q, J = 7.5 Hz,
1H), 2.10 (s, 3H), 1.57 (d, J = 7.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): 208.7, 161.6,
139.4, 135.2, 133.4, 132.6, 131.0, 129.6, 129.4, 129.3, 128.5, 128.4, 126.5, 125.1, 124.5,
75.5, 47.9, 11.4, 9.9. HRMS (ESI) m/z calcd. for [C19H16O2]+ (M+): 276.1150; found:
276.1149. β-hydroxyketone-A (1.20 g, 4.34 mmol) and 4-dimethylaminopyridine (1.50 g,
12.3 mmol) were dissolved in dry CH2Cl2 (40 mL) and cooled to 0 ºC. To the above
solution, methanesulfonyl chloride (0.84 mL, 10.9 mmol) was added under N2, and the
solution was stirred at rt for 12 h. The reaction mixture was washed with water (3 x 50
mL) and brine (50 mL) before it was dried with MgSO4, and the solvent was removed
under vacuum. The solid residue was washed with cold methanol (~ 10 mL) to give diene
12 as a white solid (0.70 g, 62 %). 1H NMR (400 MHz, CDCl3) δ 8.50–8.22 (m, 2H), 7.84
(bs, 1H), 7.68–7.44 (m, 3H), 7.22–7.15 (m, 1H), 6.93 (bs, 1H), 1.88 (s, 3H), 1.22 (s, 3H).
HRMS m/z calcd. for [(C19H14O)2]+ (2M+): 516.2089; found: 516.2078.
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11-(2-methoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanophenanthro[9,10-f]iso-indole-10,12, 14(9aH,11H)-trione. (2) Diene 12 (80 mg, 0.31 mmol) and
N-(2-methoxylphenyl) maleimide (15) (76 mg, 0.37 mmol) were dissolved in dry CH2Cl2
(10 mL) and sealed in a medium pressure tube after flushing with N2. The pressure tube
was heated to 90 ºC with stirring for 24 h. After cooling, the solvent was removed under
vacuum. The solid residue was washed with cold methanol (~10 mL) and then cold
acetonitrile (~ 2 mL) to give 2 as an off-white solid (122 mg, 84 %). 1H NMR (400 MHz,
CDCl3) δ 8.82-8.72 (m, 2H major, 2H minor), 8.41-8.32 (m, 2H major, 2H minor), 7.747.55 (m, 4H major, 4H minor), 7.10 (ddd, J = 8.4 Hz, J = 7.6 Hz, J = 1.7 Hz, 1H minor),
7.03 (ddd, J = 8.4 Hz, J = 7.6 Hz, J = 1.7 Hz, 1H major), 6.84 (dd, J = 7.8 Hz, J = 1.7 Hz,
1H minor), 6.81–6.76 (m, 1H minor), 6.71 (dd, J = 8.4 Hz, J = 1.2 Hz, 1H major), 6.43
(dd, J = 8.4 Hz, J = 1.2 Hz, 1 minor), 6.29 (ddd, J = 7.8 Hz, J = 7.6 Hz, J = 1.2 Hz, 1H
major), 4.59 (dd, J = 7.8 Hz, J = 1.7 Hz, 1H major), 3.64 (s, 3H major), 3.55 (s, 2H major),
3.54 (s, 2H minor), 2.33 (s, 6H major), 2.29 (s, 6H minor), 2.15 (s, 1H minor).

13

C NMR

(100 MHz, CDCl3) δ 201.3, 173.9, 154.3, 133.4, 133.3, 131.1, 130.8, 130.6, 130.5, 128.6,
127.8, 127.5, 127.4, 127.3, 127.2, 126.9, 125.6, 125.3, 123.4, 123.2, 120.6, 120.2, 119.7,
111.9, 111.7, 55.7, 55.2, 55.1, 53.9, 48.2, 48.0, 15.0, 14.9. HRMS (ESI) m/z calcd. for
[C30H23NO4]+ (M+): 461.1627; found: 461.1630.
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Diene 11 was synthesized using the same procedure described for diene 12 using
1,10-phenanthroline-5,6-dione (7) (1.00 g 4.76 mmol) and pentan-3-one (0.82 g, 9.52
mmol). Diene 11 was obtained as an off-white solid (0.75 g, 61 % for the two steps). The
1

H-NMR spectrum was compared with literature.

i

HRMS (ESI) m/z calcd. for

[C17H12N2O]+ (M+): 260.0950; found: 260.0959

11-(2-methoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanoisoindolo[5,6-f][1,10] phenanthroline-10,12,14(9aH,11H)-trione. (1) Diene 11 (80 mg, 0.31
mmol) and N-(2-methoxylphenyl) maleimide (15) (76 mg, 0.37 mmol) were reacted using
the same procedure as described for balance 2. Balance 1 was obtained as a white solid
(109 mg, 76%). 1H NMR (400 MHz, CDCl3) δ 9.24 (dd, J = 4.8 Hz, J = 1.5 Hz, 2H major,
2H minor), 8.73 (dd, J = 8.5 Hz, J = 1.5 Hz, 2H major, 2H minor), 7.68 (dd, J = 8.5 Hz, J
= 4.3 Hz, 2H major, 2H minor), 7.15-7.09 (m, 1H minor), 7.06 (ddd, J = 8.3 Hz, J = 7.6
Hz, J = 1.7 Hz, 1H major), 6.81-6.79 (m, 2H minor), 6.74 (dd, J = 8.4 Hz, J = 1.0 Hz, 1H
major), 6.45 (dd, J = 8.4 Hz, J = 1.0 Hz, 1H minor), 6.33 (ddd, J = 7.7 Hz, J = 7.6 Hz, J

i

Warrener, R. N.; Schultz, A. C.; Houghton, M. A.; Butler, D. N. Tetrahedron 1997, 53,
3991
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= 1.0 Hz, 1H major), 4.64 (dd, J = 7.8 Hz, J = 1.7 Hz, 1H major), 3.65 (s, 3H major), 3.61
(s, 2H major), 3.58 (s, 2H minor), 2.33 (s, 6H major), 2.31 (s, 6H minor), 2.24 (s, 3H
minor).

13

C NMR (100 MHz, CDCl3) δ 200.2, 199.1, 173.7, 154.4, 154.0, 150.8, 150.3,

146.1, 133.6, 133.5, 132.8, 132.7, 131.0, 130.8, 128.6, 127.5, 125.1, 124.7, 123.6, 123.4,
121.0, 120.5, 119.3, 119.1, 112.1, 111.8, 77.5, 55.7, 55.5, 55.4, 54.4, 47.8, 47.7, 29.9, 14.5,
14.3. HRMS (ESI) m/z calcd. for [C28H21N3O4]+ (M+): 463.1532, found; 463.1521.

11-(2,6-dimethoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanoisoindolo[5,6-f] [1,10]phenanthroline-10,12,14(9aH,11H)-trione. (1’) Diene 11 (80 mg, 0.31
mmol) and N-(2,2’-dimethoxylphenyl) maleimide (16) (108 mg, 0.46 mmol) were reacted
using the same procedure as described for balance 2. Balance 1’ was obtained as a white
solid (130 mg, 85%). 1H NMR (400 MHz, CDCl3) δ 9.23 (dd, J = 4.3 Hz, J = 1.2 Hz, 2H),
8.73 (dd, J = 8.4 Hz, J = 1.2 Hz, 2H), 7.67 (dd, J = 8.4 Hz, J = 4.3 Hz, 2H), 7.05 (t, J =
8.5 Hz, 1H), 6.38 (dd, J = 8.5 Hz, J = 1.0 Hz, 1H), 6.06 (dd, J = 8.5 Hz, J = 1.0 Hz, 1H),
3.67 (s, 3H), 3.61 (s, 2H), 2.31 (s, 6H), 2.27 (s, 3H).

C NMR (100 MHz, CDCl3) δ 199.4,

13

173.5, 155.7, 155.1, 149.9, 133.9, 133.5, 131.0, 125.3, 123.7, 107.8, 104.3, 103.7, 56.1,
55.4, 54.8, 47.7, 14.4. HRMS (ESI) m/z calcd. for [C29H23N3O5]+ (M+): 493.1638 found:
493.1635.
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Diene 13. Potassium carbonate (1.32 g, 9.55 mmol) and pentan-3-one (0.82 g, 9.52
mmol) were suspended in dry methanol (30 mL).

To the above suspension,

benzo[h]quinoline-5,6-dione (9)xi (1.00 g 4.78 mmol) was added in portion-wise over 10
min, and the mixture was stirred at rt for 12 h. The solvent was then removed under
vacuum. The residue was washed with water and dried under vacuum to give the βhydroxyketone-B (two constitutional isomers with a ratio of ~1:2.3) as a greyish white
solid (1.05 g, 79 %). 1H NMR (400 MHz, CDCl3) δ 8.65 (dd, J = 4.8 Hz, J = 1.7 Hz, 1H
major), 8.63 (dd, J = 4.8 Hz, J = 1.7 Hz, 1H major), 8.57-8.54 (m, 1H minor), 8.49-8.43
(m, 1H major), 8.01 (dd, J = 7.8 Hz, J = 1.7 Hz, 1H major), 7.80 (dd, J = 7.8 Hz, J = 1.7
Hz, 1H minor), 7.75-7.71 (m, 1H minor), 7.62-7.41 (m, 3H major and 2H minor), 7.32 (dd,
J = 7.8 Hz, J = 4.8 Hz, 1H major), 7.27 (dd, J = 7.8 Hz, J = 4.8 Hz, 1H minor), 3.10 (q, J
= 7.4 Hz, 1H major), 3.04 (q, J = 7.4 Hz, 1H minor), 2.11 (s, 3H minor), 2.09 (s, 3H major),
1.60 (d, J = 7.4 Hz, 3H major), 1.57 (d, J = 7.4 Hz, 3H minor).

13

C NMR (100 MHz,

CDCl3) δ 208.3, 208.1, 160.3, 159.6, 151.0, 150.8, 150.4, 150.0, 140.4, 136.9, 136.2, 135.8,
134.9, 134.1, 133.7, 132.7, 131.2, 130.9, 130.0, 129.7, 129.4, 128.9, 126.9, 126.3, 125.8,
124.3, 123.6, 122.9, 75.7, 75.2, 48.07, 47.9, 11.4, 11.3, 10.0, 9.7. HRMS (ESI) m/z calcd.
for [C18H15NO2]+ (M+): 277.1103; found: 277.1100. The β-hydroxyketone-B (1.05 g, 3.79
mmol) and 4-dimethylaminopyridine (1.50 g, 12.3 mmol) was dissolved in dry CH2Cl2 (40
mL) and cooled to at 0 ºC. To the above solution, methanesulfonyl chloride (0.84 mL, 10.9
mmol) was added under nitrogen and kept stirring at rt for 12 h. The reaction mixture was
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then washed with water (3 x 50 mL) and brine (50 mL) before it was dried with MgSO4,
and the solvent was removed under vacuum. The solid residue was washed with cold
methanol to give diene 13 as a white solid (0.75 g, 76 %). 1H-NMR (400 MHz, CDCl3) δ
9.25-8.72 (m, 2H), 8.26-6.78 (m, 5H), 2.03-1.73 (m, 3H), 1.25-1.14 (m, 3H). HRMS (ESI)
m/z calcd. for [C18H13NO]+ (M+): 259.0997; found: 259.1004.

11-(2-methoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanobenzo[h]isoindolo[5,6-f]quinoline-10,12,14(9aH,11H)-trione. (3) Diene 13 (80 mg, 0.31 mmol)
and N-(2-methoxylphenyl) maleimide (15) (76 mg, 0.37 mmol) were reacted using the
same procedure as described for balance 2. Balance 3 was obtained as a beige-white solid
(97 mg, 68 %). 1H NMR (400 MHz, CD2Cl2) δ 9.50-9.43 (m, 1H major, 1H minor), 8.99
(td, J = 4.5 Hz, J = 1.7 Hz, 1H major), 8.98 (dd, J = 4.5 Hz, J = 1.7 Hz, 1H minor), 8.65
(dd, J = 8.4 Hz, J = 1.7 Hz, 1H major), 8.64 (dd, J = 8.4 Hz, J = 1.7 Hz, 1H minor), 8.408.33 (m, 1H major, 1H minor), 7.81-7.70 (m, 2H major, 2H minor), 7.56 (dd, J = 8.4 Hz,
J = 4.3 Hz, 1H minor), 7.55 (dd, J = 8.4 Hz, J = 4.3 Hz, 1H major), 7.18-7.04 (m, 1H
major, 1H minor), 6.86-6.73 (m, 1H major, 2H minor), 6.47 (d, J = 8.2 Hz, 1H minor),
6.31 (td, J = 7.8 Hz, J = 1.2 Hz, 1H major), 4.51 (dd, J = 7.8 Hz, J = 1.6 Hz, 1H major),
3.64 (s, 3H major), 3.58 (s, 2H major, 2H minor), 2.32 (s, 3H major), 2.30 (s, 3H, minor),
2.28 (s, 3H major), 2.26 (s, 3H minor), 2.19 (s, 3H minor). 13C NMR (100 MHz, CDCl3) δ
200.8, 199.4, 174.1, 173.9, 173.7, 173.6, 154.7, 154.5, 154.3, 154.2, 149.3, 148.8, 146.9,

102

146.5, 140.1, 134.4, 134.2, 132.7, 132.5, 132.5, 132.4, 132.3, 132.1, 130.8, 130.6, 129.5,
129.2, 129.1, 128.9, 128.6, 127.7, 127.6, 127.3, 125.7, 125.6, 124.7, 124.5, 122.6, 122.3,
122.1, 120.8, 120.3, 119.6, 119.5, 112.0, 111.8, 55.7, 55.5, 55.4, 55.3, 55.1, 48.1, 48.0,
47.9, 47.8, 14.8, 14.6, 14.5. HRMS (ESI) m/z calcd. for [C29H22N2O4]+ (M+): 462.1580;
found: 462.1575.

11-(2,6-dimethoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanobenzo[h]isoindolo [5,6-f]quinolone-10,12,14(9aH,11H)-trione. (3’) Diene 13 (80 mg, 0.31
mmol) and N-(2,2’-dimethoxylphenyl) maleimide (16) (108 mg, 0.46 mmol) were reacted
using the same procedure as described for balance 2. Balance 3’ was obtained as a white
crystalline solid (110 mg, 72 %). 1H NMR (400 MHz, CD2Cl2) δ 9.48-9.43 (m, 1H), 8.98
(dd, J = 4.3 Hz, J = 1.7 Hz, 1H), 8.64 (dd, J = 8.4 Hz, J = 1.7 Hz, 1H), 8.40 – 8.33 (m,
1H), 7.77 – 7.71 (m, 2H), 7.56 (dd, J = 8.4 Hz, J = 4.3 Hz, 1H), 7.08 (t, J = 8.5 Hz, 1H),
6.42 (dd, J = 8.5 Hz, J = 1.0 Hz, 1H), 6.08 (dd, J = 8.5 Hz, J = 1.0 Hz, 1H), 3.67 (s, 3H),
3.59 (s, 2H), 2.29 (s, 3H), 2.25 (s, 3H), 2.20 (s, 3H). 13C NMR (100 MHz, CD2Cl2) δ 200.1,
174.3, 174.0, 156.3, 155.8, 149.2, 147.2, 134.9, 133.1, 133.0, 132.9, 131.0, 130.0, 129.0,
127.6, 125.9, 125.1, 123.1, 122.4, 104.4, 104.1, 56.5, 55.7, 55.5, 48.5, 48.4, 15.90, 14.7.
HRMS (ESI) m/z calcd. for [C30H24N2O5]+ (M+): 492.1685; found: 492.1680.
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Diene 14. Potassium carbonate (1.32 g, 9.55 mmol) and pentan-3-one (0.82 g, 9.52
mmol) were suspended in dry methanol (30 mL).

To the above suspension, 4,7-

phenanthroline-5,6-dione (10)xii (1.00 g, 4.76 mmol) was added in portion-wise over 10
min, and the mixture was stirred at rt for 12 h. The solvent was then removed under
vacuum. The residue was washed with water and dried under vacuum to give the βhydroxyketone-C as an off-white solid (0.93 g, 70 %). 1H NMR (400 MHz, DMSO-d6) δ
8.75 (dd, J = 4.7 Hz, J = 1.6 Hz, 1H), 8.61-8.56 (m, 2H), 8.48 (dd, J = 8.2 Hz, J = 1.6 Hz,
1H), 7.58 (dd, J = 8.2 Hz, J = 4.7 Hz, 1H), 7.51 (dd, J = 8.2 Hz, J = 4.7 Hz, 1H), 3.17 (t,
J = 7.4 Hz, 1H), 2.15 (s, 3H), 1.40 (d, J = 7.3 Hz, 3H). 13C NMR (100 MHz, DMSO-d6) δ
209.2, 158.8, 157.2, 149.6, 149.1, 148.1, 137.9, 132.8, 132.0, 128.3, 125.9, 124.7, 124.0,
76.5, 47.0, 10.7, 9.6. HRMS (ESI) m/z calcd. for [C17H14N2O2]+ (M+): 278.1055; found:
278.1053. The β-hydroxyketone-C (0.93 g, 3.34 mmol) and 4-dimethylaminopyridine
(1.50 g, 12.3 mmol) was dissolved in dry CH2Cl2 (40 mL) and cooled to at 0 ºC. To the
above solution, methanesulfonyl chloride (0.84 mL, 10.9 mmol) was added under nitrogen
and kept stirring at rt for 12 h. The reaction mixture was then washed with water (3 x 50
mL) and brine (50 mL) before it was dried with MgSO4, and the solvent was removed
under vacuum. The solid residue was washed with cold methanol to give diene 14 as a
white solid (0.60 g, 69 %) 1H NMR (400 MHz, CDCl3) δ 8.90 (bs, 1H), 8.50 (m, 3H), 7.53-
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7.38 (m, 2H), 2.00 (bs, 3H), 1.37-1.23 (s, 3H). HRMS (ESI) m/z calcd. for [C17H12N2O]+
(M+): 260.0950; found: 260.0948.

11-(2-ethylphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanoisoindolo
[5,6-f][1,10]phen-anthroline-10,12,14(9aH,11H)-trione. (4) Diene 11 (80 mg, 0.31 mmol)
and N-(2-ethylphenyl) maleimide (17) (92 mg, 0.46 mmol) were reacted using the same
procedure as described for balance 2. Balance 4 was obtained as a white solid (124 mg, 87
%). 1H NMR (400 MHz, CD2Cl2) δ 9.20-9.12 (m, 2H major, 2H minor), 8.76-8.65 (m, 2H
major, 2H minor), 7.73-7.58 (m, 2H major, 2H minor), 7.23-7.03 (m, 2H major, 2H minor),
6.91-6.74 (m, 2H major), 6.54 (td, J = 7.6 Hz, J = 1.6 Hz, 1H minor), 4.25 (dd, J = 7.9 Hz,
J = 1.2 Hz, 1H minor), 3.66 (s, 2H major), 3.65 (s, 2H minor), 2.32 (s, 6H minor), 2.30 (s,
6H major), 2.22 (q, J = 7.6 Hz, 2H minor), 0.99 (t, J = 7.6 Hz, 3H minor), 0.05 (q, J = 7.6
Hz, 2H major), -0.21 (t, J = 7.6 Hz, 3H major). 13C NMR (100 MHz, CD2Cl2) δ 200.4,
199.3, 174.8, 174.7, 151.1, 150.9, 147.3, 146.8, 141.8, 141.6, 134.3, 133.9, 132.9, 130.6,
130.2, 130.1, 130.0, 129.5, 128.8, 128.1, 127.2, 127.1, 126.9, 125.3, 125.1, 123.7, 123.7,
55.9, 55.8, 48.5, 48.1, 24.4, 22.1, 14.7, 14.5, 12.7.
[C29H23N3O3]+ (M+): 461.1739; found: 461.1736.
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HRMS (ESI) m/z calcd. for

11-(2-ethylphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanophenanthro[9,10-f]isoindole-10,12,14(9aH,11H)-trione. (5) Diene 12 (80 mg, 0.31 mmol) and N-(2ethylphenyl) maleimide (17) (92 mg, 0.46 mmol) were reacted using the same procedure
as described for balance 2. Balance 5 was obtained as a white solid (104 mg, 73%). 1H
NMR (400 MHz, CD2Cl2) δ 8.90-8.73 (m, 2H major, 2H minor), 8.46-8.31 (m, 2H major,
2H minor), 7.76-7.60 (m, 4H major, 4H minor), 7.20-7.07 (m, 2H major, 1H minor), 7.03
(td, J = 7.5 Hz, J = 1.2 Hz, 1H minor), 6.90-6.74 (m, 2H major), 6.47 (ddd, J = 7.8 Hz, J =
7.4 Hz, J = 1.6 Hz, 1H minor), 4.25 (dd, J = 7.8 Hz, J = 1.2 Hz, 1H minor), 3.61 (s, 2H
major), 3.59 (s, 2H minor), 2.32 (s, 6H minor), 2.29 (s, 6H major), 2.23 (q, J = 7.6 Hz, 2H
minor), 0.99 (t, J = 7.5 Hz, 3H minor), 0.20-0.04 (m, 2H major), -0.16 (t, J = 7.5 Hz, 3H
major).

13

C NMR (100 MHz, CD2Cl2) δ 201.4, 200.1, 175.0, 174.9, 142.0, 141.8, 134.1,

133.8, 131.6, 131.2, 130.9, 130.0, 129.8, 129.3, 128.6, 128.3, 128.2, 128.1, 128.0, 127.9,
127.8, 127.7, 127.2, 126.9, 126.8, 125.7, 124.0, 55.6, 55.5, 48.9, 48.4, 24.4, 21.9, 15.2,
15.1, 14.5, 12.5. HRMS (ESI) m/z calcd. for [C31H25NO3]+ (M+): 459.1834; found:
459.1837.
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11-(2-methoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanoisoindolo[5,6-f][4,7]phe-nanthroline-10,12,14(9aH,11H)-trione. (6) Diene 14 (80 mg, 0.31 mmol)
and N-(2-methoxylphenyl) maleimide (15) (76 mg, 0.37 mmol) were reacted using the
same procedure as described for balance 2. Balance 6 was obtained as a white solid (100
mg, 69 %) 1H NMR (400 MHz, CD2Cl2) δ 9.05 (dd, J = 4.3 Hz, J = 1.7 Hz, 2H minor),
9.03 (dd, J = 4.3 Hz, J = 1.7 Hz, 2H major), 8.99 (dd, J = 8.6 Hz, J = 1.7 Hz, 2H major),
8.97 (dd, J = 8.6 Hz, J = 1.7 Hz, 2H minor), 7.64 (dd, J = 8.5 Hz, J = 4.3 Hz, 2H major),
7.64 (dd, J = 8.5 Hz, J = 4.3 Hz, 2H minor), 7.14 (ddd, J = 8.4 Hz, J = 7.0 Hz, J = 2.2 Hz,
1H minor), 7.09 (ddd, J = 8.4 Hz, J = 7.6 Hz, J = 1.7 Hz, 1H major), 6.88-6.80 (m, 2H
minor), 6.78 (dd, J = 8.4 Hz, J = 1.2 Hz, 1H major), 6.50 (dd, J = 8.4 Hz, J = 1.1 Hz, 1H
minor), 6.35 (td, J = 7.7 Hz, J = 1.2 Hz, 1H major), 4.57 (dd, J = 7.7 Hz, J = 1.7 Hz, 1H
major), 3.64 (s, 3H major), 3.58 (s, 2H minor), 3.58 (s, 2H major), 2.39 (s, 6H major), 2.37
(s, 6H minor), 2.33 (s, 3H minor).

13

C NMR (100 MHz, CD2Cl2) δ 203.0, 201.5, 173.6,

173.6, 155.0, 154.9, 151,0 150.7, 144.9, 144.5, 138.6, 138.4, 131.3, 131.2, 130.9, 130.8,
129.1, 128.0, 125.8, 125.4, 122.5, 122.3, 120.8, 120.7, 120.7, 120.6, 112.5, 112.5, 56.5,
56.5, 56.2, 55.0, 49.0, 48.8, 30.3, 14.6, 14.3. HRMS (ESI) m/z calcd. for [C28H21N3O4]+
(M+): 463.1532; found: 463.1531.
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11-(2,6-dimethoxyphenyl)-9,13-dimethyl-12a,13-dihydro-9H-9,13-methanoisoindolo[5,6-f][4,7] phenanthroline-10,12,14(9aH,11H)-trione. (6’) Diene 14 (80 mg, 0.31
mmol) and N-(2,2’-dimethoxylphenyl) maleimide (16) (108 mg, 0.46 mmol) were reacted
using the same procedure as described for balance 2. Balance 6’ was obtained as a white
solid (120 mg, 78 %)

1

H NMR (400 MHz, CD2Cl2) δ 9.05 (dd, J = 4.3 Hz, J = 1.7 Hz,

1H), 8.98 (dd, J = 8.5 Hz, J = 1.7 Hz, 1H), 7.63 (dd, J = 8.5 Hz, J = 4.3 Hz, 1H), 7.09 (t,
J = 8.5 Hz, 1H), 6.44 (dd, J = 8.5 Hz, J = 1.0 Hz, 1H), 6.11 (dd, J = 8.6 Hz, J = 1.0 Hz,
1H), 3.67 (s, 3H), 3.59 (s, 2H), 2.36 (s, 6H), 2.34 (s, 3H). 13C NMR (100 MHz, CD2Cl2) δ
201.9, 173.5, 156.3, 155.9, 150.6, 144.9, 138.6, 131.1, 130.9, 125.7, 122.2, 104.5, 104.3,
56.5, 56.4, 55.2, 49.0, 14.6. HRMS (ESI) m/z calcd. for [C29H23N3O5]+ (M+): 493.1638;
found: 493.1641.

1.2 Characterization
1

1’,

H and 13C NMR spectra for all newly reported compounds and crystal data (cif) of

2’

and

6’

are

available

free

http://pubs.acs.org/doi/abs/10.1021/ol502418k
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of

charge

via

Internet

at

2. Characterization of the CH-π interactions in crystal structures 1’-3’and 6’
Formation of the intramolecular CH-π interactions was confirmed in the X-ray
crystal structures of two-armed balances 1’-3’ and 6’. It was found in all four crystal
structures that the arm (O)CH3 in the folded conformation stayed close above the one outer
six-membered ring on the shelf (Figure 3.6a). Characterization of the CH-π interactions
between the arm (O)CH3 and opposing six-membered ring was carried out using a set of
parameters as demonstrated in Figure 3.6b. The interacting CH proton was found to point
toward the opposing six-membered ring with an atom-to-plane distance (H) of 2.56 to 2.61
Å, and a C-H-plane accessing angle (α) of 147˚ to 154 (Table 3.2). The projection of CH
proton on the ring reside plane was found to be off the ring centroid by a displacement (d1)
of 0.25 to 1.30 Å, These observations are in well agreement with the reported geometry
for aliphatic CH-π interactions (H = ~2.75 Å, d1 ≤ 1.47 Å, and α = ~157˚).i

i

Nishio, M.; Umezawa, Y.; Honda, K.; Tsuboyama, S.; Suezawa, H. CrystEngComm
2009, 11, 1757
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Figure 3.6 (a) Side views (top row) and truncated top views (bottom row) of the
X-ray crystal structures 1’-3’ and 6’ highlighting the relative position between the
interacting arm OCH3 and shelf arene. The bridgehead functional groups are
omitted for viewing clarity. The major structure observed in 3’ is shown here. (b)
Definition of the geometric parameters for characterizing the intramolecular CH-π
interactions in these crystal structures: the hydrogen-to-plane distance (H); the CH-plane accessing angle (α); the hydrogen projection-to-centroid displacement
(d1), the closet annular sp2 atom of the interacting CH projection (X), the hydrogen
projection-to-X displacement (d2).
Table 3.2 Measured geometric parameters for characterizing CH-π
interactions in crystal structures 1’-3’ and 6’: the atom-to-plane distance
(D), CH-to-plane accessing angle (α) and the hydrogen projection-tocentroid displacement (d1), the closest annular sp2 atom (X), and the
hydrogen projection-to-X displacement (d2).
Balance.
D [Å]
α
d1[Å]
d2[Å]
X
2.61
154.02°
1.30
0.47
N
1’
2.57
154.56°
0.25
1.20
C
2’
2.57
148.21°
0.85
0.56
C/Na
3’
2.56
147.32°
0.47
0.96
C
6’
a
Two different but highly superimposable structures were observed for 3’.
X atom was nitrogen in the major structure (62%) and carbon in the minor
structure (38%)
The above crystal structures of two-armed balances were considered to adequately
reproduce the geometry of the intramolecular CH-π interactions occurred to the one-armed
balances 1-3 and 6. Crystal packing and other intermolecular interactions were found to
impact little these crystal structures. This is supported by the similarity between the
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calculated optimal geometry for the folded conformers and the folded part of these crystal
structures. The folded conformers of balances 1-3 and 6 were optimized at the DFT-M06/631G** level of theory i using Spartan 10 (Figure 3.7). The methoxyl arms in these
optimized conformations adopted similar positions as compared with the folded arms in
the two-armed crystal structures.

Figure 3.7 Front views of the optimized geometry (DFT-M06/6-31G**, in
vacuum) for the folded balances 1 (A), 2 (B), 3 (D and E) and 6 (C). To lower
the computational cost, the bridgehead groups were eliminated. The
interacting methyl groups and six-membered aromatic units are highlighted
in green.

3. In-Solution Conformational Analysis for Balances 1-6.
A series of 2D NMR spectroscopic analyses were carried out to study the geometry
of the intramolecular CH-π interactions in balances 1-6 in solution.

1

H-NMR spectral

assignment for balances 1-6 , 1’, 3’ and 6’ (Figure 3.8 to 3.16) were done with aid from

i

Nijamudheen, A.; Jose, D.; Shine, A.; Datta, A. J. Phys. Chem. Lett. 2012, 3, 1493.
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1

H-13C HSQC and 1H-1H COSY experiments. Next, 1H-1H NOESY experiments were

carried out to probe the spatial relationship between the arm (O)CH3 and shelf arene in
balances 1-3, 6, 1’-3’, and 6’ in solution (Figure 3.17 to 3.23).

Figure 3.8 Assignment of the 1H NMR spectrum for balance 1 in CD2Cl2.
The indexing of protons in balances is provided. The unfolded and folded
conformers are indicated in parenthesis.
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Figure 3.9 Assignment of the 1H NMR spectrum for balance 1’ in CD2Cl2.
The indexing of protons in balances is provided.

Figure 3.10 Assignment of the 1H NMR spectrum for balance 2 in CD2Cl2.
The indexing of protons in balances is provided. The unfolded and folded
conformers are indicated in parenthesis.
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Figure 3.11 Assignment of the 1H NMR spectrum for balance 3 in CD2Cl2.
The indexing of protons in balances is provided. The unfolded and folded
conformers are indicated in parenthesis.

Figure.3.12 Assignment of the 1H NMR spectrum for balance 3’ in CD2Cl2. The
indexing of protons in balances is provided.
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Figure 3.13 Assignment of the 1H NMR spectrum for balance 4 in CD2Cl2.
The indexing of protons in balances is provided. The unfolded and folded
conformers are indicated in parenthesis

Figure 3.14 Assignment of the 1H NMR spectrum for balance 5 in CD2Cl2.
The indexing of protons in balances is provided. The unfolded and folded
conformers are indicated in parenthesis.
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Figure 3.15 Assignment of the 1H NMR spectrum for balance 6 in CD2Cl2.
The indexing of protons in balances is provided. The unfolded and folded
conformers are indicated in parenthesis

Figure 3.16 Assignment of the 1H NMR spectrum for balance 6’ in CD2Cl2.
The indexing of protons in balances is provided.
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Figure 3.17 Partial 1H-1H NOESY spectrum of balance 1
highlighting the spatial proximity between the arm OCH3 with the
shelf aromatic surface in the folded conformer.

Figure 3.18 Partial 1H-1H NOESY spectrum of balance 2 highlighting
the spatial proximity between the arm OCH3 with the shelf aromatic
surface in the folded conformer.
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Figure 3.19 Partial 1H-1H NOESY spectrum of balance 3 highlighting
the spatial proximity between the arm OCH3 with the shelf aromatic
surface in the folded conformer.

Figure 3.20 Partial 1H-1H NOESY spectrum of balance 6 highlighting
the spatial proximity between the arm OCH3 with the shelf aromatic
surface in the folded conformer
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Figure 3.21 Partial 1H-1H NOESY spectrum of balance 1’
highlighting the spatial proximity between the arm OCH3 with the
shelf aromatic surface in the folded conformer.

Figure 3.22 Partial 1H-1H NOESY spectrum of balance 3’
highlighting the spatial proximity between the arm OCH3 with the
shelf aromatic surface in the folded conformer
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Figure 3.23 Partial 1H-1H NOESY spectrum of balance 6’
highlighting the spatial proximity between the arm OCH3 with the
shelf aromatic surface in the folded conformer

3 Quantification of the folded and unfolded conformers in solution
Quantification of the folded and unfolded conformers for balances 1, 2, 3 and 6 in
solution was based on the spectral integrations of the differently shifted arm OCH3 proton
signals on the 1H NMR spectra. As shown in the above section, the arm OCH3 proton
(Harm in Figure 3.24) in the folded conformer was significantly upfield shifted (s, δ: ~2.2
to 2.3 ppm) due to its proximity to the arene shelf than in the unfolded conformer (s, δ:
~3.6 ppm). Identification of the two singlets was done by analyzing the 1H-13C HSQC
spectra where the two Harm singlets correlate to the two slightly differently shifted

13

C

signals between 55 and 60 ppm. For the accuracy concern, the spectral deconvolution
using Mnova NMR software multiplet line fitting was applied to the corresponding region
on the spectra. The measured folded/unfolded ratios were converted to the folding energies
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(ΔG’s) [ΔG = –RTln([folded]/[unfolded])]. Similar quantitative analysis was also carried
out in other six common organic solvents of different polarity (Table 3.3).

Figure 3.24 The unfolded ⇌ folded conformational
equilibrium of balance 1 highlighting the protons (Harm and
Hs) for quantifying the two conformers in solution on the 1HNMR spectra.
Table 3.3 Measured folding energies (∆G, kcal/mol)a for balances 1, 2, 3 and 6 in six
common organic solvents at 25 ˚C
C6D6
C6D5Br
CDCl3
CD2Cl2
CD3CN
DMSO-d6
ET(30)b
34.3
36.6
39.1
40.7
45.6
45.1
+0.09
+0.06
+0.21
-0.02
-0.33
-0.31
1
+0.45
+0.28
+0.41
+0.31
+0.04
+0.05
2
+0.31
+0.13
+0.27
+0.14
-0.11
-0.15
3
+0.56
+0.36
+0.49
+0.25
-0.09
-0.05
6
a. Uncertainty less than ± 0.03 kcal/mol. b Matyushov, D. V.; Schmid, R.; Ladanyi,
B. M. J. Phys. Chem. B 1997, 101, 1035.
The arm OCH3 protons’ (Harm) signals were chose to quantify the conformers in
this study rather than the succinimide protons’ (HS) signals which were used previously.i
This was due to the fact that the Harm’s displayed a consistent significant chemical shift
change (∆δ) between the unfolded and folded conformers. In contrast, HS signal displayed
a relatively smaller even, in some cases, non-identifiable ∆δ among two conformers, which
can compromise the accuracy of quantification. The consistency between these two ways

i

Carroll, W. R.; Zhao, C.; Smith, M. D.; Pellechia, P. J.; Shimizu, K. D. Org. Lett. 2011,
13, 4320
121

of quantification was verified. The [folded]/[unfolded] ratios were measured by tracking
both sets of peaks and compared. As shown in Table 3.4, the [folded]/[unfolded] ratios
measured by tracking the Harm and HS signals are essentially identical (within the error of
experiments), suggesting high consistency.
Table 3.4 Measured [folded]/[unfolded] ratios using two different sets of peaks, i.e., the
arm OCH3 protons (Harm) and the succinimide methide protons (HS) in six solvents at 25
˚C.
C6D6
C6D5Br
CDCl3
CD2Cl2
CD3CN DMSO-d6
by Harm
0.86
1.10
0.70
1.04
1.73
1.69
1
by HS
0.88
1.10
0.71
1.04
1.73
1.67
by Harm
0.47
0.62
0.50
0.59
0.93
0.92
2
by HS
0.48
0.62
0.54a
0.60
0.92
0.92
by Harm
0.59
0.81
0.64
0.79
1.21
1.30
3
by HS
0.57
NAa
0.65
NAa
1.24
1.27
by Harm
0.39
0.54
0.44
0.66
1.17
1.09
6
by HS
0.40
0.55
NAa
0.65
1.21
1.07
a. Observable overlap between the two singlets. b Non-observable chemical shift
difference.
Quantification of the folded and unfolded conformers for balances 4-5 in solution
was done by tracking the terminal CH3 signals (triplets) in the two conformers on the 1HNMR spectra. The 1H-NMR spectral assignments are provided in Figure 3.12 and 3.13.
The ΔG’s were measured in three solvents of different polarity (C6D6, CD2Cl2 and DMSOd6) (Table 3.5).
Table 3.5 Measured ∆G’s (kcal/mol)a for balances 4
and 5 in C6D6, CD2Cl2 and DMSO-d6 at 25 ˚C
C6D6
CD2Cl2
DMSO-d6
ET(30)
34.3
40.7
45.1
-0.18
-0.17
-0.67
4
-0.26
-0.20
-0.61
6
a. Uncertainty less than ± 0.03 kcal/mol
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CHAPTER 4
CORRELATION BETWEEN SOLID-STATE AND SOLUTION CONFORMATIONAL
RATIOS IN A SERIES OF N-(O-TOLYL)SUCCINIMIDE MOLECULAR ROTORSi

i

Reproduced with permission from: Li, P.; Hwang, J.; Maier, J. M.; Zhao, C.; Kaborda,
D. V.; Smith, M. D.; Pellechia, P. J.; Shimizu, K. D. Cryst. Growth Des. 2015, 15, 3561.
Copyright 2015 American Chemical Society.
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1. Introduction
X-ray crystallography is a powerful tool in modern chemistry and biochemistry for
the determination of the three-dimensional structure of natural products,1,2 rational drug
design,3,4 the study of non-covalent interactions,5-7 and solid-form pharmaceuticals.8,9 An
important question in these studies is whether an X-ray crystal structure accurately reflects
the conformation in solution.10-12 Conversely, can the conformation in solution be used to
predict the conformation in a crystal structure? To address these questions, the X-ray
crystal structure and solution conformational ratios for a series of 30 molecular rotors based
on an atropisomeric bicyclic N-(o-tolyl)succinimide framework were measured and
compared (Figure 4.1).

Figure 4.1 Schematic representation of the anti-syn conformational
equilibrium of a bicyclic N-(o-tolyl)succinimide molecular rotor.
The suitability of atropisomeric N-arylsuccinimides for studying the correlation
between solid-state and solution structures was previously recognized by Verma,13
Kishikawa,14 and Grossmann.15 The rigid bicyclic framework fixes the position of most of
the atoms, which greatly simplifies its conformational analysis. The only major degree of
rotational freedom is the C-N single bond connecting the o-tolyl rotor to the succinimide
ring. Due to steric repulsion between the ortho-methyl group of the rotor and the imide
carbonyls, the N-tolyl and succinimide rings avoid the co-planar geometry. This leads to
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anti- and syn- atropisomers that are conformationally distinct due to the asymmetry of the
succinimide ring arising from the fused bicyclic framework.
In the course of our studies using molecular balances to measure weak non-covalent
interactions,16-23 we realized that we had access to a library of 30 N-(o-tolyl)succinimide
rotors that displayed a wide range of anti-/syn- conformational ratios (Figure 4.2). This
provided a unique opportunity to examine the correlation or lack of correlation between
their solid-state and solution structures. By comparison, the scope of previous studies
utilizing this framework18,20,23 was based on a small number of structures (12-14) limiting
the certainty and generality of the observed trends.

Figure 4.2 Structures of molecular rotors 1-30 used in the solid-state versus solution
correlation study. The o-tolyl rotor is highlighted in red, and the shelf surface is highlighted
in blue
We specifically focused on bicyclic N-(o-tolyl)succinimides with ortho-methyl
groups because their atropisomers are generally bereft of the common factors that lead to
differences in solid-state and solution structures.24,25 First, the ortho-methyl group is nonpolar and does not form strong intermolecular interactions such as hydrogen bonds or
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dipole-dipole interactions.26,27

Second, the methyl group is relatively small, which

minimizes the differences in the packing forces between the syn- and anti-conformers.
This study was enabled by the ability to rapidly assemble a large library of o-tolyl
rotors containing different shelves, bicyclic frameworks, and rotor substituents. The
modular rotors were typically synthesized in one to two steps via previously described
synthetic routes.18,20 The library included twenty new rotors (1-6, 8-11, 15-21, 24, 25, 29,
and 30), seven previously described rotors from our group (7, 17, 22, 23, and 26-28),18,23
and three from the literature (12-14).14,15

2. Results and discussion
First, the mole fraction of the syn-conformers (𝜒 syn) were measured in solution via
1

H NMR (Table 4.1 in SI). Due to restricted rotation around the Ctolyl-Nimide bond, the syn-

and anti-conformers were in slow exchange at room temperature leading to distinct sets of
peaks for each conformer. Integration of the syn- and anti-methyl singlets yielded the
equilibrium 𝜒 syn values with an accuracy from ±1.4% (𝜒 syn = 0.41) to ±5.2% (𝜒 syn = 0.97)
(See SI for details). The solution 𝜒 syn values for the rotors spanned the entire range from
0.13 to 0.97. These variations were attributed to: 1) the absence or presence of an
intramolecular CH-π interaction between the o-tolyl methyl group and the aromatic
shelves18,20 2) repulsive steric interactions between the o-tolyl methyl group and the
aromatic shelf,28 and 3) differences in the ‘bite-angle’ of the bicyclic framework due to the
different steric and geometric constraints of the bicyclic bridge (X-groups in Figure 4.1).29
The 𝜒 syn values were also measured in the solid-state via X-ray crystallographic
analysis. Single crystals for 27 rotors were obtained through slow evaporation from
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organic solutions, yielding 28 structures (two crystal forms for rotor 7, see Figure 4.1 in
SI). The structures of the three rotors (12, 13 and 14) in literature were obtained from the
CSD (refcodes: RIZCOS; UJULUG; IHUBOC). As in the solution studies, the crystal
structures displayed a range of 𝜒 syn values from 0 to 1. More interestingly, approximately
a third of the structures (13 out of 31) contained a mixture of syn- and anti-conformers,
introducing the possibility that we might observe quantitative correlations between the
crystal and solution 𝜒 syn values.
Closer examination of these structures confirmed that the crystallization process
did not appear to impose a strong bias toward one conformer, as the two conformers
appeared to have very similar packing energies. This conclusion was reached based on the
following observations. First, there were almost an equal number of crystals favoring each
conformer. Strong packing forces would have most likely favored one conformer over the
other. Second, the two conformers had similar shapes and volumes (Figure 4.3).30-32
Although the anti-conformer with its protruding ortho-methyl group appears to be the
larger conformer, the imide nitrogen can readily pyramidalize33,34 reducing the size of the
anti-conformer and allowing it to fit in the same space as the syn-conformer. For example,
the syn- and anti-conformers occupied the same crystallographic space in the majority of
the mixed conformer crystals. Third, no strong intermolecular interactions were observed
such as hydrogen bonding or dipole-dipole interactions in the extended structures.35 The
only exceptions were the hydrogen bonds formed by the carboxylic acid groups of 16 and
24. However, these carboxylic groups were positioned on the rotating axis of the o-tolyl
rotors, and thus these hydrogen bonding interactions act equally on the syn- and anticonformers.
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Figure 4.3 (a) Schematic representation for the anti- and synconformers of o-tolyl rotor 7 occupying the same
crystallographic site in crystal. (b) Partial side-view of crystal
structures 7 highlighting the partial disorder at the o-tolyl
rotor motif; the syn-conformer is highlighted in red and the
anti-conformer is highlighted in blue.
Next, a comparison of the solution and crystal 𝜒 syn values was performed (Figure
4.4). This analysis revealed a strong qualitative correlation between the solution and
crystal 𝜒 syn values. For every rotor, the favored conformer in solution was also the favored
conformer in the crystal. For example, there are no “mismatched” data points in the upper
left or lower right quadrants of the plot in Figure 4.4 where the solution 𝜒 syn was > 0.5 and
crystal 𝜒 syn was < 0.5 or vice versa. However, the correlation was not a 1:1 linear
correlation as depicted by the broken line in Figure 4.4. The correlation was better
described as a step-function (Figure 4.4, solid line) or steep sigmoidal function. Thus, the
rotors fell into two distinct groups based on their solution 𝜒 syn values. Group 1 were rotors
(1-8 and 23-30) that displayed a conformational preference in solution (solution 𝜒 syn > 0.56
or < 0.44). The corresponding crystal structures all displayed the same conformational
preference but usually with a stronger bias as the crystal 𝜒 syn values of 1.0 and 0.0 were
the most common. Group 2 were rotors (9-22) that did not show a clear conformational
preference in solution (solution 𝜒 syn = 0.50 ±0.06). Their corresponding crystal structure
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𝜒 syn values likewise showed no clear preference but with a very wide variation from 0.0 to
1.0 with an average 𝜒 syn of 0.64 ±0.11.

Figure 4.4 A correlation plot of the measured solution and
crystal 𝜒syn values for a library of 30 o-tolyl molecular rotors
Rotors that deviated from the step-function correlation curve were examined to see
if they possessed unusual packing or structural features. These included the 4 crystal
structures (3, 5, 7, and 25) in Group 1 (solution 𝜒 syn values > 0.5 or < 0.5) that did not form
pure syn- or anti-crystals and the 5 crystal structures (11, 12, 14, 16, and 18) in Group 2
(solution 𝜒 syn values ≈ 0.5) that formed pure syn- or anti-crystals. Analysis of these
structures showed no significant difference in their crystallographic parameters from the
other structures in their group such as space group, presence or absence of solvent, or
specific intermolecular interactions (Table 4.1 in SI).
One possibility was that the conformational 𝜒 syn values observed in the crystals
were due to the rotation and equilibration of the rotamers in the solid-state. However, a
number of observations suggested that the rotors could not rotate and interconvert within
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the crystals.

This was also consistent with previous studies by Kishikawa14 and

Grossmann15 that did not report any signs of interconversion of crystalline N-(o-tolyl)
succinimides at room temperature.

First, two crystals (17 and 19) contained

crystallographically independent syn- and anti-conformers suggesting that the conformers
were kinetically locked in the crystals. If the conformers were able to interconvert then
these crystals should have been conformationally disordered36,37 Second, the 𝜒 syn values
for a single crystal of 7 (non-solvate) were measured at two different temperatures and
were exactly the same (𝜒 syn = 0.07). This provided further evidence for the lack of
interconversion in the crystals because, in solution where the conformers can interconvert,
the 𝜒 syn values vary with temperature due to the entropy term. Finally, the rotational
barriers of the N-(o-tolyl) succinimides rotors in solution are (20-21 kcal/mol)14 which is
near the upper limit for rotation at room temperature. Rotational barriers in the crystallinestate are typically significantly higher,38 which would raise the barriers above the threshold
to allow rotation in the crystals.
Although the main goal of this study was to empirically test the correlation between
X-ray crystal and solution-state conformational preferences, it is interesting to hypothesize
on the origins of the observed trends. Overall, the trends appear to be consistent with the
current theories of the crystallization process39-42 and the relative rates of interconversion
in crystals versus solution. For rotors in Group 1, the preferred conformer has a higher
concentration in solution providing a driving force for its selective crystallization. This
conformational preference in solution is maintained throughout the crystallization process
because the preferred conformer concentration is continually being replenished, as the rate
of interconversion in solution is much faster than the rate of crystallization.14 For rotors in
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Group 2, there is an equal concentration of the two conformers in solution and thus there
is a similar driving force for the crystallization of the syn- and anti-conformers. This
explains the higher prevalence of mixed conformer crystals within this group. Also, these
rotors would be more sensitive to any small differences in the packing energies and thus,
there were also a significant percentage of crystals that were all syn or anti.
Another possible origin of the step-function correlation of the 𝜒 syn values was the
formation of stable homo-dimers (syn-syn or anti-anti) in the crystallization process. This
would explain the predominance of all syn- or all anti- crystals in Group 1. However, the
majority of crystals in Group 2 contained mixtures of syn- and anti-conformers, which
suggests that formation of stable homo-dimers was not the origin of the step-function
correlation.

3. Conclusion
In summary, we have carried out a correlation study between the solution and
crystal structures for a library of bicyclic N-(o-tolyl) succinimide molecular rotors. A
strong qualitatively correlation was found between the atropisomeric 𝜒 syn values in
solution and in crystal structures. The dominant conformer in solution was consistently
found to be the dominant conformer in the crystal structures. However, the correlation was
not linear and was better characterized as a step-function. Hopefully, this study will
provide empirical guidance in the applications of X-ray structure analysis in the design of
functional solid-state crystalline materials, and the development of stable solid-form
pharmaceuticals.
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Broader conclusions drawn from this study should be constrained to the subset of
molecules, which 1) have conformers that are rapidly interconverting at room temperature
and 2) have minimal differences in packing energy and intermolecular interactions. For
this subset of molecules, the crystalline conformational preferences can be accurately
predicted based on the solution conformational preferences.

The only caveats are

conformers in Group 2, which have very similar energies in solution (∆∆G ≤ 0.15 kcal/mol,
based on the solution 𝜒 syn ranges of ±0.06). The crystalline conformational preferences in
Group 2 are difficult to predict because they vary widely. Fortunately, it is easy to identify
the rotors in Group 2 based on their solution 𝜒 syn values.
Conversely, prediction of solution conformational preferences using crystal
structures is less certain. The crystalline conformational preferences generally matched
those in solution. In particular, it is unlikely that a molecule that displays a strong
conformational preference in the crystal structure will have the opposite conformational
preference in solution. However, due to the poor correlation for rotors in Group 2 and the
lack of a 1:1 quantitative correlation, it is possible for a crystal structure to have a strong
conformational preference but no clear conformational preference in solution. Fortunately,
Group 2 spans a very narrow energy range of conformers, and thus, even a small difference
in energy (∆∆G > 0.15 kcal/mol) would place the conformers in the more predictable Group
1.
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Supporting Information
1. Additional tables and figures
Table 4.1 Measured mole fraction of syn-conformer (𝜒syn ) in solution a and in solidstate crystals and relevant information of crystal structure.
𝜒syn

Inclusion
solvent
molecule

Space
group

Z

Z’

Kitaigorodskii
coefficiency
(Ck)b

Conformer
in crystal

Crystallization
solvents

In
solution

In
crystal

1

0.13

0.00

-

P-1

4

2

67.5%

anti-c

C6H6

2

0.14

0.00

-

P21/n

4

1

66.1%

anti-

CHCl3

3

0.17

0.12k

-

Pca21

4

1

66.6%

bothd

CHCl3

4

0.18

0.00

-

P21/n

4

1

65.7%

anti-

CH2Cl2

5

0.19

0.19k

-

P21/n

4

1

74.2%

bothd

CH3OHCH3CN

6

0.19

0.00

-

P21/n

4

1

67.9%

anti-

CHCl3

0.27f

CH3CN

P21/c

4

1

68.8%

bothc,d

CH3CN

7

0.19
0.07k

-

Pca21

4

1

68.72

bothd

CHCl3

8

0.20

0.00

CHCl3

P-1

2

1

64.4%

anti-c

CHCl3

9

0.43

0.47

CH2Cl2

P-1

2

1

70.1%

bothd

CH2Cl2

10

0.47

0.23

CH3CN

P-1

2

1

71.4%

bothd

CHCl3/CH3CN

11

0.47

1.00

unknowne

R-3

18

1

n/a

syn-

CHCl3

12

0.47h

1.00h

-

P21/n

4

1

64.6%

syn-

C6H6

13

0.47

0.46g

-

R-3r

6

1

69.0%

bothd

CH3Ph or
CHCl3

14

0.47

1.00i

CH3NO2

P21/n

4

1

65.5%

syn-

CH3NO2

15

0.48

0.64

CHCl3

P-1

2

1

74.9%

bothd

CHCl3CH3COCH3
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16

0.49

1.00

-

P21/n

4

1

71.3%

syn-

CH3OHCH3COCH3

17

0.49

0.50 f

-

P21/c

8

2

66.9%

bothc

CHCl3CH3CN

18

0.50

1.00

-

P212121

4

1

67.8%

syn-

CHCl3

19

0.50

0.50

-

P21/c

8

2

65.9%

bothc

CHCl3CH3COCH3

20

0.51

0.26

-

C2/c

8

1

71.1%

bothd

CH2Cl2CH3CN

21

0.51

0.88

CH3Ph

P-1

2

1

60.0%

bothd

CHCl3

22

0.56

1.00 f

-

P-1

2

1

68.0%

syn-

EtOAcCH3CN

23

0.60

1.00 f

CH2Cl2

P21/c

8

4

67.3%

syn-c

CH2Cl2CH3CN

24

0.61

1.00

CHCl3

P-1

2

1

66.2%

syn-

CHCl3

25

0.62

0.77 k

-

R-3

18

1

68.3%

bothd

CHCl3

26

0.77

1.00

-

P21/n

4

1

69.4%

syn-

CHCl3

27

0.84

1.00

-

P-1

2

1

67.0%

syn-

CHCl3

28

0.96

1.00

-

P21/c

4

1

66.1%

syn-

CH3OH

29

0.97j

1.00

-

P-1

2

1

68.8%

syn-

CHCl3

30

0.97 j

1.00

-

P21/c

8

2

68.9%

syn-c

CHCl3

a

Measured in CDCl3; Error is within 7.1% (see Error Analysis section). b Kitaigorodski, A. I. Organic
Chemical Crystallography, Consultants Bureau: New York, 1961; Packing coefficient is calculated by using
the following equation: Ck = Z*Vmol/Vcell, where Vmol is the molecular volume of the formula unit (A3), Vcell
is the volume of the unit cell (A3), and Z is the number of formula unit in the unit cell. c More than one
crystallographically independent molecules were observed. d Co-existence of the syn- and anti-conformers
was identified as partial disorder as the o-tolyl rotor motif. e Large amount of unknown/unidentifiable solvent
exist. f Ref. Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J. Am.
Chem. Soc. 2012, 134, 14306. g Ref. Grossmann, G.; Potrzebowski, M. J.; Olejniczak, S.; Ziolkowska, N. E.;
Bujacz, G. D.; Ciesielski, W.; Prezdo, W.; Nazarov, V.; Golovko, V. New J. Chem. 2003, 27, 1095. h Ref.
Kishikawa, K.; Yoshizaki, K.; Kohmoto, S.; Yamamoto, M.; Yamaguchi, K.; Yamada, K. J. Chem. Soc.,
Perkin Trans. 1 1997, 1233. i Ref. Csoregh, I.; Finge, S.; Weber, E. Struct. Chem. 2003, 14, 241. j The
detection limit for 𝜒syn in solution was set to be 0.03 to 0.97. (See Error Analysis section) k. Repeating
crystallization gave the same result.
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Figure 4.5 Schematic representation for the
bite angle (θ) in the bicyclic framework: the
green and purple planes were defined using
the eight carbon atoms highlighted in color.
Table 4.2 Measured bite angle (θ) for 30 rotors in their crystal structures.
No.
θ
No.
θ
No.
θ
No.
θ
No.
θ
1
52.8a
7
52.7a
13
58.8
19
59.2a
25
62.0
2
52.6
8
52.0
14
60.6
20
52.9
26
53.4
3
51.6
9
53.5
15
55.4
21
56.1
27
55.8
4
51.8
10
55.4
16
52.8
22
56.0
28
60.7
5
55.3
11
62.8
17
52.9a
23
56.1a
29
55.7
6
55.0
12
59.0
18
56.7
24
60.3
30
57.3a
a Average of multiple crystal structures or crystallographically independent molecules.
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Figure 4.6 Correlation between the measure χsyn in CHCl3 and in four other common
solvents: CH2Cl2(A), C6 H6(B), CH3CN(C), and CH3COCH3 (D), highlighting the
minimal solvent impact over χsyn in solution. Numerical data are tabulated in Table
4.3
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Table 4.3 The measured in-solution χsyn for 30 rotors in this study. a
No
CDCl3
CD2Cl2
C6D6
CD3CN
CD3COCD3
0.13
0.16
0.15
0.21
0.24
1
0.14
0.15
0.14
0.17
0.17
2
0.17
0.19
0.17
0.27
0.27
3
0.18
0.19
0.20
0.21
0.22
4
b
0.18
0.19
n/a
0.20
0.20
5
0.19
0.19
0.19
0.23
0.23
6
0.19
0.21
0.22
0.24
0.25
7
0.20
0.29
0.24
0.21
0.27
8
0.44
0.49
0.47
0.47
0.54
9
b
0.47
0.46
n/a
0.58
0.58
10
0.47
0.50
n/ab
0.57
0.56
11
c
d
d
d
0.47
n/a
n/a
n/a
n/ad
12
0.47
0.49
0.45
0.53
0.48
13
0.47
0.46
0.47
0.48
0.50
14
0.49
0.50
0.50
0.50
0.55
15
b
0.49
0.50
n/a
0.55
0.52
16
0.50
0.52
0.51
0.59
0.58
17
0.50
0.49
0.52
0.54
0.59
18
0.50
0.52
0.51
0.59
0.58
19
0.51
0.55
0.51
0.58
0.59
20
0.51
0.49
0.52
0.47
0.57
21
0.56
0.55
0.59
0.54
0.60
22
0.60
0.57
0.60
0.57
0.63
23
b
0.61
0.62
n/a
0.69
0.68
24
0.62
0.65
0.63
0.67
0.68
25
0.77
0.73
0.71
0.60
0.68
26
0.83
0.80
0.79
0.70
0.76
27
0.96
0.94
0.94
0.88
0.90
28
b
b
0.97
0.97
n/a
n/a
n/ab
29
0.97
0.97
n/ab
n/ab
n/ab
30
a Error is within 5.4% (see Error Analysis section). b Insoluble c Ref. Kishikawa, K.;
Yoshizaki, K.; Kohmoto, S.; Yamamoto, M.; Yamaguchi, K.; Yamada, K. J. Chem.
Soc., Perkin Trans. 1 1997. d Unavailable in literature.
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2. Synthesis and characterization
2.1 Synthesis
All rotors in this study except for 12 were synthesized via one of the two previously
reported synthetic routes (Figure 4.7). i,ii In Route I the final rotor was obtained via a
thermal condensation of an endo-bicyclic anhydride containing the shelf-unit and an omethyl aniline derivative.xxv In Route II the rotor was obtained via a Diels-Alder reaction
between the diene bearing the shelf-unit and a maleimide bearing the o-tolyl rotor.ii The
o-methyl aniline and bicyclic anhydride derivatives in Route I and the diene and maleimide
derivatives in Route II (Figure 4.8) were either purchased from commercial suppliers or
obtained following the literature procedures without modifications (vide infra). For the
sake of brevity, the anhydride and diene derivatives were indexed arbitrarily as shown in
Figure 4.7 and referred to accordingly throughout the text. The syntheses for rotors 6 and
9 were provided in detail to illustrate the two synthetic routes, respectively.

i

Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547.; Carroll, W. R.;
Zhao, C.; Smith, M. D.; Pellechia, P. J.; Shimizu, K. D. Org. Lett. 2011, 13, 4320.; Zhao,
C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J. Am.
Chem. Soc. 2012, 134, 14306.; Zhao, C.; Li, P.; Smith, M. D.; Pellechia, P. J.; Shimizu,
K. D. Org. Lett. 2014, 16, 3520. Hwang, J.; Li, P.; Carroll, W. R.; Smith, M. D.; Pellechia,
P. J.; Shimizu, K. D. J. Am. Chem. Soc. 2014, 136, 14060.
ii
Li, P.; Zhao, C.; Smith, M. D.; Shimizu, K. D. J. Org. Chem. 2013, 78, 5303.; Li, P.;
Parker, T. M.; Hwang, J.; Deng, F.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu,
K. D. Org. Lett. 2014, 16, 5064
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Figure 4.7 Two modular synthetic routes for assembling the o-tolyl
rotors: (left) Diels-Alder reaction between a diene derivative
containing the aromatic shelf and a maleimide derivative containing
the o-tolyl rotor and thermal imide formation (right) between a
bicyclic anhydride bearing the aromatic shelf and an o-methyl aniline
derivative.

Figure 4.8 The anhydride and diene derivatives (with arbitrary indexes) used in the
syntheses.
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(3aR,4R,9S,9aS)-2-(o-tolyl)-3a,4,9,9a-tetrahydro-1H-4,9-methanobenzo[f]isoindole-1,3(2H)-dione.(6) Rotor 6 was synthesized using Route I from anhydride Bi and omethyl aniline. Anhydride B (100 mg, 0.47 mmol) and o-toluidine (54 mg, 0.50 mmol)
were dissolved in 10 mL acetic acid. The mixture was heated at reflux with stirring for 24
h. The solvent was then removed under vacuum. The residue was dissolved in 25 mL of
EtOAc, washed twice with 50 mL of water. The organic layer was collected and dried
under vacuum. The crude product was washed with cold methanol (~10 mL) and then cold
acetonitrile (~ 2 mL) to give 6 as an off-white solid (109 mg, 77 %). mp: 214 °C 1H NMR
(400 MHz, CDCl3) δ 7.31-6.82 (m, 7H syn and anti), 6.76 (dd, J = 7.6 Hz, J = 1.4 Hz, 1H
syn), 5.34 (d, J = 7.8 Hz, 1H anti), 3.88-3.81 (m, 2H syn), 3.63 (dd, J = 3.0 Hz, J = 1.8 Hz,
2H syn), 3.61 (dd, J = 3.1 Hz, J = 1.8 Hz, 1H anti), 2.14-1.85 (m, 5H anti and 2H syn),
0.94 (s, 3H syn).

13

C NMR (100 MHz, CDCl3) δ 176.06, 143.14, 142.77, 136.41, 135.51,

130.91, 130.68, 130.57, 129.32, 129.29, 127.97, 127.54, 127.36, 126.73, 126.53, 123.28,
54.44, 52.31, 48.10, 48.00, 46.74, 46.29, 17.71, 16.96. HRMS (EI) (m/z) calcd for
[C20H17NO2]+ (M+): 303.1259; found: 303.1259.

i

Fotins, J.; Smithrud, D. B. J. Org. Chem. 2005, 70, 4452.
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(9R,9aS,12aS,13S)-9,13-dimethyl-11-(o-tolyl)-9,9a,12a,13-tetrahydro-10H-9,13methano-isoindolo[5,6-f][1,10]phenanthroline-10,12,14(11H)-trione. (9)

Rotor 9 was

synthesized using Route II from diene A,i and N-(o-tolyl) maleimide.ii Diene A (80 mg,
0.31 mmol) and N-(o-tolyl) maleimide (70 mg, 0.37 mmol) were dissolved in dry CH2Cl2
(10 mL) in a pressure tube. The vessel was flushed with N2, sealed and heated to 90 ºC
with stirring for 24 h. After cooling, the solvent was removed under vacuum. The solid
residue was washed with cold methanol (~10 mL) and then cold acetonitrile (~ 2 mL) to
give 9 as an off-white solid (110 mg, 79 %). mp: 290 °C (dec)

1

H NMR (400 MHz,

CD2Cl2) δ 9.18-9.13 (m, 2H syn and anti), 8.75-8.69 (m, 2H syn and anti), 7.72-7.62 (m,
2H syn and anti), 7.17-6.70 (m, 4H syn and 2H anti), 6.59-6.51 (m, 1H anti), 4.35 (dd, J =
7.9 Hz, J = 1.2 Hz, 1H anti), 3.65 (s, 2H syn), 3.64 (s, 2H anti), 2.32 (s, 6H anti), 2.31 (s,
6H syn), 1.93 (s, 3H anti), -0.07 (s, 3H syn).

13

C NMR (100 MHz, CD2Cl2) δ 200.39,

199.50, 174.47, 174.28, 151.06, 150.92, 147.28, 146.81, 136.16, 135.77, 134.18, 133.90,
132.91, 132.88, 131.25, 131.18, 130.56, 129.98, 129.79, 128.58, 128.34, 128.10, 127.19,
126.68, 125.42, 125.14, 123.73, 123.68, 55.93, 55.81, 48.44, 48.09, 17.79, 15.74, 14.70,
14.54. HRMS (EI) m/z calcd. for [C28H21N3O3]+ (M+): 447.1583; found: 447.1591.

i

Warrener, R. N.; Schultz, A. C.; Houghton, M. A.; Butler, D. N. Tetrahedron 1997, 53,
3991
ii
Matuszak, N.; Muccioli, G. G.; Labar, G.; Lambert, D. M. J. Med. Chem. 2009, 52, 7410.
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(3aS,4R,9S,9aS)-2-(2-methyl-5-(trifluoromethyl)phenyl)-4,9-diphenyl-3a,4,9,9atetrahydro-1H-4,9-epoxybenzo[f]isoindole-1,3(2H)-dione. (1) Anhydride A i (100 mg,
0.27 mmol) and 2-methyl-5-(trifluoromethyl) anilineii (52 mg, 0.30 mmol) were reacted
using Route I to give 1 as an off-white solid (117 mg, 83 %) mp: 242 °C 1H NMR (300
MHz, CDCl3) δ 8.15-7.92 (m, 4H syn and anti), 7.65-6.98 (m, 13H syn and 12H anti), 5.69
(s, 1H anti), 4.38 (s, 2H syn), 4.33 (s, 2H anti), 2.16 (s, 3H anti), 1.15 (s, 3H syn).

13

C

NMR (75 MHz, CDCl3) δ 173.15, 144.32, 140.30, 136.29, 131.47, 130.98, 128.97, 128.82,
128.63, 128.41, 128.39, 127.26, 126.39, 125.08, 121.28, 90.89, 54.83, 17.92. HRMS (EI)
(m/z) calcd for [C32H22F3NO3]+(M+): 525.1552; found: 525.1554.

(3aR,4R,9S,9aS)-2-(2,5-dimethylphenyl)-4,9-diphenyl-3a,4,9,9a-tetrahydro-1H4,9-epoxy-benzo[f]isoindole-1,3(2H)-dione. (4). Anhydride Ai (100 mg, 0.27 mmol) and
2,5-dimethyl-anilineii (36 mg, 0.30 mmol) were reacted using Route I to give 4 as an offwhite solid (122 mg, 96 %). mp: 254 °C 1H NMR (300 MHz, CDCl3) δ 8.16-6.83 (m, 17H

i
ii

Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547.;
Commercially available.
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syn and 15H anti), 6.76 (s, 1H syn), 5.26 (s, 1H anti), 4.32 (s, 2H syn), 4.29 (s, 2H anti),
2.27 (s, 3H syn), 2.14 (m, 3H anti), 2.04 (s, 3H anti), 1.04 (s, 3H syn).

13

C NMR (75 MHz,

CDCl3) δ 173.54, 144.55, 136.59, 136.53, 132.44, 130.68, 130.44, 130.24, 128.83, 128.75,
128.46, 128.31, 127.84, 127.27, 121.32, 121.25, 90.72, 54.79, 20.73, 17.29. HRMS (EI)
(m/z) calcd for [C32H25NO3]+(M+): 471.1834; found: 471.1838.

4-((3aR,4R,9S,9aS)-1,3-dioxo-1,3,3a,4,9,9a-hexahydro-2H-4,9-methanobenzo[f]iso-indol-2-yl)-3-methylbenzoic acid. (5) Anhydride B i (100 mg, 0.47 mmol) and 4amino-3-methylbenzoic acidii (40 mg, 0.30 mmol) were reacted using Route I to give 5 as
an off-white solid (130 mg, 80 %). mp: 284 °C 1H NMR (400 MHz, CDCl3) δ 7.99-7.63
(m, 2H syn and anti), 7.38-7.06 (m, 4H syn and anti), 6.97 (d, J = 8.2 Hz, 1H syn), 5.52 (d,
J = 8.2 Hz, 1H anti), 3.99-3.88 (m, 2H syn and anti), 3.82-3.68 (m, 2H syn and anti), 2.222.13 (m, 1H syn and anti), 2.08 (s, 3H anti), 2.07-1.98 (m, 1H syn and anti), 1.10 (s, 3H
syn).

13

C NMR (101 MHz, CDCl3) δ 175.70, 175.64, 170.69, 143.09, 142.75, 137.17,

136.32, 135.96, 135.58, 132.85, 132.58, 130.02, 129.97, 128.66, 128.48, 128.37, 128.06,
127.73, 127.55, 123.41, 123.37, 54.52, 52.39, 48.35, 48.24, 46.91, 46.45, 17.85, 17.14.
HRMS (EI) (m/z) calcd for [C21H17NO4]+ (M+): 347.1158; found: 347.1159.

i
ii

Fotins, J.; Smithrud, D. B. J. Org. Chem. 2005, 70, 4452.
Commercially available.
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(3aR,4R,9S,9aS)-4,9-diphenyl-2-(o-tolyl)-3a,4,9,9a-tetrahydro-1H-4,9-epoxybenzo[f] isoindole-1,3(2H)-dione.i (7) Anhydride Aii (100 mg, 0.27 mmol) and 2-methyl
anilineiii (32 mg, 0.30 mmol) were reacted using Route I to give 7 as an off-white solid
(102 mg, 83 %). 1H NMR (400 MHz, CDCl3) δ 8.12-8.00 (m, 2H anti and syn), 7.60-6.92
(m, 15H anti and 16H syn), 5.51 (d, J = 7.8 Hz, 1H anti), 4.34 (s, 2H syn), 4.30 (s, 2H anti),
2.09 (s, 3H anti), 1.08 (s, 3H syn). The spectral data were in agreement with the literature
reported.

(3aR,4R,9S,9aS)-2-(4-bromo-2-methylphenyl)-4,9-diphenyl-3a,4,9,9a-tetrahydro1H-4,9-epoxybenzo[f]isoindole-1,3(2H)-dione. (8) Anhydride Aii (100 mg, 0.27 mmol)
and 4-bromo-2-methylanilineiii (55 mg, 0.30 mmol) were reacted using Route I to give 8
as an off-white solid (107 mg, 74 %). mp: 214 °C 1H NMR (300 MHz, CDCl3) δ 8.177.95 (m, 4H syn and anti), 7.68-6.95 (m, 13H syn and 12H anti), 6.83 (d, J = 8.4 Hz, 1H
syn), 5.39 (d, J = 8.4 Hz, 1H anti), 4.34 (s, 2H syn), 4.31 (s, 2H anti), 2.08 (s, 3H anti),
1.07 (s, 3H syn).

13

C NMR (75 MHz, CDCl3) δ 173.10, 172.89, 144.99, 144.40, 138.00,

i

Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306.
ii
Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547.
iii
Commercially available.
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136.57, 136.33, 133.85, 129.99, 129.58, 128.99, 128.91, 128.86, 128.78, 128.49, 128.37,
127.24, 127.20, 123.53, 121.33, 121.17, 90.72, 90.35, 54.73, 17.73, 17.03. HRMS (EI)
(m/z) calcd for [C31H22BrNO3]+ (M+): 535.0783; found: 535.0787.

4-((9R,9aS,12aR,13S)-9,13-dimethyl-10,12,14-trioxo-9,9a,10,12,12a,13-hexahydro-11H-9,13-methanophenanthro[9,10-f]isoindol-11-yl)-3-methylbenzoic acid. (10)
Diene B,i. (80 mg, 0.31 mmol) and N-(p-carboxy-o-tolyl) maleimideii (72 mg, 0.37 mmol)
were reacted using Route II to give 10 as an off-white solid (106 mg, 70 %). mp: 294 °C
(dec) 1H NMR (400 MHz, CD2Cl2) δ 8.93-8.62 (m, 2H syn and anti), 8.37 (dd, J = 8.2 Hz,
J = 1.0 Hz, 2H syn and anti), 7.86-7.55 (m, 5H syn and anti), 7.44 (d, J = 1.7 Hz, 1H syn),
7.15 (dd, J = 8.2 Hz, J = 1.7 Hz, 1H anti), 6.93 (d, J = 8.2 Hz, 1H syn), 4.40 (d, J = 8.2 Hz,
1H anti), 3.63 (s, 2H syn), 3.61 (s, 2H anti), 2.32 (s, 6H anti), 2.30 (s, 6H syn), 1.99 (s, 3H
anti), 0.03 (s, 3H syn).

C NMR (100 MHz, CDCl3) δ 200.76, 199.60, 173.90, 173.69,

13

170.21, 136.76, 135.80, 135.54, 135.04, 133.36, 133.07, 132.68, 132.53, 131.31, 130.85,
130.05, 129.75, 128.39, 128.06, 127.62, 127.53, 127.42, 127.29, 126.87, 125.26, 125.16,
123.56, 123.48, 55.34, 55.18, 53.88, 48.44, 48.05, 31.87, 31.13, 31.08, 29.37, 17.74, 15.44,
14.96, 14.84. HRMS (EI) (m/z) calcd for [C31H23NO5]+ (M+): 489.1576; found: 489.1591

i

Fuchs, B.; Pasternak, M.; Scharf, G. J. Chem. Soc. Chem. Comm. 1976, 53; Li, P.; Zhao,
C.; Smith, M. D.; Shimizu, K. D. J. Org. Chem. 2013, 78, 5303.
ii
Matuszak, N.; Muccioli, G. G.; Labar, G.; Lambert, D. M. J. Med. Chem. 2009, 52, 7410.
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4-((9R,10S,11R,15S)-12,14-dioxo-9,10-dihydro-9,10-[3,4]epipyrroloanthracen13-yl)-3-methylbenzoic acid. (11) Anhydride Ci (100 mg, 0.36 mmol) and 4-amino-3methylbenzoic acidii (60 mg, 0.40 mmol) were reacted using Route I to give 11 as an offwhite solid (103 mg, 70 %). mp: 274 °C (dec) 1H NMR (400 MHz, CDCl3) δ 8.15-7.12
(m, 10H syn and anti), 7.05 (d, J = 8.2 Hz, 1H syn), 5.61 (d, J = 8.2 Hz, 1H anti), 4.92 (s,
2H syn), 4.90 (s, 2H anti), 3.48-3.41 (m, 2H syn and anti), 2.13 (s, 3H anti), 1.12 (s, 3H
syn).

13

C NMR (100 MHz, CDCl3) δ 175.76, 175.62, 170.91, 170.80, 141.91, 141.26,

139.34, 138.94, 137.21, 137.00, 136.31, 135.77, 135.72, 135.13, 134.76, 133.19, 132.94,
132.73, 130.19, 129.18, 129.09, 128.84, 128.55, 128.38, 127.92, 127.61, 127.43, 127.09,
126.99, 125.66, 125.42, 124.53, 124.40, 47.48, 46.01, 45.49, 17.85, 16.63. HRMS (EI)
(m/z) calcd for [C26H19NO4]+ (M+): 409.1314; found: 409.1318.

(9R,10S,11R,15S)-13-(o-tolyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene12,14 -dione.i (13) Anhydride Ci (100 mg, 0.36 mmol) and 2-methylanilineii (41 mg, 0.39
mmol) were reacted using Route I to give 13 as an off-white solid (105 mg, 80 %).

i

1

H

Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306.
ii
Commercially available
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NMR (400 MHz, CDCl3) δ 6.79-7.43 (m, 12H syn and 11H anti), 5.43 (d, J = 7.6 Hz, 1H
anti), 4.76-4.88 (m, 2H syn and anti), 3.29-3.41 (m, 2H syn and anti), 1.98 (s, 3H anti),
0.97 (s, 3H syn). The spectral data were in agreement with the literature reported.

(9R,10S,11R,15S)-13-(2,3-dimethylphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione.

i

(14). Anhydride C

ii

(100 mg, 0.36 mmol) and 2,3-

dimethylanilineiiixxxi (48 mg, 0.40 mmol) were reacted using Route I to give 14 as an offwhite solid (109 mg, 80 %). 1H NMR (400 MHz, CDCl3) δ 7.48-6.94 (m, 10H syn and
anti), 6.84 (t, J = 7.7 Hz, 1H anti), 6.70 (dd, J = 7.5 Hz, J = 1.1 Hz, 1H syn), 5.27 (d, J =
7.8 Hz, 1H anti), 4.85 (s, 2H syn), 4.83 (s, 2H anti), 3.38-3.29 (m, 2H syn and anti), 2.16
(s, 3H anti), 2.09 (s, 3H syn), 1.86 (s, 3H anti), 0.81 (s, 3H syn).

13

C NMR (100 MHz,

CDCl3) δ 176.31, 176.22, 142.09, 141.48, 139.46, 138.99, 138.31, 138.12, 134.71, 133.98,
131.06, 131.03, 130.87, 130.68, 128.17, 127.93, 127.69, 127.52, 127.30, 126.95, 126.87,
126.36, 126.18, 125.62, 125.39, 125.35, 124.91, 124.46, 124.34, 47.34, 47.27, 45.97,
45.47, 20.34, 14.38, 12.88.

i

Csoregh, I.; Finge, S.; Weber, E. Struct. Chem. 2003, 14, 241.; Weber, E.; Finge, S.;
Csoregh, I. J. Org. Chem. 1991, 56, 7281.
ii
Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306.
iii
Commercially available
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(9R,9aS,12aR,13S)-9,13-dimethyl-11-(o-tolyl)-9,9a,12a,13-tetrahydro-10H-9,13methanobenzo[h]isoindolo[5,6-f]quinoline-10,12,14(11H)-trione. (15). Diene Ci (80 mg,
0.31 mmol) and N-(o-tolyl) maleimideii (70 mg, 0.37 mmol) were reacted using Route II to
give 15 as an off-white solid (110 mg, 80 %). mp: 238 °C (dec)

1

H NMR (400 MHz,

CD2Cl2) δ 9.52-9.38 (m, 1H syn and anti), 9.02-8.97 (m, 1H syn and anti), 8.69-8.63 (m,
1H syn and anti), 8.42-8.33 (m, 1H syn and anti), 7.82-7.69 (m, 2H syn and anti), 7.607.50 (m, 1H syn and anti), 7.14-6.94 (m, 2H syn and anti), 6.83-6.73 (m, 1H syn and anti),
6.55-6.46 (m, 1H anti), 4.33 (dd, J = 7.9 Hz, J = 1.3 Hz, 1H anti), 3.61 (s, 2H syn), 3.60 (s,
2H anti), 2.34 (s, 3H anti), 2.33 (s, 3H syn), 2.30 (s, 3H anti), 2.29 (s, 3H syn), 1.93 (s, 3H
anti), -0.06 (s, 3H syn).

C NMR (100 MHz, CDCl3) δ 200.48, 199.49, 174.30, 174.03,

13

173.95, 173.89, 149.25, 149.14, 135.80, 134.93, 134.54, 134.17, 132.61, 132.35, 132.13,
130.91, 130.78, 130.58, 129.94, 129.60, 129.38, 129.34, 129.29, 129.22, 129.03, 127.84,
127.76, 127.56, 126.84, 126.73, 126.33, 125.75, 125.72, 124.52, 124.47, 122.49, 122.32,
122.25, 122.19, 55.57, 55.41, 55.29, 55.15, 48.09, 48.05, 47.79, 47.60, 17.63, 15.38, 14.78,
14.61, 14.59, 14.50. HRMS (EI) (m/z) calcd for [C29H22N2O3]+ (M+): 446.1630; found:
446.1622.

i

Li, P.; Parker, T. M.; Hwang, J.; Deng, F.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.;
Shimizu, K. D. Org. Lett. 2014, 16, 5064.
iiii
Matuszak, N.; Muccioli, G. G.; Labar, G.; Lambert, D. M. J. Med. Chem. 2009, 52, 7410.
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4-((3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol2-yl)-3-methylbenzoic acid. (16) Anhydride D i (100 mg, 0.61 mmol) and 4-amino-3methylbenzoic acidi (101 mg, 0.67 mmol) were reacted using Route I to give 15 as an offwhite solid (150 mg, 83 %) mp: 245 °C 1H NMR (400 MHz, CDCl3) δ 7.99-7.63 (m, 2H
syn and anti), 7.38-7.06 (m, 4H syn and anti), 6.97 (d, J = 8.2 Hz, 1H syn), 5.52 (d, J = 8.2
Hz, 1H anti), 3.99-3.88 (m, 2H syn and anti), 3.82-3.68 (m, 2H syn and anti), 2.22-2.13
(m, 1H syn and anti), 2.08 (s, 3H anti), 2.07-1.98 (m, 1H syn and anti), 1.10 (s, 3H syn).
C NMR (100 MHz, CDCl3) δ 175.70, 175.64, 170.69, 143.09, 142.75, 137.17, 136.32,

13

135.96, 135.58, 132.85, 132.58, 130.02, 129.97, 128.66, 128.48, 128.37, 128.06, 127.73,
127.55, 123.41, 123.37, 54.52, 52.39, 48.35, 48.24, 46.91, 46.45, 17.85, 17.14. HRMS
(EI) (m/z) calcd for [C21H17NO4]+ (M+): 347.1158; found: 347.1159.

(3aR,4S,7R,7aS)-2-(o-tolyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3
(2H)-dione.ii (17) Anhydride Di (100 mg, 0.61 mmol) and and 2-methylanilinei (71 mg,
0.67 mmol) were reacted using Route I to give 17 as an off-white solid (100 mg, 65 %).

i
ii

Commercially available
Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306.
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1

H NMR (400 MHz, CDCl3) δ 7.38-7.20 (m, 3H syn and anti), 7.03 (d, J = 7.5 Hz, 1H

syn), 6.91 (d, J = 7.5 Hz, 1H anti), 6.35 (t, J = 1.6 Hz, 2H anti), 6.32 (t, J = 1.6 Hz, 2H
syn), 3.56-3.44 (m, 4H syn and anti), 2.18 (s, 3H anti), 2.15 (s, 3H syn), 1.80-1.88 (m, 1H
syn and anti), 1.60-1.69 (m, 1H syn and anti). The spectral data were in agreement with
the literature reported.

(9R,9aR,12aS,13S)-11-(5-fluoro-2-methylphenyl)-9,13-diphenyl-9,9a,12a,13tetra hydro-10H-9,13-methanophenanthro[9,10-f]isoindole-10,12,14(11H)-trione. (18)
Anhy-dride Ei (200 mg, 0.42 mmol) and 5-fluoro-2-methylanilineii (57 mg, 0.46 mmol)
were reacted using Route I to give 18 as an off-white solid (204 mg, 85 %). mp: 290 °C
(dec) 1H NMR (400 MHz, CD2Cl2) δ 8.77 (d, J = 8.4 Hz, 2H syn and anti), 8.70 (d, J =
8.4 Hz, 2H syn and anti), 8.45-8.27 (m, 2H syn and anti), 7.86-6.66 (m, 17H syn and 16H
anti), 4.70 (s, 2H syn), 4.69 (s, 2H anti), 3.96 (dd, J = 9.0 Hz, J = 2.7 Hz, 1H anti), 2.12 (s,
3H anti), -0.11 (s, 3H syn).

13

C NMR (100 MHz, CDCl3) δ 197.05, 195.86, 173.33, 173.05,

161.66, 159.55, 159.22, 133.76, 133.74, 133.54, 131.85, 131.79, 131.68, 131.60, 131.37,
131.11, 131.05, 130.97, 129.57, 129.54, 129.28, 129.16, 128.88, 128.76, 128.69, 128.65,
127.62, 127.38, 127.15, 126.92, 126.55, 126.37, 126.15, 125.92, 123.33, 123.10, 116.69,

i
ii

Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547.
Commercially available
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116.54, 116.33, 114.98, 114.75, 113.94, 113.70, 63.73, 45.54, 45.11, 17.13, 14.68. HRMS
(EI) (m/z) calcd for [C31H22FNO3]+ (M+): 587.1897; found: 587.1895.

(9R,10S,11R,15S)-13-(3-methylpyridin-4-yl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione. (19). Anhydride Ci (100 mg, 0.36 mmol) and 3-methylpyridin-4amineii (43 mg, 0.40 mmol) were reacted using Route Iiii to give 19 as an off-white solid
(85 mg, 65 %). mp: 248 °C 1H NMR (400 MHz, CDCl3) δ 8.53-8.22 (m, 2H syn and anti),
7.51-7.09 (m, 5H syn and anti), 6.94 (d, J = 5.2 Hz, 1H syn), 5.57 (d, J = 5.2 Hz, 1H anti),
4.89 (t, J = 7.0 Hz, 2H syn and anti), 3.46-3.43 (m, 2H syn and anti), 2.08 (s, 3H anti), 1.12
(s, 3H syn).

13

C NMR (101 MHz, CDCl3) δ 175.12, 174.92, 151.99, 151.85, 148.09,

147.73, 141.70, 141.07, 139.23, 139.06, 139.00, 138.83, 131.82, 131.29, 127.61, 127.45,
127.14, 127.04, 125.62, 125.38, 124.54, 124.42, 122.50, 121.94, 100.10, 47.54, 47.51,
45.97, 45.47, 15.02, 13.95. HRMS (EI) (m/z) calcd for [C24H18N2O2]+ (M+): 366.1368;
found: 366.1370.

i

Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306.
ii
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(9R,9aS,12aR,13S)-9,13-dimethyl-11-(o-tolyl)-9,9a,12a,13-tetrahydro-10H-9,13methano-isoindolo[5,6-f][4,7]phenanthroline-10,12,14(11H)-trione. (20)

Diene D i (80

mg, 0.31 mmol) and N-(o-tolyl) maleimideii (70 mg, 0.37 mmol) were reacted using Route
II to give 20 as an off-white solid (110 mg, 80 %). mp: 296 °C (dec) 1H NMR (400 MHz,
CD2Cl2) δ 9.12-8.87 (m, 4H syn and anit), 7.74-7.54 (m, 2H syn and anti), 7.15-6.68 (m,
4H syn and 2H anti), 6.58-6.50 (m, 1H anti), 4.39 (dd, J = 7.9 Hz, J =1.3 Hz, 1H anti), 3.62
(s, 2H syn), 3.60 (s, 2H anti), 2.41 (s, 6H anti), 2.40 (s, 6H syn), 1.92 (s, 3H anti), 0.03 (s,
3H syn).

13

C NMR (100 MHz, CD2Cl2) δ 202.68, 201.64, 174.07, 173.75, 151.04, 150.94,

144.70, 144.49, 138.61, 138.32, 136.10, 136.05, 131.61, 131.34, 131.27, 131.24, 131.05,
130.96, 129.67, 129.50, 128.57, 128.16, 128.09, 127.10, 126.72, 125.98, 125.48, 122.59,
122.52, 56.58, 56.54, 49.08, 48.65, 30.25, 17.85, 15.85, 14.56, 14.34. HRMS (EI) (m/z)
calcd for [C28H21N3O3]+ (M+): 447.1583; found: 447.1585.

i

Li, P.; Parker, T. M.; Hwang, J.; Deng, F.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.;
Shimizu, K. D. Org. Lett. 2014, 16, 5064.
ii
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(9R,9aS,12aR,13S)-9,13-dimethyl-11-(o-tolyl)-9,9a,12a,13-tetrahydro-10H-9,13methano-phenanthro[9,10-f]isoindole-10,12,14(11H)-trione. (21) Diene Bi (80 mg, 0.31
mmol) and N-(o-tolyl) maleimideii (70 mg, 0.37 mmol) were reacted using Route II to give
21 as an off-white solid (124 mg, 90 %). mp: 240 °C 1H NMR (400 MHz, CDCl3) δ 8.838.68 (m, 2H syn and anti), 8.41-8.34 (m, 2H syn and anti), 7.74-7.58 (m, 4H syn and anti),
7.08-6.64 (m, 4H syn and 2H anti), 6.51-6.41 (m, 1H anti), 4.40 (dd, J = 7.9 Hz, J = 1.1
Hz, 1H anti), 3.57 (s, 2H syn), 3.56 (s, 2H anti), 2.34 (s, 3H anti), 2.32 (s, 3H syn), 1.94 (s,
3H anti), -0.01 (s, 3H syn).

13

C NMR (100 MHz, CD2Cl2) δ 201.37, 200.28, 174.74,

174.46, 136.60, 135.94, 134.97, 134.05, 133.80, 131.74, 131.62, 131.51, 131.23, 131.08,
130.96, 129.78, 129.54, 129.35, 128.58, 128.34, 128.13, 128.10, 127.90, 127.75, 127.69,
127.66, 127.33, 127.03, 126.89, 126.83, 125.74, 125.68, 123.99, 123.91, 55.66, 55.50,
48.78, 48.42, 17.80, 15.59, 15.21, 15.08. HRMS (EI) (m/z) calcd for [C30H23NO3]+ (M+):
445.1678; found: 445.1677.

i
ii

Li, P.; Zhao, C.; Smith, M. D.; Shimizu, K. D. J. Org. Chem. 2013, 78, 5303.;
Matuszak, N.; Muccioli, G. G.; Labar, G.; Lambert, D. M. J. Med. Chem. 2009, 52, 7410
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(9R,9aR,12aS,13S)-9,13-diphenyl-11-(o-tolyl)-9,9a,12a,13-tetrahydro-10H-9,13methanophenanthro[9,10-f]isoindole-10,12,14(11H)-trione.i (22) Anhydride Eii (200 mg,
0.42 mmol) and 2-methylanilineiii (50 mg, 0.46 mmol) were reacted using Route II to give
22 as an off-white solid (196 mg, 82 %). 1H NMR (400 MHz, CDCl3) δ 8.73 (d, J = 8.5
Hz, 2H syn), 8.67 (d, J = 7.6 Hz, J = 1.2 Hz, 2H anti), 8.38 (td, J = 7.6 Hz, J =1.2 Hz, 2H
syn and anti), 7.72 (td, J = 7.6 Hz, J =1.2 Hz, 2H syn and anti), 7.63-6.86 (m, 17H syn and
16H anti), 6.74 (d, J = 7.4 Hz, 1H syn), 6.46 (t, J = 7.4 Hz, 1H anti), 4.65 (s, 2H syn), 4.64
(s, 2H anti), 4.35 (dd, J = 7.9 Hz, J = 1.3 Hz, 1H anti), 2.06 (s, 3H anti), -0.02 (s, 3H syn).
The spectral data were in agreement with the literature reported.

(9R,9aR,12aS,13S)-9,13-diphenyl-11-(o-tolyl)-9,9a,12a,13-tetrahydro-10H-9,13methano-pyreno[4,5-f]isoindole-10,12,14(11H)-trione.i (23) Anhydride Fii (200 mg, 0.40
mmol) and 2-methylanilineiii (50 mg, 0.46 mmol) were reacted using Route I to give 23 as
an off-white solid (206 mg, 87 %). 1H NMR (400 MHz, CDCl3) δ 8.52-8.40 (m, 2H syn
and anti), 8,14-8.05 (m, 2H syn and anti), 8.04 (s, 2H anti), 8.03 (s, 2H syn), 7.77 (td, J =

i

Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306.
ii
Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547.
iii
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7.6 Hz, J = 1.1 Hz, 2H syn and anti), 7.68-6.76 (m, 15H syn and 14H anti), 6.54 (d, J = 7.6
Hz, 1H syn), 6.06 (t, J = 7.6 Hz, 1H anti), 4.72 (s, 2H anti), 4.70 (s, 2H syn), 3.78 (dd, J =
7.9 Hz, J =1.2 Hz, 1H anti), 2.02 (s, 3H anti), -0.58 (s, 3H syn). The spectral data were in
agreement with the literature reported.

4-((6R,13S,15R,19S)-16,18-dioxo-6,13-dihydro-6,13-[3,4]epipyrrolopentacen-17yl)-3-methylbenzoic acid. (24) Anhydride G i (150 mg, 0.40 mmol) and 4-amino-3methylbenzoic acidii (66 mg, 0.44 mmol) were reacted using Route I to give 24 as an offwhite solid (152 mg, 75 %) mp: 300 °C (dec) 1H NMR (400 MHz, CDCl3) δ 8.02-7.14
(m, 12H), 7.03 (d, J = 8.3 Hz, 1H syn), 5.15 (s, 2H, syn), 5.13 (s, 2H anti), 5.03 (d, J = 8.2
Hz, 1H anti), 3.68-3.53 (m, 2H syn and anti), 2.12 (s, 3H anti), 0.55 (s, 3H syn).

13

C NMR

(100 MHz, CDCl3) δ 175.82, 175.68, 169.69, 138.57, 138.12, 136.83, 136.25, 136.02,
135.69, 133.06, 132.83, 132.77, 132.71, 132.63, 130.01, 129.91, 128.68, 128.50, 128.34,
128.21, 127.92, 127.78, 127.60, 126.63, 126.49, 126.45, 124.44, 124.12, 123.21, 123.08,
47.47, 47.41, 45.88, 45.38, 17.84, 15.77. HRMS (EI) (m/z) calcd for [C34H23NO4]+ (M+):
509.1622; found: 509.1627.

i
ii

Jia, Z. Y.; Li, S.; Nakajima, K.; Kanno, K.; Takahashi, T. J. Org. Chem. 2011, 76, 293.
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(6R,13S,15R,19S)-17-(o-tolyl)-6,13-dihydro-6,13-[3,4]epipyrrolopentacene16,18-dione. (25) Anhydride Gi (150 mg, 0.40 mmol) and 2-methylanilineii (47 mg, 0.44
mmol) were reacted using Route I to give 25 as an off-white solid (130 mg, 70 %). mp:
282 °C 1H NMR (400 MHz, CDCl3) δ 7.98-7.67 (m, 8H syn and anit), 7.55-7.39 (m, 4H
syn and anti), 7.22-6.87 (m, 4H syn and 2H anti), 6.62 (t, J = 7.6 Hz, 1H anti), 5.16 (s, 2H
syn), 5.13 (s, 2H anti), 4.97 (d, J = 7.7 Hz, 1H anti), 3.57 (s, 2H syn and anti), 2.06 (s, 3H
anti), 0.49 (s, 3H syn).

C NMR (75 MHz, CDCl3) δ 176.28, 175.99, 146.62, 144.28,

13

144.19, 135.49, 134.89, 132.26, 132.08, 132.01, 131.91, 124.27, 124.22, 124.12, 123.71,
53.01, 52.62, 47.06, 46.13, 45.71, 45.39, 19.42, 18.34. HRMS (EI) (m/z) calcd for
[C33H23NO2]+ (M+): 465.1729; found: 465.1731.

(3aR,4S,7R,7aS)-2-(3-methylpyridin-2-yl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione.iii (26). Anhydride Eii (100 mg, 0.61 mmol) and 3-methylpyridin2-amineii (72 mg, 0.67 mmol) were reacted using Route Iiv to give 26 as an off-white solid

i

Jia, Z. Y.; Li, S.; Nakajima, K.; Kanno, K.; Takahashi, T. J. Org. Chem. 2011, 76, 293.
Commercially available
iii
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iv
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ii
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(108 mg, 70 %). 1H NMR (400 MHz, CD2Cl2) δ 8.41-8.36 (m, 1H syn and anti), 7.68-7.63
(m, 1H syn and anti), 7.33-7.25 (m, 1H syn and anti), 6.33 (t, J = 1.8 Hz, 2H syn) 6.29 (t,
J = 1.8 Hz, 2H anti), 3.53-3.44 (m, 4H syn and anti), 2.14 (s, 3H anti), 2.11 (s, 3H syn),
1.84-1.58 (m, 2H syn and anti).

13

C NMR (100 MHz, CDCl3) δ 176.40, 176.16, 147.60,

147.55, 145.57, 145.48, 140.13, 139.80, 135.45, 134.66, 131.98, 131.56, 124.67, 124.62,
52.87, 52.44, 47.28, 46.26, 45.54, 45.21, 18.01, 17.27. Copies of 1H and 13C NMR spectra
were provided. HRMS (EI) (m/z) calcd for (C14H14N2O2) (M+): 254.1055; found:
254.1053.

(3aR,4R,9S,9aS)-2-(3-methylpyridin-2-yl)-4,9-diphenyl-3a,4,9,9a-tetrahydro-1H4,9-epoxy-benzo[f]isoindole-1,3(2H)-dione.i (27). Anhydride Aii (100 mg, 0.27 mmol) and
3-methylpyridin-2-amineiii (32 mg, 0.30 mmol) were reacted using Route IIiv to give 27 as
an off-white solid (93 mg, 75 %). 1H NMR (400 MHz, CD2Cl2) δ 8.42-7.97 (m, 5H syn
and anit), 7.62-7.44 (m, 7H syn and anti), 7.33-6.97 (m, 5H syn and anti), 4.40 (s, 2H syn),
4.32 (s, 2H anti), 2.11 (s, 3H anti), 1.13 (s, 3H syn).

13

C NMR (100 MHz, CD2Cl2) δ

173.20, 147.74, 147.63, 145.71, 145.69, 144.36, 140.21, 139.98, 137.30, 137.21, 132.71,
131.98, 129.26, 129.15, 129.12, 128.95, 128.92, 127.73, 127.70, 125.26, 125.09, 121.69,

i

Maier, J. M.; Li, P.; Hwang, J.; Smith, M. D.; Shimizu, K. D. J. Am. Chem. Soc. 2015,
137, 8014
ii
Carroll, W. R.; Pellechia, P.; Shimizu, K. D. Org. Lett. 2008, 10, 3547
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121.20, 91.06, 90.70, 55.44, 55.31, 20.05, 17.43, 16.49. Copies of 1H and 13C NMR spectra
were provided.

HRMS (EI) (m/z) calcd for [C30H22N2O3]+ (M+): 458.1630; found:

458.1623

(9R,10S,11R,15S)-13-(3-methylpyridin-2-yl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione.i (28) Anhydride Cii (100 mg, 0.36 mmol) and 3-methylpyridin2-amineiii (43 mg, 0.40 mmol) were reacted using Route Iiv to give 28 as an off-white solid
(101 mg, 77 %). 1H NMR (400 MHz, CDCl3) δ 8.38-8.32 (m, 1H syn), 8.22-8.17 (m, 1H
anti), 7.55-6.99 (m, 10H syn and anti), 5.01-4.82 (m, 2H syn and anti), 3.50-3.41 (m, 2H
syn and anti), 2.09 (s, 3H anti), 1.12 (s, 3H syn).

C NMR (100 MHz, CDCl3) δ 175.50,

13

147.28, 145.05, 141.85, 139.97, 139.52, 132.33, 127.39, 126.89, 125.57, 124.82, 124.35,
47.61, 45.40, 15.67. Copies of 1H and 13C NMR spectra were provided. HRMS (EI) (m/z)
calcd for [C24H18N2O2]+ (M+): 366.1368; found: 366.1368.

i

Maier, J. M.; Li, P.; Hwang, J.; Smith, M. D.; Shimizu, K. D. J. Am. Chem. Soc. 2015,
137, 8014
ii
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Am. Chem. Soc. 2012, 134, 14306.
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(9R,9aR,12aS,13S)-11-(3-methylpyridin-2-yl)-9,13-diphenyl-9,9a,12a,13-tetrahydro-10H-9,13-methanophenanthro[9,10-f]isoindole-10,12,14(11H)-trione. (29). Anhydride D i (200 mg, 0.42 mmol) and 3-methylpyridin-2-aminexxxi (50 mg, 0.46 mmol) were
reacted using Route Iii to give 29 as an off-white solid (196 mg, 84 %). mp: 298 °C (dec)
Only the syn conformer was observed in the NMR spectra. 1H NMR (400 MHz, CDCl3) δ
8.67 (d, J = 8.5 Hz, 2H), 8.36 (d, J = 7.8 Hz, 2H), 8.28 (d, J = 3.7 Hz, 1H), 7.83-6.97 (m,
16H), 4.69 (s, 2H), 0.06 (s, 3H).

13

C NMR (100 MHz, CDCl3) δ 196.12, 173.19, 133.96,

133.78, 131.76, 131.08, 129.61, 129.37, 128.72, 128.61, 127.35, 126.92, 126.61, 126.23,
124.84, 123.07, 63.70, 45.89, 14.54. . HRMS (m/z) calcd for [C39H26N2O3]+ (M+)
570.1943; found: 570.1946.

(9R,9aR,12aS,13S)-11-(3-methylpyridin-2-yl)-9,13-diphenyl-9,9a,12a,13-tetrahydro-10H-9,13-methanopyreno[4,5-f]isoindole-10,12,14(11H)-trione. (10) Anhydride Fi
(200 mg, 0.40 mmol) and 3-methylpyridin-2-amineii (49 mg, 0.45 mmol) were reacted
using Route Iiii to give 30 as an off-white solid (202 mg, 85 %). mp: 300 °C (dec) Only
the syn conformer was observed in the NMR spectra. 1H NMR (400 MHz, CDCl3) δ 8.45

i
ii
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(d, J = 7.9 Hz, 2H syn), 8.24 (dd, J = 4.7 Hz, J = 0.8 Hz, 1H syn), 8.08 (dd, J = 7.6 Hz, J
= 0.8 Hz, 2H syn), 8.01 (s, 2H syn), 7.82-7.24 (m, 12H syn), 7.00 (dd, J = 7.6 Hz, J = 4.7
Hz, 1H syn), 6.95 (dd, J = 7.6 Hz, J = 0.8 Hz, 1H syn), 4.78 (s, 2H), -0.50 (s, 3H).

13

C

NMR (100 MHz, CDCl3) δ 196.60, 173.18, 134.83, 133.74, 131.50, 131.25, 129.67,
129.56, 128.75, 128.71, 127.67, 126.23, 126.17, 125.68, 125.63, 124.81, 123.73, 63.94,
46.08, 13.83. HRMS (m/z) calcd for [C41H26N2O3]+ (M+): 594.1943; found: 594.1955.

2.2 Characterization
1

H and 13C NMR spectra for all newly reported compounds and crystal data (cif) of

rotors 1−11, 15, 16, 18−21, 24, 25, 29, 30 are available free of charge via Internet at
http://pubs.acs.org/doi/abs/10.1021/acs.cgd.5b00906

3. Measurement of the Mole Fraction of syn-Conformer (χsyn) In Solution.
Quantification of the syn- and anti-conformers in solution was carried out by
comparing the integration of the corresponding peaks in 1H NMR spectra. i The separate
signals for the ortho-methyl protons of the rotor motif were used to measure the syn-anti
conformational equilibrium. The ortho-methyl group in the syn-conformer is positioned
close to the aromatic, and thus the singlet for the syn-conformer of the ortho-methyl group
displays an upfield shift of 0.02~2.50 ppm in the 1H NMR spectra in comparison to the
singlet for the anti-conformer. For rotors with small alkene shelves, the chemical shift
difference for the ortho-methyl group between syn- and anti- conformers was often too
small to accurately integrate the ratio. In those cases, other protons on the o-tolyl rotor

i

Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306; Zhao, C.; Li, P.; Smith, M. D.; Pellechia, P. J.; Shimizu,
K. D. Org. Lett. 2014, 16, 3520.
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motif were used to measure the syn-/anti- ratios. i The mole fraction of syn-conformer (χsyn)
in solution was then calculated from the syn/anti ratio (Equation 4.1). The solution χsyn
values for the 30 rotors were measured in chloroform and four other common
crystallization solvents (Table 4.3)

csyn=

[syn]
[syn]+[anti]

(Equation 4.1)

Error Analysis for Solution χsyn
The NMR samples in this work were prepared by dissolving ~10 mg of the purified
molecular rotors in 0.7 mL of the deuterated solvent of choice, giving a total concentration
of ~ 33 mM (assuming an average molecular weight of 440). NMR peak areas were
measured using the MestRenova line-fitting function to reduce the error in integration. The
error of quantitative NMR analysis was considered to be 1% for concentrations above 10
mM as appropriate line-fitting methods were adopted. ii Therefore, the error for χsyn
1

(𝐸𝑟𝑟𝑜𝑟χsyn ) would reach the minimum at χsyn = 1+√2 = 0.41 (assuming the integration error
proportionally relates to the isomer concentration) and was estimated to be 1.7% (Equation
4.2) as both conformers had a concentration above 10 mM.

Errorsyn  Error[ 2syn ]  Error([2syn ][ anti ])
 Error[ 2syn ]  Error[ 2syn ]  Error[ 2anti ]

(Equation 4.2)

 2* Error[ 2syn ]  Error[ 2anti ]

i

Zhao, C.; Parrish, R. M.; Smith, M. D.; Pellechia, P. J.; Sherrill, C. D.; Shimizu, K. D. J.
Am. Chem. Soc. 2012, 134, 14306; Zhao, C.; Li, P.; Smith, M. D.; Pellechia, P. J.; Shimizu,
K. D. Org. Lett. 2014, 16, 3520.
ii
See references in: Rizzo, V.; Pinciroli, V. J. Pharmaceut. Biomed. 2005, 38, 851.
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However the integration error in χsyn values near the extreme values (χsyn = 0 or 1)
is larger due to the lower concentration and larger error of the minor conformer. Precise
measurements of error at different concentrations were not performed. However, Rizzo et
al. found that,i “In our experience with 400–500 MHz instruments and non-refrigerated
1

H-probes, qNMR (quantitative NMR) may be applied to solutions with concentration as

low as 1 mM if a precision of 5% is acceptable” We, thus, set our detection limit
conservatively at 1 mM in order to keep error in integration no higher than 5%. The
measurable limit for χsyn were estimated to be 0.03 to 0.97 based the smaller peak being
5% of the larger peak. 𝐸𝑟𝑟𝑜𝑟χsyn at these χsyn limits was estimated to be 7.1% (χsyn = 0.03)
and 5.2% (χsyn = 0.97).

i

Rizzo, V.; Pinciroli, V. J. Pharmaceut. Biomed. 2005, 38, 851.
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CHAPTER 5
SOLVENT-INDUCED REVERSIBLE SOLID-STATE COLOR CHANGE OF AN
INTRAMOLECULAR CHARGE-TRANSFER COMPLEXi

i

Reproduced with permission from: Li, P.; Maier, J. M.; Hwang, J.; Smith, M. D.;
Krause, J. A.; Mullis, B. T.; Strickland, S. M. S.; Shimizu, K. D. Chem. Comm. 2015,
51, 14809. Copyright 2015 Royal Society of Chemistry.
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1. Introduction
Aromatic CT complexes1 have found applications in host-guest complexes,2,3
supramolecular assemblies,4-6 self-healing,7-9 and responsive materials,10-12 and organic
electronics.13,14 Interestingly, aromatic CT interactions have not been as widely utilized in
sensing applications, which is probably due to their low extinction coefficients and/or low
association constants.15-17

However, CT interactions have a number of unique

characteristics that are advantageous for sensing, molecular switches, and dynamic
supramolecular systems. First, CT complexes typically absorb in the visible region of the
UV-vis spectrum, and thus CT sensors can be monitored by the naked-eye. Second, the
colors of CT complexes are highly sensitive to the electronic properties of the donor and
acceptor units18 and to the relative geometry of the donor and acceptor units.19-21 Thus,
binding effects that induce changes in the CT complex geometry can be easily monitored
by variations in their colours.15-17,22,23
The goal of this study was to develop a responsive colorimetric system based on an
intramolecular CT interaction. Unlike the majority of CT sensors,24 CT molecule 1
contains both the donor and acceptor units. The two pyrene (PYR) donor units are linked
to a central 1,4,5,8-naphthalenedimide (NDI) acceptor unit (Figure 5.1a) forming a
sandwich-type 2:1 aromatic stacking complex. Thus, the guest .molecule does not need to
contain a donor or acceptor unit, which greatly expands the number of potential guests and
the general utility of this design. The sensing mechanism is the guest-induced changes in
geometry of the intramolecular CT interaction, which could be monitored by changes in
color of the CT complex.
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Figure 5.1 (a) Molecular CT platform 1 highlighting the
intramolecular donor-acceptor-donor sandwich complex;
and (b) a schematic representation of the solvationdesolvation induced complexation change in color and
geometry in 1

2. Results and Discussion
The CT molecule 1 was readily prepared in three steps from commercially available
1-pyreneacetic acid, 2-amino-4-tert-amylphenol, and 1,4,5,8-naphthalenedianhydride
(Scheme 5.1).i The two PYR donor units were connected to the central NDI acceptor unit
via two short but flexible linkers, which ensured the formation of the intramolecular
aromatic stacking complex but also allowed sufficient conformational freedom to allow the
donor and acceptor units to adopt different geometries. The 5-atom linker (-C=C-O-C-C)
was designed based on a similar 5-atom linker that was previously used to form a similar
sandwich aromatic stacking complex around a NDI core.25 Since 1 did not contain
recognition groups that form strong directional interactions, the guest-induced colorimetric
properties of 1 were initially studied in the solid-state where the confined condensed-phase

i

For synthesis details see Supporting Information..
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environment could allow guest molecules to sterically influence the relative geometry of
the donor and acceptor units. Thus, the 2:1 PYR to NDI stoichiometry of the sandwich
complex25,26 was important to ensure that both surfaces of the NDI would be occupied and
could not form additional interactions with adjacent molecules of 1.i
Scheme 5.1 Synthesis of the molecular CT model 1 and control 2.

The ability of 1 to form an intramolecular CT complex was first confirmed in
solution by the observation of the distinctive CT band in the visible region of the absorption
spectrum. The λmax at 505 nm was consistent with previous reports of PYR-NDI CT
complexes.3,6,9,11,27-29 The effectiveness of the linker in forming and maintaining the
intramolecular PYR-NDI complexation was also demonstrated by comparison with an
intermolecular PYR-NDI complex formed between pyrene and control 2, a structural
analogue containing the same symmetrically substituted NDI core but lacking of the two
pyrene donor groups. The intermolecular 2•pyrene complex displayed a similar CT band
(λmax at 510 nm) but only at higher concentrations (> 10 mM).

i

CT molecule 1 appears to be locked in the anti-conformation due to restricted rotation
with the PYR groups on opposite sides of the NDI surface (See Ref. 25). The rotational
barrier for these N-arylimide rotor was previously measured to be 27 kcal/mol (Ref. 26),
which is too high for isomerization to the syn-conformer at the room temperature.
Furthermore, heating anti-1 in solution and the solid-state at the elevated temperature (80
°C) for 24 h showed no indications of the syn-conformer when monitored by 1H NMR.
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Next, the observation of different colored solid samples of 1 upon treatment with
different solvents provided the first indications that the geometry and color of the
intramolecular CT complex in 1 were sensitive to solvent inclusion. When 1 was
precipitated from dichloromethane, a purple solid was obtained, which was similar to the
color of 1 in solution. However, when 1 was precipitated from acetone, a distinctly
different orange colored solid was obtained. The purple and orange solids of 1 were further
characterized by diffuse reflectance UV-vis spectroscopy (Figure 5.2). The purple solid of
1 showed a well-resolved CT absorption band with a λmax at 530 nm. In comparison, the
orange solid of 1 showed a similar but blue-shifted CT band with a λmax at 500 nm. By
comparison, control 2, which only contained an NDI unit showed no CT band in the visible
region of the diffuse reflectance UV-vis spectrum.

Figure 5.2 Normalized diffuse reflectance UV-vis spectra of
the purple CH2Cl2-solvate solid of 1 (purple line), the orange
non-solvate solid of 1 (orange line), and the white solid of
control 2 (dotted black line).
1

H NMR and HRMS analysis confirmed that both the purple and orange solids

contained pure samples of 1. The only differences were that the purple solid was a solvate
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of 1 containing two equivalents of dichloromethane; whereas, the orange solid was a nonsolvate of 1. Thermogravimetric analysis (TGA) of the purple solid further confirmed the
presence of two CH2Cl2 molecules. A clear weight loss of 13%was observed when the
purple solid was heated to 180 °C, which was consistent with the loss of two equivalents
of CH2Cl2. After heating in the TGA, the purple solid became red-orange.i In contrast, the
orange solid showed no observable weight loss on heating in the TGA to 200 °C.
Interestingly, the purple CH2Cl2-solvate of 1 was stable as the stoichiometry and coloration
did not change after a month at room temperature as monitored by 1H NMR and UV-vis
spectrometry.
The purple and orange solids of 1 could be easily and repeatedly interconverted by
precipitation from the appropriate solvent. First, the purple CH2Cl2-solvate could be
readily regenerated from the orange non-solvate by precipitation from dichloromethane
(Figure 5.3a). Conversely, the orange non-solvate solid of 1 could be regenerated from
purple 1 by precipitation from acetone. Acetone is a poor solvent for 1 and efficiently
extracts any included solvent from solid samples of 1. The ease with which 1 can uptake
or lose included solvent molecules was demonstrated by simply wetting samples of 1 with
a minimum amount of the CH2Cl2 or acetone, which yielded the corresponding color
change for the CH2Cl2 solvate or non-solvate forms, respectively (Figure 5.9 in SI).ii

i

The post-TGA sample of the purple solvate was a low crystalline solid form and
displayed a red coloration (Figure 5.8 in SI).
ii
Exposing the purple and orange solid samples of 1 to solvent vapors for 5 h showed no
noticeable color change.
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Figure 5.3 (a) The reversible color switching of solid 1
between purple CH2Cl2-solvate and orange non-solvate solid
forms by precipitation from dichloromethane and acetone,
respectively. (b) The CH2Cl2-solvate (left) and non-solvate
(right) crystals of 1, highlighting the distinct difference in
color.
To test the hypothesis that the different colored solid forms of 1 were due to
variations in the orientation of the PYR donor and NDI acceptor units in the intramolecular
CT complex, X-ray quality single crystals of 1 from CH2Cl2 and acetone were obtained
and analyzed by X-ray crystallography (Figure 5.3b). Dark purple plate crystals were
obtained from CH2Cl2 containing two equivalents of CH2Cl2 per 1 molecule. Conversely,
orange thin plate crystals were obtained from acetone, which do not contain any trapped
solvent molecules.i The colors of the crystals formed from each solvent were similar to the
purple and orange solids formed in the earlier precipitation studies in the same two
solvents. This suggested that the single crystals were the same structural forms as the
colored precipitated solids, which was confirmed in the matching XRD patterns for the
precipitated solids with the simulated XRD patterns from the X-ray crystal structures
(Figure 5.10 in SI).

i

The similarity in color between single crystals and precipitates were further confirmed
quantitatively by diffuse reflectance UV-vis spectroscopy of the single crystals (Figure
5.9 in SI).
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Despite the differences in color and solvation, the structures of the sandwich CT
complexes in the purple and orange crystals of 1 were surprisingly similar (Figure 5.4).
The folded conformations of 1 in both structures adopted the desired sandwich complex
with the PYR donor units forming centrosymmetric aromatic stacking interactions on both
faces of the central NDI unit (Figure 5.4). The PYR-center to NDI-plane distances (3.5
and 3.6 Å) for the solvate and non-solvate structures were very similar and were consistent
with an intramolecular aromatic stacking interaction.

Figure 5.4 Side views of the X-ray structures of (a) the dark
purple 1•(CH2Cl2)2 and (b) the orange non-solvate 1 crystals.
Insets are top views of the PYR and NDI surfaces (with
linkers, frameworks, and bottom PYR surface omitted for
viewing clarity). The pyrene surfaces in both crystals were
disordered and only the major conformers (76% and 72%)
are shown.
To help identify the geometric variations that lead to the dramatic differences in
color of the solids, additional four crystal structures of 1 containing different solvent
molecules (CH2Cl2/CH3CN, CH3NO2, EtNO2, and dioxane) were obtained and analyzed.
In each case, the solvate structure displayed a similar centrosymmetric aromatic stacking
complex in 1 with two included solvent molecules. These solvate crystals were all purple
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or purple-red in contrast with the orange color of non-solvate crystal of 1. This confirmed
that the solvent molecules themselves were not participating directly in the CT complex as
the solvents varied widely in their atomic and electronic structures and yet all of the
solvates of 1 had a similar purple color. The only consistent difference between the solvate
and non-solvate was in the orientation of the PYR and NDI surfaces as defined by the
dihedral angle (θ) between the long axes of the two surfaces (Figure 5.4).i The purple
solvate crystals consistently had θ angles greater than 50° (57°, 53°, 64-66°,ii and 52°) and
the orange non-solvate had θ values less than 50° (33 and 42°).iii This same structural
parameter (θ) has recently been identified by a recent computational study by Lin to help
explain the orientations of PYR and NDI units in previous reported CT crystal structures.30
The computational study by Lin predicted that θ angles from 50° to 75° would be
the most thermodynamically stable for aromatic stacked PYR and NDI surfaces due to
more favorable attractive electrostatic interactions.30 This prediction is consistent with the
observed geometries of the crystal structures of the 1 solvates. In the presence of included
solvent, the PYR and NDI units of 1 have sufficient room and freedom to adopt the more
stable stacking geometries (θ > 50°). The solvent molecules are able to fill the voids
created by the more perpendicular X-shaped arrangement of the PYR and NDI units (Fig
5.1b). In contrast, in the absence of included solvent molecules, the PYR and NDI units
adopt a more compact and aligned geometry (θ < 50°) to avoid forming voids. Thus the

i

The distances between the PYR and NDI units were also examined (See Table 5.1 in SI)
but no correlation of these distances with the color of the crystals was observed.
ii Two crystallographically independent molecules were observed in the 1•(EtNO ) crystal
2 2
structure.
iii The two θ angles are both for the same orange non-solvate crystal of 1. The pyrene arms
are disordered with two distinct populations leading to two separate θ angles.
173

packing forces in the non-solvate structure prevent the PYR and NDI units from adopting
the more stable X-shaped geometry.

3. Conclusion
In conclusion, we have developed an intramolecular CT molecule 1 which can
reversibly change color from purple to orange in the presence and absence of solvent in the
solid-state. The color switching abilities were attributed to solvent-induced changes in the
intramolecular stacking geometry. The presence of solvent in the crystalline matrix allows
the PYR and NDI units to form the more stable purple CT complex. In the absence of
included solvent molecules, the PYR and NDI units are forced into a less stable orange CT
complex. What is striking from the comparison of the crystal structures of 1 is how
sensitive the CT band is to these subtle variations in the PYR-NDI dihedral angles. Small
variations in θ angles (~10°) are readily observable by the naked-eye from the different
colors of the resulting solids. Rathore and Kochi have previously shown that the intensity
of the CT band and transition energies are highly sensitive to very small differences in the
distances between aromatic donor and acceptor units.21 However, we have not come across
a similar example demonstrating the sensitivity of the CT band to the orientations (angles)
of the aromatic donor and acceptor units. This sensitivity could form the basis for a new
type of intramolecular CT sensor, which can be read out by the naked-eye or inexpensive
visible spectrometers. Further studies on the impact of the donor-acceptor orientation on
the CT transition energy are currently underway in our laboratories.

174

Reference
[1]. Briegleb, G. Elektronen-Donator-Acceptor-Complexes. Springer-Verlag, Berlin and
New York, 1961.
[2]. Zhu, Z. X.; Cardin, C. J.; Gan, Y.; Colquhoun, H. M. Nat. Chem. 2010, 2, 653.
[3]. Colquhoun, H. M.; Williams, D. J.; Zhu, Z. J. Am. Chem. Soc. 2002, 124, 13346.
[4]. Kumar, M.; Rao, K. V.; George, S. J. Phys. Chem. Chem. Phys. 2014, 16, 1300.
[5]. Das, A.; Ghosh, S. Angew. Chem., Int. Ed. 2014, 53, 2038.
[6]. Jalani, K.; Kumar, M.; George, S. J. Chem. Comm. 2013, 49, 5174.
[7]. Burattini, S.; Greenland, B. W.; Merino, D. H.; Weng, W. G.; Seppala, J.; Colquhoun,
H. M.; Hayes, W.; Mackay, M. E.; Hamley, I. W.; Rowan, S. J. J. Am. Chem. Soc. 2010,
132, 12051.
[8]. Fox, J.; Wie, J. J.; Greenland, B. W.; Burattini, S.; Hayes, W.; Colquhoun, H. M.;
Mackay, M. E.; Rowan, S. J. J. Am. Chem. Soc. 2012, 134, 5362.
[9]. Burattini, S.; Colquhoun, H. M.; Fox, J. D.; Friedmann, D.; Greenland, B. W.; Harris,
P. J. F.; Hayes, W.; Mackay, M. E.; Rowan, S. J. Chem. Comm. 2009, 6717.
[10]. Haino, T.; Watanabe, A.; Hirao, T.; Ikeda, T. Angew. Chem., Int. Ed. 2012, 51, 1473.
[11]. (a) Das, A.; Ghosh, S. Angew. Chem., Int. Ed. 2014, 53, 1092; (b) Das, A.; Ghosh, S.
Chem. Comm. 2014, 50, 11657.
[12]. Tian, Y. K.; Shi, Y. G.; Yang, Z. S.; Wang, F. Angew. Chem., Int. Ed. 2014, 53, 6090.
[13]. Tayi, A. S.; Shveyd, A. K.; Sue, A. C. H.; Szarko, J. M.; Rolczynski, B. S.; Cao, D.;
Kennedy, T. J.; Sarjeant, A. A.; Stern, C. L.; Paxton, W. F.; Wu, W.; Dey, S. K.;
Fahrenbach, A. C.; Guest, J. R.; Mohseni, H.; Chen, L. X.; Wang, K. L.; Stoddart, J. F.;
Stupp, S. I. Nature 2012, 488, 485.
[14]. Sagade, A. A.; Rao, K. V.; Mogera, U.; George, S. J.; Datta, A.; Kulkarni, G. U. Adv.
Mater. 2013, 25, 559.
[15]. Mukhopadhyay, P.; Iwashita, Y.; Shirakawa, M.; Kawano, S.; Fujita, N.; Shinkai, S.
Angew. Chem., Int. Ed. 2006, 45, 1592.
[16]. Rasberry, R. D.; Smith, M. D.; Shimizu, K. D.; Org. Lett. 2008, 10, 2889.
[17]. Trivedi, D. R.; Fujiki, Y.; Goto, Y.; Fujita, N.; Shinkai, S.; Sada, K. Chem. Lett. 2008,
37, 550.
[18]. Mulliken, R. S.; Person, W. B.; Annu. Rev. Phys. Chem. 1962, 13, 107.
[19]. (a) Staab, H. A.; Herz, C. P.; Krieger, C.; Rentea, M. Chem. Ber. 1983, 116, 3813;
(b) Staab, H. A.; Knaus, G. H.; Henke, H. E.; Krieger, C. Chem. Ber. 1983, 116, 2785;
(c) Reimann, R.; Staab, H. A. Angew. Chem., Int. Ed. Engl. 1978, 17, 374; (d) Staab, H.
A.; Reimannhaas, R.; Ulrich, P.; Krieger, C. Chem. Ber. 1983, 116, 2808.; (e) Staab, H.
A.; Gabel, G.; Krieger, C. Chem. Ber. 1983, 116, 2827.
[20]. Schroff, L. G.; Zsom, R. L. J.; Vanderweerdt, A. J. A.; Schrier, P. I.; Geerts, J. P.;
Nibbering, N. M. M.; Verhoeven, J. W.; Deboer, T. J. Recl. Trav. Chim. Pays-Bas, 1976,
95, 89.
[21]. Rathore, R.; Lindeman, S. V.; Kochi, J. K. J. Am. Chem. Soc. 1997, 119, 9393.

175

[22]. Leight, K. R.; Esarey, B. E.; Murray, A. E.; Reczek, J. J.; Chem. Mater. 2012, 24,
3318.
[23]. (a) B. K. Kaletas, R. Dobrawa, A. Sautter, F. Wurthner, M. Zimine, L. De Cola, R.
M. Williams, J. Phys. Chem. A 2004, 108, 1900.; (b) N. Van Anh, F. Schlosser, M. M.
Groeneveld, I. H. M.; van Stokkum, F. Wurthner, R. M. Williams, J. Phys, Chem. C
2009, 113, 18358.
[24]. B. Wang, E. V. Anslyn, Chemosensors principles, strategies, and applications. In
Wiley Series in Drug Discovery and Development; John Wiley & Sons: Hoboken, N.J.,
2011
[25]. Y. S. Chong, W. R. Carroll, W. G. Burns, M. D. Smith, K. D. Shimizu, Chem.–Eur.
J. 2009, 15, 9117.
[26]. R. D. Rasberry, K. D. Shimizu, Org. Biomol. Chem. 2009, 7, 3899.
[27]. Q. Jiang, H. Y. Zhang, M. Han, Z. J. Ding, Y. Liu, Org. Lett. 2010, 12, 1728.
[28]. H. A. Staab, D. Q. Zhang, C. Krieger, Liebigs Ann-Recl. 1997, 1551.
[29]. M. R. Molla, S. Ghosh, Chem.–Eur. J. 2012, 18, 9860.
[30]. M. Y. Yeh, H. C. Lin, Phys. Chem. Chem. Phys. 2014, 16, 24216.

176

Supporting Information
1. Additional Figures and Tables

Figure 5.5 UV-vis spectra of molecular CT model 1 (red
trace) and control 2 (black trace) at 0.25 mM in chloroform
and the intermolecular 2•PYR complex (green trace) at 6.55
mM in chloroform.

Figure 5.6 Partial UV/vis spectra of 1 in chloroform from 0.1 to 0.5 mM highlighting the
charge-transfer absorption band (left), and the linear fitting of absorption (A) at λmax = 505
nm against the concentration of 1 (right).
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Figure 5.7 Partial UV/vis spectra of 2·PYR in chloroform from 4.2 to 20 mM highlighting
the charge-transfer absorption band (left), and the polynomial fitting of absorption (A) at
λmax = 511 nm against the concentration of [2] (right).

Figure 5.8 (a) Normalized solid-state diffuse reflectance UV-vis spectra for purple and red
solid of 1 (inlet) and white solid of control 2; (b) TGA traces of the purple (black) and
orange (red) powders of 1.
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Figure 5.9 (a) Solid-state diffuse reflectance UV-vis spectra of purple and orange solids
(colored solid traces) and dichloromethane-solvate and non-solvate crystals (colored
dashed traces) of 1, highlighting the similarity in color between the solid and crystal
samples. (b) Soaking 1 in a minimum amount of dichloromethane and acetone, highlighting
the sensitivity of color change.

Figure 5.10 Powder X-ray diffraction data for the orange and
purple solids of 1 together with the simulated powder patterns
from the crystal structures 1 and 1•(CH2Cl2)2.
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Figure 5.11 Scatter plot of the CT band λmax against the
rotational angle (θ) between PYR and NDI units of the
intramolecular CT complexes in the six crystal structures of 1,
highlighting the θ angle difference between the solvate (■) and
non-solvate structures (▲).

Figure 5.12 (a) Scatter plot of the CT band λmax against the PYR-NDI interplanar distance
(h) of the intramolecular CT complexes in the six crystal structures of 1, highlighting their
insignificant correlation due to the small difference in h (~0.05 Å) between the solvate and
non-solvate structures. (b) Double-Y plot of the linker-to-NDI dihedral angle (α) and PYRNDI interplanar distance (h) of the intramolecular CT complexes in the six crystal
structures, highlighting that variations in the PYR-NDI interplanar distance were tightly
related to the linker rotation. All observed conformations were included. Definitions of
geometric parameters α and h are illustrated in Figure 5.13
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2. Synthesis and Characterization
Bisphenol 5 was obtained as previous reported;i thermal condensation of 1,4,5,8naphthalenetetracarboxylic dianhydride (3) and 2-amino-4-tert-amylphenol (4).
esterification

of

1-pyreneacetic

acid

and

bisphenol

5

using

The

1-ethyl-3-(3-

dimethylaminopropyl)carbodiimide (EDCI) and N, N-dimethylaminopyridine (DMAP) in
acetonitrile at room temperature gave the crude product 1 that consisted of both anti and
syn conformers. The crude 1 was then thermally equilibrated at 80 ºC for 10 h in 1,1,2,2tetrachloroethane (TCE) and precipitated in CH2Cl2/acetonitrile giving the pure anti
conformer of 1 as purple color powder. Control 2 was obtained similarly from bisphenol
5 and acetic acid as a white powder. Thermal equilibration of 2 gave a mixture of
approximately 1:1 anti- and syn- conformers. Molecular models 1 and control 2 are newly
reported compounds, and their 1H and 13C spectra are provided.ii
(1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn][3,8]phenanthroline-2,7-diyl)bis(4-(tert-pentyl)-2,1-phenylene) bis(2-(pyren-1-yl)acetate). (1) Bisphenol 5 (100 mg, 0.17
mmol) was dissolved in 5 mL of dried acetonitrile. To the above solution, 1-pyreneacetic
acid (130 mg, 0.51 mmol), DMAP (10 mg, 0.09 mmol) and EDCI (80 mg, 0.51 mmol)
were added. The reaction mixture was stirred at room temperature for 12 h, and the solvent
was then removed under vacuum. The residue was dissolved in dichloromethane (40 mL),
washed with water (2×40 mL), sodium carbonate solution (2×40 mL), and brine (40 mL),
and dried with MgSO4. The solvent was removed in vacuum, and solid residue was

i

Chong, Y. S.; Carroll, W. R.; Burns, W. G.; Smith, M. D.; Shimizu, K. D. Chem.-Eur. J.
2009, 15, 9117.
ii
Available
free
of
charge
via
Internet
at
http://pubs.rsc.org/en/Content/ArticleLanding/2015/CC/c5cc06140g
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suspended in acetone. The orange insoluble was collected by filtration as crude 1 (130 mg,
71 %). Crude 1 was dissolved in TCE (5 mL) and heated at 80 °C under N2 for 10 h to
equilibrate. The solvent was removed under vacuum giving a purple solid residue, which
upon recrystallization in CH2Cl2/AcCN gave pure anti conformer of 1 as a purple solid. 1H
NMR (400 MHz, CDCl3) δ 8.04 (d, J = 9.2 Hz, 2H), 7.76 – 7.27 (m, 20H), 6.95 (s, 4H),
4.22 (s, 4H), 1.84 (q, J = 7.5 Hz, 4H), 1.50 (s, 12H), 0.93 (t, J = 7.4 Hz, 6H). 13C NMR
(100 MHz, TCE-d2) δ 167.95, 160.83, 148.37, 143.95, 129.74, 129.35, 129.16, 128.22,
128.06, 127.77, 127.38, 126.95, 126.79, 126.60, 125.87, 125.66, 125.54, 125.09, 124.75,
124.25, 123.30, 123.21, 123.14, 123.13, 122.73, 122.62, 77.43, 77.31, 77.11, 76.79, 39.80,
37.91, 36.94, 29.60, 28.43, 9.27. HRMS (ESI) m/z calcd for [C72H54N2O8]+ (M+):
1075.3958; found 1075.3925.
(1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn][3,8]phenanthroline-2,7-diyl)bis(4-(tert-pentyl)-2,1-phenylene) diacetate. (2) Control 2 was synthesized using the same
procedure described for 1 using bisphenol 5 (0.30 g, 0.51 mmol), acetic acid (87 µL, 1.52
mmol), DMAP (30 mg, 0.25 mmol) and EDCI (0.24 g, 1.52 mmol). Crude 2 was obtained
as a white powder (0.25 g, 73%). Thermal equilibration in TCE at 80 ºC under N2 for 10
h gave a mixture of anti and syn conformers (1.2:1). 1H NMR (400 MHz, CDCl3) δ 8.87
(s, 4H syn and anti), 7.51 (dd, J = 8.7 Hz, J = 2.3 Hz, 2H syn and anti), 7.38 (d, J = 8.7 Hz,
2H anti), 7.37 (d, J = 8.7 Hz, 2H syn), 7.32 (d, J = 2.3 Hz, 2H anti), 7.29 (d, J = 2.3 Hz,
2H syn), 2.06 (s, 4H syn), 2.04 (s, 4H anti), 1.68 (q, J = 7.1 Hz, 4H syn), 1.67 (q, J = 7.1
Hz, 4H anti), 1.33 (s, 12H syn), 1.33 (s, 12H anti), 0.78 (t, J = 7.4 Hz, 6H syn and anti).
C NMR (100 MHz, TCE-d2) δ 167.99, 167.94, 161.96, 148.11, 143.88, 131.44, 127.66,

13

127.34, 127.16, 127.08, 126.61, 126.58, 125.27, 125.17, 122.65, 37.72, 36.78, 28.14,
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20.96, 20.81, 9.11. HRMS (ESI) m/z calcd for [C40H38N2O8]+ (M+): 674.2628; found:
674.2618.

3. Solvate and Non-Solvate Single Crystals of 1.
Five solvate and one non-solvate forms of single crystals of 1 were obtained
through slow evaporation from organic solvents. Their resolved crystal structures were
summarized as below. i
One solvate single crystal was obtained from CH2Cl2 solution, and was found to
have an empirical formula of C74H54N2O8•2CH2Cl2. Solvate 1•2CH2Cl2 was an intense red
plate crystal, in which C74H54N2O8 molecule (1) crystallized in the monoclinic space group
P21/n.

The asymmetric unit consist of half of C74H54N2O8 molecule and one

dichloromethane molecule. The pyrene unit was found to disorder over two closely spaced,
co-planar orientations via a ca. 12.5° 'pivot' around the ipso carbon. The population was
refined to two conformations of 0.76/0.24 ratio. Disorder was also found for the inclusion
dichloromethane over two positions. Repeating crystallization in CH2Cl2 gave the same
crystal.
One solvate single crystal was obtained from the CH2Cl2/AcCN system, and was
found to have an empirical formula of C74H54N2O8•1.36(CH3CN)0.64(CH2Cl2). Solvate
1•2(CH3CN/CH2Cl2) was a dark red blocklike crystal in which C74H54N2O8 (1) crystallized
in the monoclinic space group P21/n. The asymmetric unit consists of half of C74H54N2O8
molecule, which is located on an inversion center, and a volume of disordered solvent,
which are CH3CN and CH2Cl2. The solvent disorder was modeled with three independent

i

Detail X-ray crystallographic data and cif files are available free of charge via Internet at
http://pubs.rsc.org/en/Content/ArticleLanding/2015/CC/c5cc06140g
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groups: one acetonitrile and two dichloromethane groups. A slight positional disorder exist
at the far end of pyrene units as suggested by the elongated displacement ellipsoids. A
reasonable refinement, however, was achieved giving an average position for the pyrene
unit. Disorder was also found at the tert-amyl group.
One non-solvate form of small crystal i was obtained from the CHCl3/CH3CN
system, and was found to have an empirical formula of C74H54N2O8. Non-solvate 1 was a
thin yellow-orange plate in which C74H54N2O8 (1) crystallized in the triclinic space group
P-1. The asymmetric unit consists of half of C74H54N2O8 molecule, which is located on an
inversion center. The disorder primarily takes the form of differently orientated but
essentially co-planar pyrene motifs. The population fraction of each orientation was
refined to be 0.72/0.28. The tert-amyl groups were also found to be disordered. No
inclusion solvent molecules were found. Repeating crystallization in the CHCl 3/CH3CN
system failed in obtaining good quality single crystals. Recrystallization in acetone,
however, gave quality single crystals of the same non-sovlate 1 but with greater
dimensions.
One solvate form of crystal was obtained from the CH3NO2, and was found to have
an empirical formula of C74H54N2O8•2(CH3NO2). Solvate 1•2(CH3NO2) was a red plate
crystal in which C74H54N2O8 (1) crystallized in the triclinic space group P-1.

The

asymmetric unit consists of half of C74H54N2O8 molecule, which is located on an inversion
center, and one CH3NO2. No disorder was found. Repeating crystallization in CH3NO2
gave the same crystal.

i

The data for structure resolution was instead collected using synchrotron at the X-ray crystallography
facility at the Department of Chemistry, University of Cincinnati, Cincinnati, OH.
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One solvate form of crystal was obtained from the nitroethane, and was found to
have an empirical formula of C74H54N2O8•2(CH3CH2NO2). Solvate 1•2(CH3CH2NO2) was
a dark red tablet crystal in which C74H54N2O8 (1) crystallized in the triclinic space group
P-1. The asymmetric unit consists of half each of two crystallographically independent
C74H54N2O8 molecules, each of which is located on an inversion center, and two
independent nitroethane molecules. The tert-amyl groups of each C74H54N2O8 molecule
were found to be rotationally disordered. Repeating crystallization in the EtNO2 system
gave the same crystal.
One solvate form of crystal was obtained from the dioxane, and was found to have
an empirical formula of C74H54N2O8•2(C4H8O2). Solvate 1•2(C4H8O2) was a thin red plate
crystal in which C74H54N2O8 (1) crystallized in the monoclinic space group P21/c. The
asymmetric unit consists of half of C74H54N2O8 molecule, which is located on an inversion
centers, and one dioxane molecule. No disorder was found. Repeating crystallization in
the dioxane system gave the same crystal.
One non-solvate crystal of 2 was obtain from chloroform, and was found to have
an empirical formula of C40H38N2O8. Non-solvate 2 was a colourless tablet in which
C40H38N2O8 (2) crystallized in the monoclinic space group P21/c. The asymmetric unit
consists of half of C40H38N2O8 molecule, which is located on a crystallographic inversion
center. No disorder was found. Repeating crystallization in chloroform gave the same
crystal.
To effectively characterize and analyze these crystal structures and intramolecular
PYR-NDI CT complex therein, several parameters were defined and measured (Figure
5.13). To characterize the length of the five-atom covalent linker, the distance (l) between
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carbonyl α-C and Caryl-Nimide bond was measured. To characterize the conformational
flexibility of the covalent linker, the dihedral angle (α) between phenyl ring and
naphthalenediimide residing planes was measured.

To characterize the rotational

displacement between PYR and NDI units in the intramolecular CT complex, the rotational
angle (θ) between their long axes was measured. To characterize the intramolecular
aromatic stacking interaction between PYR and NDI units, the stacking angle (β) as defined
by the dihedral angle of the PYR and NDI residing planes, the interplanar distance (h) as
defined by the PYR centroid to NDI residing plane distance, and the horizontal
displacement (d) as defined by the distance between the PYR centroid project and NDI
centroid were measured. The measured values are provided in Table 5.1.

Figure 5.13 Geometric parameters defined to characterize the intramolecular PYR-NDI
CT complex in 1: (a) Chemdraw representation of 1 in side view; (b) the C-to-CN bond
distance (l) for characterizing linker length; (c) the dihedral angle (α) between the N-Ph
and NDI residing planes for characterizing the conformational flexibility of linker motif;
(d) the twist angle (θ) defined by the long axes of PYR and NDI units; (e) the interplanar
distance (h) between the PYR and NDI residing planes, the horizontal off-set (d) between
the centroids of PYR and NDI units, and PYR-NDI stacking angle (β) for characterizing
the intramolecular aromatic stacking interaction
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Table 5.1. Measured geometric parameters in crystal structures of 1 and 2
solventto-1
ratios

relative
populationa

CH2Cl2

2:1

76% b
24% b

56.5
63.6

78.4
78.4

3.49
3.54

4.48
4.48

0.17
0.57

6.3
7.1

CH2Cl2
&
CH3CNd

2:1

100%

57.4

76.9

3.55

4.48

0.25

6.4

inclusion
solvent

rotation
angle
(θ)

dihedral interplanar
angle
distance
(α)
(h)

linker
length
(l)

stacking
horizontal
angle
offset (d)
(β)

λmax
(nm)

CT profilee
λhalfλonheight

set

(nm)

(nm)

533

613

638

531

620

646

28% b
33.1
75.4
3.68
4.41
0.58
5.1
494
553
578
b
72%
42.2
75.4
3.60
4.36
0.35
5.7
CH3NO2
2:1
100%
53.2
83.5
3.48
4.43
0.19
5.6
544
629
658
c
50%
65.7
74.6
3.51
4.49
0.80
7.4
EtNO2
2:1
535
612
643
c
50%
63.9
72.2
3.54
4.51
0.55
7.4
dioxane
2:1
100%
51.9
73.8
3.55
4.50
0.38
4.7
547
591
612
none
0
100%
n/a
89.5
n/a
4.64
n/a
n/a
n/a
n/a
n/a
2
a
Relative population of multiple PYR-NDI geometries from partial disorder or multiple crystallographically independent molecules.
(See later structure analysis section for details); b Partial disorder at the pyrene motif was resolved into two slightly differently CT
interaction geometries; c Two crystallographically independent molecules of 1 were observed; d A volume of disordered solvent was
modeled into three independent groups: one acetonitrile and two dichloromethane groups. e The UV-vis spectra were provided in Figure
S10.
1

none

0

187

Figure 5.14 Solid-state diffuse reflectance UV-vis spectra of six-single crystals of 1
highlighting the λmax, λhalf-height, and λon-set of the CT absorption band.
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CHAPTER 6
FUTURE WORK
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1. Introduction
We have demonstrated that the C-shape N-arylimide molecular balances are indeed
excellent tools to investigate weak aromatic interactions in solution and solid-state
environments. However, this system still has the potential to be used in many other
physical organic studies. Some ideas for future work have already been mentioned in
Section 7 in Chapter 1. In this chapter, we briefly discussed two other on-going projects
in our laboratory with the aim of highlighting the ability of these molecular balances to
further contribute to the study of aromatic interactions. The primary focus will be on the
necessary molecular designs for these applications.

2. Water-soluble molecular balance
Aqueous solvent systems have been a “holy grail” in the experimental studies of
non-covalent interactions due to their biological relevance.1-4 Moreover, the unique polar
and cohesive nature of aqueous environment may exert dramatic impacts on various
dispersion-driven aromatic interactions.5-7 One interesting research topic in this regard
thus has been to isolate the solvophobic contributions to the interaction energy for various
aromatic interactions in water.3,7,8 Unfortunately, our current molecular balances do not
dissolve in protic solvents due to their predominant hydrophobic. Therefore, modifications
of this versatile model system that would lead to solubility in aqueous solvent systems are
particularly desirable (Figure 6.1).
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Figure 6.1 Schematic representation of two retro-synthetic
strategies to prepare water-soluble molecular balances
together with their corresponding starting materials. The
solubilizing groups or their precursors are highlighted in
yellow.
Figure 6.1 highlights two general strategies to water-soluble π-stacking molecular
balances. The common underlying idea is to incorporate solubilizing groups (highlighted
in yellow) to counterbalance the predominant hydrophobic domain.

To effectively

solubilize the molecular balance in solvents with high water content, however, the watersolubilizing groups should contain multiple strong ionic hydrophilic sites, such as
ammonium, carboxylate, phosphonate and sulfonate. For example, strategy A that installs
two tri-glycol methyl ether groups at the bridgehead of the bicyclic framework yielded a
balance that dissolved in methanol but not in water. In this regard, the strategy B is more
promising since the carboxylic group could either turned into an ionic group as the salt
form or serve as a “handle” to attach additional solubilizing groups. Moreover, the
carboxylic group can be masked into a less hydrophilic precursor, such as a methyl ester,
during the synthesis and then unmasked in the last step, greatly relieving the complication
of handling polar hydrophilic intermediates during the synthesis and purification.
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3. Orthogonal multipolar interaction of N-heteroarenes
Since the pioneering study on weak attractive C-F∙∙∙C=O interactions by Diederich
and co-workers,9 more attention has been focused on the dipolar interactions between polar
function groups in orthogonal alignments.10,11 The nature of multipolar interactions has
been still under debate. For example, the observed orthogonal C-F∙∙∙C=O interactions have
been argued to come from an “n→π*” bond instead of a dipole-dipole interaction.12 The
dipolar interactions of N-heteroarenes, however, have been rarely studied despite of their
abundance in biological processes and pharmaceuticals.

Therefore, one interesting

question is “do C-F and N-heteroarene form the unique multipolar interaction?” Fluorine
has been profoundly utilized in medicinal research to modulate the activity, selectivity, and
stability of biologically active compounds.13 The unique ring dipole of N-heteroarenes
may help better probe the nature of orthogonal multipolar interaction of C-F bonds.
The ability of our C-shape N-arylimide molecular balances to enforce the designed
intramolecular interaction geometry offers a means to experimentally investigate the
orthogonal interactions between a C-F bond and pyridine ring (Figure 6.2 A). Preliminary
results suggest the existence of these favorable interaction. The orthogonal C-F∙∙∙pyridine
interaction (the dipole-dipole angle: 92°) observed in our molecular balance was clearly
much more stabilizing in comparison with the C-F∙∙∙benzene interaction (Figure 6.2 B).
Study of heterocyclic balance with the pyridine ring fixed in the opposite direction could
help to test the “n→π*” hypothesis for the orthogonal interactions of C-F bonds. This
approach is currently being carried out in our laboratory.
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Figure 6.2 (A) Front view of the X-ray crystal structure of a two-arm fluorineheteroarene balance (top) together with the ChemDraw representation (bottom),
highlighting the orthogonal alignment between the C-F bond dipole and opposing
pyridine ring dipole; (B) Measured folding energies for a series of F-arm balances
with zero, one, and two heterocyclic nitrogens on the tricyclic shelf arene,
highlighting the stabilizing orthogonal C-F∙∙∙pyridine interaction.

4. Concluding Remark
We briefly looked at two on-going projects utilizing the C-shape N-arylimide
balances. Future work will surely expand beyond those mentioned in this dissertation. We
hope this short chapter served to highlight the greater potential and bright future of this
versatile balance model in exploring and assessing aromatic interactions.
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